Structural studies of Burkholderia pseudomallei invasion protein D (BipD), 2,4'-dihydroxyacetophenone dioxygenase (DAD) and L-threonine dehydrogenase (TDH) by Bowyer, Alexandra
University of Southampton Research Repository
ePrints Soton
Copyright © and Moral Rights for this thesis are retained by the author and/or other 
copyright owners. A copy can be downloaded for personal non-commercial 
research or study, without prior permission or charge. This thesis cannot be 
reproduced or quoted extensively from without first obtaining permission in writing 
from the copyright holder/s. The content must not be changed in any way or sold 
commercially in any format or medium without the formal permission of the 
copyright holders.
  
 When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given e.g.
AUTHOR (year of submission) "Full thesis title", University of Southampton, name 
of the University School or Department, PhD Thesis, pagination
http://eprints.soton.ac.uk 
 
 
UNIVERSITY OF SOUTHAMPTON 
 
FACULTY OF MEDICINE, HEALTH AND LIFE SCIENCES 
 
School of Biological Sciences 
 
 
 
 
Structural Studies of 
Burkholderia pseudomallei invasion protein D 
(BipD), 2,4’ dihydroxyacetophenone 
dioxygenase (DAD) and L threonine 
dehydrogenase (TDH) 
 
 
 
 
 
 
 
by 
 
 
Alexandra Bowyer 
 
Thesis submitted for the degree of Doctor of Philosophy 
 
 
November 2008 
 i 
 
UNIVERSITY OF SOUTHAMPTON 
 
Abstract 
 
FACULTY OF MEDICINE, HEALTH AND LIFE SCIENCES 
SCHOOL OF BIOLOGICAL SCIENCES 
 
Doctor of Philosophy 
 
STRUCTURAL STUDIES OF BURKHOLDERIA PSEUDOMALLEI INVASION PROTEIN D 
(BIPD), 2,4’ DIHYDROXYACETOPHENONE DIOXYGENASE (DAD) AND L THREONINE 
DEHYDROGENASE (TDH) 
 
by Alexandra Bowyer 
 
The determination of novel protein structures is essential in advancing our understanding of how 
they function within their molecular environments, therefore providing some of the information 
necessary to exploit them in ways that will benefit society.  Three very different novel proteins have 
been studied by X ray crystallography, and it is hoped that the information gained can be applied to 
real life challenges. 
 
Burkholderia pseudomallei invasion protein D (BipD) not only has the potential for misuse as a 
bioterrorist weapon, due to its air borne infectivity, but also causes the disease melioidosis, which 
can kill within 48 hours.  The structure of this novel protein was determined by MAD phasing 
methods to 2.1 Å, and has been found to be highly homologous with IpaD from Shigella flexneri.  
This knowledge has enabled proposals to be made for a homopentameric ring structure of this 
protein and identified possible pH induced conformational changes which may have relevance in 
vivo. 
 
2,4’ Dihydroxyacetophenone Dioxygenase (DAD) from Alcaligenes sp. is of interest for quite a 
different reason.  Aromatic hydrocarbons, are especially damaging to the environment because they 
are not naturally degraded.  The expression and purification protocols for DAD have now been 
refined and the native protein has been crystallised and diffraction data collected.  However, 
because it is a novel structure, a selenomethionine derivative must also be crystallised and data 
collected; these optimisation trials are continuing.  Structural knowledge about the enzymes 
involved in aromatic catabolic pathways will result in a better understanding of the whole system 
and therefore present opportunities for manipulation for bioremediation purposes. 
 
Knowledge of a protein’s structure can also help identify how specific properties are conferred, 
such as thermostability at extreme temperatures.  L Threonine Dehydrogenase from the 
hyperthermophilic archaeon Thermococcus kodakaraensis (TkTDH) is involved in the first of a 
two step biochemical pathway conversion of threonine to glycine, by catalysing the NAD
+ 
dependent metabolism of L threonine to 2 amino 3 ketobutyrate (KBL).  The structure of this 
enzyme has been determined to 2.4 Å bound to its co factor NAD
+.  It has been proposed that a 
structural and catalytic zinc are present in each monomer of this homotetramer as observed in the 
structurally similar alcohol dehydrogenases, but both were absent in this structure.  The conserved 
residues postulated to co ordinate these zinc ions were however in conformation that would allow 
metal ion coordination.  Attempts have also been made to model the TDH tetramer with 2 dimers of 
KBL, as it is though that these enzymes form a complex and pass the intermediate substrate 
between them.  This modelling is continuing. 
 
The structures of BipD and TkTDH  have been solved and work is continuing on DAD  This has 
made available a large amount of structural and functional information that would otherwise be 
inaccessible, contributing to our overall understanding of these macromolecules, as well as 
providing specific information that can be applied to particular challenges.  
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1.1  Burkholderia pseudomallei Invasion Protein D 
 
1.1.1  Melioidosis 
First identified in opium addicts in Rangoon, Burma in 1911, the British pathologist Captain Alfred 
Whitmore (1876 – 1946), together with C.S. Krishnaswami, discovered the infectious disease 
melioidosis, and initially called it Whitmore’s Disease.  It was found to be caused by the bacterium 
Burkholderia pseudomallei, a gram negative saprotroph.  This disease is particularly prevalent 
during the rainy season in endemic regions, mainly Southeast Asia and Northern Australia, with the 
highest documented rate being in North Eastern Thailand.  Here melioidosis accounts for around 
20% of all community acquired septicaemias (Holden et al. 2004;Blocker et al. 2000;Mecsas and 
Strauss 1996). 
 
The bacterium is able to enter the human body through open wounds or abrasions to the skin, or by 
inhalation, and mainly affects the immunocompromised and those with an underlying predisposition 
to infection.  People who come into direct contact with wet soils, such as rice farmers, are often 
infected (White 2003).  For example, in Thailand this bacterium can readily be recovered in 
abundance from more than 50% of rice paddies (Wuthiekanun et al. 1995;Wuthiekanun et al. 
1995). 
 
Melioidosis is pathologically similar to Glanders disease, a bacterial infection that predominately 
affects horses and other equines, caused by the closely related organism Burkholderia mallei, also 
identified over a century ago (White 2003).  Glanders is now very rare in Europe and North 
America and is largely restricted to parts of Africa, Asia, the Middle East and Central and South 
America.  It was previously thought the two organisms were closely related but multilocus sequence 
typing has shown that B. mallei can in fact be considered a descendant of B. pseudomallei (Godoy 
et al. 2003). 
 
B. pseudomallei is known to infect almost all cell types and it is this broad cellular tropism that 
contributes to its versatility as a pathogen and translates into a wide spectrum of clinical 
manifestations, making it difficult to accurately diagnose (Gan 2005).  Symptoms of melioidosis 
can be categorised as either acute or localised infection, acute bloodstream infection, acute 
pulmonary infection or chronic suppurative infection:  
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Acute, localised infection: generally localised as a nodule as a result of inoculation through a break 
in the skin.  This can cause fever and general muscle aches and may progress rapidly to infect the 
bloodstream. 
 
Acute bloodstream infection: this affects people with other conditions, particularly HIV, renal 
failure and diabetes, usually resulting in septic shock.  Symptoms vary depending on the original 
site of infection but generally include respiratory stress, severe headache, fever, diarrhoea, 
development of pus filled lesions on the skin, muscle tenderness, and disorientation.  This is 
typically an infection of short duration, and abscesses will be found throughout the body. 
 
Pulmonary infection: this can take the form of mild bronchitis to severe pneumonia and is 
typically accompanied with high fever, headaches, anorexia and general muscle soreness.  Chest 
pain is common but a non productive or productive cough with normal sputum is the hallmark of 
this type of melioidosis. 
 
Chronic suppurative infection: this typically affects the joints, viscera, lymph nodes, skin, brain, 
liver, lung, bones, and spleen (US Department of Health and Human Services, 2006). 
 
The recorded incidences of clinical melioidosis each year in endemic regions such as Thailand is 
estimated to be around 4.4 cases per 100,000 (Suputtamongokol et al. 1994).  However, because the 
clinical manifestations of melioidosis are so varied, the symptoms are often mistaken for other 
diseases and so consequently it is not accurately recorded.  Even with the recent improvements in 
diagnostic techniques and a greater awareness of the disease, it is thought current figures may still 
be grossly underestimated. 
 
The fact that melioidosis is able to kill within 48 hours, coupled with the risk of the use of B. 
pseudomallei as a biochemical weapon, has meant that it is becoming more and more important to 
improve our understanding of the way in which this bacterium is able to infect and persist within 
host cells.  A Canadian group has been exploring potential vaccination strategies but despite recent 
work demonstrating some protection in animal models following vaccination with B. thailandensis 
and other attenuated strains, it is unlikely that this strategy alone will provide sufficient protection 
(Druar et al. 2007).  Indeed it was found that neither BipB, BipC nor BipD are protective antigens, 
because vaccination of mice with any single protein did not result in protection against experimental 
melioidosis (Druar et al. 2007).  Even if a vaccine were to be developed, it is expected that 
economic constraints may make vaccination an unrealistic option for many regions of endemicity  
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(Cheng 2005).  It is therefore important to further understand the method of infection in order to not 
only identify better vaccine targets, but also potential targets for new drugs.  This will make it 
possible to design drugs specifically against B. pseudomallei, possibly by blocking the TTSS as its 
method of infection. 
 
 
1.1.2  Burkholderia pseudomallei 
B. pseudomallei is a motile, aerobic, non spore 
forming, gram negative bacillus, shown in Figure 
1.1.  This resilient saprotrophic bacterium feeds by 
absorbing dead or decaying organic matter and is 
able to survive either in the soil or within human 
cells for many years, only re emerging when 
conditions once again become favourable for its 
growth and replication (White 2003).  Its ability to 
produce specialised secondary metabolites and its 
adaptation of complex catabolic pathways and 
transport systems contribute to this organism's 
capacity for survival in diverse, competitive 
environments. 
 
 
B. pseudomallei obtains its nutrition primarily from decomposing non living organic matter and, 
when possible, by parasitizing soil dwelling amoebae and absorbing the resultant soluble organic 
compounds.  It is able to enter and survive within these free living amoebae of the genus 
Acanthamoeba (Inglis et al. 2000) and it is thought that its ability to infect human cells may be an 
unfortunate consequence of the mechanisms that allow it to parasitize amoebae, although these are 
poorly understood (Aldhous 2005). 
 
The bacterium is able to survive for many years in environments with a low nutrient concentration, 
illustrated by the fact that it has been successfully cultured from a sample stored in distilled water 
for 10 years (Aldhous 2005).  It is also tolerant of adverse environmental conditions, such as low 
pH (Stevens and Galyov 2004).  There have been case reports describing recrudescent melioidosis 
Figure 1.1: Burkholderia pseudomallei 
This bacterium is an aerobic, gram negative bacillus, 2 5µm 
in size that is able to survive in the soil or within human cells 
(Wellcome Trust Sanger Institute press release).  
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after an initial exposure 26 and 18 years previously (Mays and Ricketts 1975;Koponen et al. 1991), 
illustrating just how resilient this bacterium can be. 
 
Another factor of B. pseudomallei’s ability to survive in adverse conditions is its reduced 
susceptibility to antibiotics.  Having evolved to compete with other organisms in the soil that 
secrete antibacterial compounds, the bacterium is resistant to many drugs (Aldhous 2005).  This 
may explain in part why relapse of melioidosis patients is common, even when treated with 
appropriate antibiotics (Stevens and Galyov 2004).  However, in general it is susceptible to 
chloramphenicol, carbapenems, tetracyclines, trimethoprim sulfamethoxazole, ureidopenicillins, 
third generation cephalosporins, and (unusually for a pseudomonad) amoxicillin clavulanate.  It has 
also been shown that the highly conserved immunodominant antigen of lipopolysaccharide (LPS), 
which forms part of the bacterial cell wall, is recognised by LPS2 antibodies that, in high 
concentrations, are associated with improved survival in cases of severe melioidosis. 
 
In addition to this intrinsic resistance to many antibiotics, B. pseudomallei is able to produce a 
highly hydrated glycocalyx polysaccharide capsule that assists the formation of a slime capsule.  
This allows the development of microcolonies in which the bacteria is both protected from 
antibiotic penetration and phenotypically altered, as a result of which its susceptibility to antibiotics 
is reduced (White 2003). 
 
Another feature of B. pseudomallei that makes it particularly virulent is its ability to escape 
endocytic vesicles and spread from cell to cell through the formation of membrane protrusions as 
shown in Figure 1.2 (Holden et al. 2004).  These are caused by the initiation of actin 
oligomerisation at one pole of the infected cell (Stevens and Galyov 2004).  In pathological 
specimens this can also be seen within phagocytic cells, where the bacterium is able to survive and 
proliferate for prolonged periods before lysing the endosome membrane and escaping (White 2003).  
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B. pseudomallei’s ability to survive intracellularly is likely to be necessary for its pathogenesis and 
the recrudescence of melioidosis in patients.  When B. pseudomallei moves to the periphery of the 
host cell, it initiates the continuous polymerisation of actin within its own cytoplasm.  These actin 
formations create a protrusion of the host’s plasma membrane with the bacterium at the tip end 
pushing against it (Breitbach et al. 2003).  B. pseudomallei is able to project these membrane 
protrusions into adjacent cells, enabling cell to cell spread and inducing the fusion of adjacent cells, 
resulting in the formation of giant multinucleated cells in infected monolayers (Suparak et al. 2005). 
 
For many years B. pseudomallei attracted very little attention.  However, recent fears that the 
organism may one day be used as a bioterrorist agent, due to its worldwide availability, severe 
course of infection and in particular its aerosol infectivity (Stevens et al. 2002), have resulted in a 
surge of interest in the bacterium.  It now appears on the category B list of critical agents, published 
by the US Centers for Disease Control and Prevention (White 2003). 
 
This interest in the bacterium has resulted in the completion of the genome sequence for B. 
pseudomallei, shown schematically in Figure 1.3, published by the Wellcome Trust Sanger Institute 
(Holden et al. 2004).  It was reported that, unlike most bacteria, the genome comprises two 
chromosomes of 4.07 megabase pairs and 3.17 megabase pairs, showing significant functional 
partitioning of genes between them. 
Figure 1.2: B. pseudomallei cells escaping from infected cells 
The bacterium achieves this using actin "rockets".  B. pseudomallei is 
stained red.  It is thought BipD somehow plays a role in this process 
of rearranging the actin cytoskeleton.  The actin is coloured red. 
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The large chromosome encodes many of the core functions associated with central metabolism and 
cell growth, whereas the small chromosome carries more accessory functions associated with 
adaptation and survival in different environments.  At 7.24 Mb the B. pseudomallei genome is large 
in comparison to a typical prokaryotic genome, perhaps accounting for the bacterium’s versatility 
and adaptability (Holden et al. 2004). 
 
 
1.1.3  Bacterial Pathogenicity 
Bacteria are able to invade many different tissues within the human body, which consequently 
results in patients displaying a wide variety of symptoms.  Initially it seemed reasonable to theorise 
that each individual disease might be generated by a different molecular mechanism (Mecsas and 
Strauss 1996).  However, as researchers have made greater use of the molecular and genomic 
information now available to them, it has become apparent that the spectrum of methods is far 
narrower than first thought and that bacteria actually only utilise a relatively small number of 
common molecular tools to achieve a wide range of results (Finlay and Falkow 1989). 
 
Figure 1.3: Schematic diagram of the B. pseudomallei genome 
The complete genome of strain K96243 consists of two circular replicons, one large and one small, which encode 
essential and accessory functions respectively (Holden et al. 2004) (European Molecular Biology Laboratory accession 
nos. BX571965 and BX 571966).  
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Obviously one of the most important components of bacterial virulence is the ability to invade host 
cells and then subvert the cell’s machinery to its advantage.  Amongst the tools used to achieve this 
are the protein secretion systems; type I, type II, type III, type IV and type V, with type III being the 
most recently identified through studies of the Yersinia bacteria. 
 
When bacterial genomes were searched it was observed that virulence genes, such as those 
encoding these secretion systems, were often found clustered in functionally related groups.  
Furthermore, it appeared in many instances that these genes had been acquired from another 
organism, because features of this specific DNA differed from the bulk of the bacterial genome.  
These observations led to the concept of pathogenicity islands; discrete segments of DNA that 
encode virulence traits and often appear to be foreign in origin (Mecsas and Strauss 1996). 
 
Many of these pathogenicity islands appear to have been acquired in one step.  This ability to obtain 
complex virulence traits in one genetic event, as opposed to undergoing natural selection for many 
generations, provides a method for sudden radical changes in bacterial host interactions.  This 
flexibility is a big advantage for the bacteria’s survival and rapid adaptation to new and altered 
environments. 
 
 
1.1.4  Protein Secretion Systems 
It has long been known that secreted or surface exposed bacterial proteins (effectors) play key roles 
in an organism’s ability to interact with host cells.  Bacteria can utilise one or a combination of 
general secretory pathways and five specialized (Type I V) secretion systems to transport proteins 
(Henderson et al. 2004).  The function of the protein secretion systems is to actually transport these 
‘effector’ proteins, amongst others, to the surface of the bacterium.  In order to do this it must span 
the bacterial inner membrane surrounding the cytoplasm, and the outer envelope that encloses the 
periplasm and acts as a barrier to the environment (Mecsas and Strauss 1996). 
 
The components of the secretion systems are synthesised in the cytoplasm and secreted across the 
membranes by a nano machine (Mota et al. 2005), which can be visualised as an ATP driven 
molecular syringe that serves to inject bacterial proteins into target cells.  The systems operate in 
different ways and the translocation apparatus varies in complexity and design as illustrated in 
Figure 1.4.   The protein secretion systems themselves are well conserved amongst bacteria,  
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whereas the specific properties of the effectors and hence the resulting symptomatic effects on the 
host organism vary widely 
 
The type I system secretes proteins across both the inner membrane and cell envelope in one 
operation, transporting them directly from the cytoplasm to the bacterial cell surface.  In contrast, 
the type II system utilises the cell’s general secretory pathway to transport the proteins from the 
cytoplasm to the periplasm, and from there uses a dedicated protein channel to transport them to the 
outer surface of the cell envelope.  Type I is a one step process whereas type II is a two step 
process. 
 
The type III protein secretion system (TTSS) is present in many gram negative bacteria and, like 
type I, also functions in a single step manner to transport proteins directly from the cytoplasm to the 
cell surface where they can interact with the target cell membrane.  It is interesting to note that the 
genes encoding many components of the TTSS are homologous to those that encode flagella export 
machinery in both gram negative and gram–positive bacteria.  A schematic diagram of the type I, II 
and III secretion systems is shown in Figure 1.4. 
 
 
 
 
 
Type I and type III secrete proteins across both the inner membrane and cell envelope, whereas type II does this 
in two steps with the proteins stopping intermediately in the periplasm (Mecsas and Strauss 1996). 
Figure 1.4: Schematic diagram of type I, type II and type III secretion systems  
 
10 
 
The type IV and type V protein secretion systems also consist of a single structure crossing both the 
bacterial inner membrane and the cell envelope.  Of the secretion systems, type IV is considered the 
most versatile because it mediates conjugative DNA transfer, uptake and secretion of DNA, as well 
as the export of effector molecules (Schroder and Lanka 2005).  Proteins secreted by the type V 
secretion system are referred to as autotransporters because they are translocated across the outer 
membrane via a transmembrane pore formed by a ß barrel and they contain all the information 
required for translocation through the cell envelope.  Typically, autotransporters are expressed as 
precursor proteins with three basic functional domains, including an N terminal signal peptide, an 
internal passenger domain, and a C terminal translocator domain (the beta domain) (Henderson et 
al. 2004). 
 
A strong indication that the TTSS is involved in the virulence of B. pseudomallei, through the 
translocation of effector proteins, comes from the fact that it is present in this bacterium but absent 
from the closely related avirulent B. thailandensis (Rainbow et al. 2002). 
 
 
1.1.5  The Type III Protein Secretion System 
Studies indicate that a central component of the TTSS nano machine is the needle complex or 
injectisome.  This organelle is comprised of three distinct parts; a cylindrical base, similar to the 
flagella basal body, consisting of two pairs of rings that span the inner membrane and cell envelope, 
joined together by a inner rod that is physically linked to a hollow, elongated, and stiff needle like 
structure as shown in Figure 1.5 (Marlovits et al. 2004). 
 
Upon contact of the bacterium with the target cell a signal is sent to the injectisome, which then 
secretes the translocator and effector proteins across the membranes to the area of contact between 
the two cells (Pettersson et al. 1996).  The translocators somehow form a pore in the lipid 
membrane of the target cell through which the effector proteins are able to pass (Blocker et al. 
2000).  It is thought chaperones are present in the cytoplasm of the bacterial cell to ensure the 
delivery of the translocator and effector proteins to the injectisome when required (Mecsas and 
Strauss 1996). 
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These effector proteins commonly mimic eukaryotic enzymes in 
their function or structure, and may directly interact with cellular 
proteins (Stevens et al. 2004).  It appears that often they are toxins 
and enzymes (kinases, phosphatases, G proteins etc.) that are able 
to interfere with the signal transduction pathways of the host and 
‘reprogramme’ it to facilitate bacterial infection.  This is achieved, 
for instance, by endocytosing the bacterium, evading phagocytic 
cells that would otherwise recognise and destroy the bacterium, 
suppressing the production of proinflammatory cytokines and 
chemokines, inhibiting an adaptive immune response, regulating 
the actin cytoskeleton, anti apoptosis and more (Viboud and Bliska 
2005). 
 
 
 
Figure 1.6: Needle of the TTSS 
Figure 1.5: Bacterial secretion system injectisome 
The needle, especially, displays great sequence and structural homology to the proteins of the flagella apparatus.  It is 
generally thought that the injectisome serves as a tube through which the secreted proteins travel (Mota et al. 2005).  The 
needle is formed through the polymerization of a major subunit as shown in Figure 1.6; BsaL in B. pseudomallei, MxiH in 
Shigella and Prg1 in Salmonella (Sekiya et al. 2001).  The length of the needle varies between 45nm   80nm depending on 
bacterial species and is approximately 70Å in diameter, traversed by a central channel 20–30 Å wide. 
 
The needle has a central pore through 
which effector proteins can be 
transported from the bacterial 
cytoplasm to the external surface of 
the bacterial outer membrane. 
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Obviously variations exist between the TTSS of different bacterial species and this is because it is 
thought that the pathogenicity islands encoding the TTSS gene sequence in one bacterium were 
acquired independently of another as no ‘common bacterial ancestor’ has been identified.  
Consequently the proteins involved in the TTSS of different species of bacteria differ greatly, both 
in number and structure, but the crucial proteins in each TTSS appear to share substantial homology 
(Mecsas and Strauss 1996). 
 
 
1.1.6  Type III Protein Secretion System in Burkholderia pseudomallei 
It has been found that B. pseudomallei contains at least 3 loci encoding putative TTSS (Rainbow et 
al. 2002), one of which shares homology with the inv/spa/prg TTSS of Salmonella typhimurium 
(Attree and Attree 2001) and the ipa/mxi/spa TTSS of Shigella flexneri (Stevens et al. 2002).  This 
gene cluster has been designated Bsa (Burkholderia secretion apparatus) in keeping with the 
proposed nomenclature (Hueck 1998).  The other two TTSS in B. pseudomallei are homologous to 
the hrp locus of the plant pathogen Ralstonia solanacearum.  It is of interest to determine if these 
two systems are involved in pathogenic and/or symbiotic interactions with plants and the 
rhizosphere, as such interactions could influence the persistence of B. pseudomallei in the soil and 
aquatic environments (Stevens et al. 2004). 
 
 
1.1.7  BipD Homologues 
Within the B. pseudomallei TTSS that is homologous to those of Shigella and Salmonella, the 
effector proteins are termed Bop proteins and the translocators termed Bip; Burkholderia invasion 
protein (Stevens et al. 2004;Diaz 2006), as shown in Figure 1.7. 
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These effector and translocator proteins appear to be homologous in structure and function, 
although they share relatively low sequence similarity and identity as illustrated in Table 1. 
 
 
identity
 similarity 
Burkholderia pseudomallei  Shigella flexneri  Salmonella typhimurium 
BipB  BipC  BipD  BopA  BopE  IpaB  IpaC  IpaD  IcsB  SipB  SipC  SipD  SopE 
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  BipB  100              48           50          
BipC     100              34           38       
BipD        100              36           39    
BopA           100              43             
BopE              100                       37 
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  IpaB  30              100           60          
IpaC     17              100           48       
IpaD        22              100           53    
IcsB           26              100             
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SipB  32              40           100          
SipC     21              30           100       
SipD        24              35           100    
SopE              23                       100 
 
 
 
 
 
Figure 1.7: The relative loci of type three section systems 
Cognate type III secretion loci in B. pseudomallei and S. typhimurium, showing the homologous 
translocator and effector proteins.  Only part of the B. pseudomallei bsa putative type III secretion 
locus is shown (adapted from Stevens et. al. 2003). 
The effectors and translocators from B. pseudomallei, S. typhimurium and S. flexneri are compared here.  
A NeedleP global alignment with an Eblosum62 matrix from the EMBL website http://srs.ebi.ac.uk was 
used for the analysis.  For sequence data see appendix. 
Table 1: Sequence identity and similarity of known homologues of TTSS  
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1.1.8  The Role of BipD within the TTSS of Burkholderia pseudomallei 
It appears that BipD performs several roles within the TTSS of B. pseudomallei.  It acts as a plug to 
prevent the leakage of effector proteins from the needle, therefore mediating their secretion on to 
the surface of a host cell (Menard et al. 1994).  The location of BipD at the tip of the needle implies 
it may also play a role in sensing contact with potential target cells and sending a message to the 
bacterium (Espina et al. 2006).  BipD may also assist the other translocator proteins form a pore in 
the plasma membrane of a host cell (Blocker et al. 2000) and has been putatively associated with 
affecting actin cytoskeleton rearrangement to allow B. pseudomallei escape from an endocytic 
vesicle once it has entered the cell (Stevens et al. 2002).  In Salmonella, SipB, SipC and SipD have 
been shown to be required for the injection of effector proteins and the invasion of epithelial cells in 
vitro (Kaniga et al. 1995), and it is thought that the B. pseudomallei homologues BipB, BipC and 
BipD perform a similar function. 
 
Although the Salmonella and Shigella TTSS have been studied in some detail, less is known about 
the Bsa TTSS of B. pseudomallei, therefore much of our current theories regarding the method by 
which this TTSS functions has come from studying these homologous TTSS.  It appears the TTSS 
secretes translocator and effector proteins upon contact with the host cell (Pettersson et al. 1996).  
The translocators then facilitate the delivery of the effector proteins across the plasma membrane 
where they somehow bring about membrane ruffling to allow the engulfment of the bacterium 
(Stevens et al. 2002). 
 
Experiments have shown that strains of B. pseudomallei containing a defined BipD deletion mutant 
exhibit impaired invasion of HeLa cells (Stevens et al. 2002;Stevens et al. 2004).  Once the bacteria 
have been engulfed by the cell, the endosome is lysed and polymerisation of actin is triggered, 
possibly by an interaction between the effector and translocator proteins, which then enables the 
bacterium to move fully into the host cell where it can subvert the normal cellular process for its 
growth and replication (Stevens et al., 2004). 
 
It is also believed that BipD is somehow involved in this actin tail formation that facilitates the 
escape of B. pseudomallei from endocytic vesicles.  The Ipa/Mxi/Spa TTSS of Shigella has been 
shown to be necessary for lysis of the endosome membrane, particularly the secreted proteins IpaB 
and IpaC (High and Dobberstein 1992;Fernandez Prada et al. 2000).  The fact that B. pseudomallei  
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contains a homologous TTSS implies that it may use a similar mechanism to escape from 
endosomes.  Consistent with this idea, it has been reported that B. pseudomallei mutants lacking 
putative components of the Bsa secretion and translocation apparatus (BsaZ and BipD, respectively) 
are confined to endosomes with intact membranes following infection of J774.2 murine 
macrophage like cells.  It was also noted that no actin induced membrane protrusions were 
observed, but the growth rate of the cells was not affected (Stevens et al. 2002).  Observations made 
during these experiments support the idea that a functional Bsa TTSS is required for full virulence 
of B. pseudomallei. 
 
 
1.1.9  BipD may Prevent the Leakage of Effector Proteins from the Needle 
It is not yet understood how the needle of a TTSS is able to detect the presence of a target cell and 
then send this signal to the base of the injectisome in the bacterial cytoplasm.  Several laboratories 
have shown that cell contact by most animal pathogens expressing a functional TTSS is a 
prerequisite for increased production and subsequent delivery of anti host effector proteins across 
host cell plasma membranes (Holden et al. 2004). 
 
IpaD (invasion plasmid antigen) a BipD homologue, has recently been shown to exist at the tip of 
the MxiH needle in Shigella flexneri (Espina et al. 2006).  A key role for IpaD has been identified at 
the tip of the needle, where it is proposed to be essential for mediating the correct insertion of the 
IpaB / IpaC translocon into host cell membranes (Picking et al. 2005). 
 
IpaD is perhaps the best studied homologue of BipD; a crystal structure has been solved and a 
model for an IpaD / IpaB hetero pentamer at the tip of the MxiH needle was recently proposed, 
based on crystal contacts in one of the crystal forms (Johnson et al. 2006).  This model, shown in 
Figure 1.8, involves the export of four copies of IpaD to the tip of the needle, where they pack into 
the needle via C terminal residues.  It is thought that a copy of IpaB then slots in via its central 
coiled coil, locking the pentamer and preventing further secretion or leakage of other effectors. 
Earlier experiments have shown that the ability of IpaD to control effector protein secretion can be 
separated from its ability to aid cellular invasion (Picking et al. 2005).  This implies that IpaD has 
more than one functional domain in order to achieve these functions and it is thought that BipD may 
also.  
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Although IpaD is homologous to BipD, structural differences have been observed between them, 
implying that caution should be used when comparing the two proteins too closely.  For example, it 
is known that IpaD possesses two independently folding domains (Espina et al. 2006;Johnson et al. 
2006) but there is no evidence that BipD has multiple folding domains.  Observations of the 
conformational stability and differential structural analysis have led some researchers to claim that 
IpaD and SipD possess properties that distinguish them from the other tip proteins of TTSS (Espina 
et al., 2006). 
 
 
1.1.10  How Does BipD Fulfill its Other Functions? 
Many questions still exist as to how BipD mediates the secretion of effector proteins from the 
needle, what role (if any) it plays in orchestrating the insertion of other translocator proteins into the 
Figure 1.8: A proposed pentameric structure for IpaD 
This was prepared using the non crystallographic symmetry from crystal form 2.  The model on the left shows a ribbon 
representation and to the right the bottom surface view (Johnson et al. 2006).  Here five molecules of IpaD form a pentamer, 
but it has been suggested that one monomer of IpaB may replace the IpaD monomer shown in green.  
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plasma membrane to form a pore through which the effector protein can pass, and when and how it 
affects the actin cytoskeleton.  Hopefully by elucidating the structure of BipD we will be able to 
glean more information about the exact role(s) of BipD within the TTSS and how it fulfils its 
various indicated functions. 
1.2  2,4’ Dihydroxyacetophenone Dioxygenase 
 
1.2.1  Aromatic Compounds 
Aromatic compounds are molecules whose molecular structure includes one or more benzene rings; 
that is, a planar ring of six carbon atoms connected by delocalised electrons (Evans and Fuchs 
1988).  Many aromatic compounds occur naturally in the environment such as lignin, the major 
constituent of woody tissue that comprises approximately 25% of the earth’s land based biomass.  
However, the majority of aromatic compounds are synthetically produced, especially the aromatic 
hydrocarbons (Diaz et al. 2001), making them alien to the biosphere and potentially hazardous to 
the environment. 
 
Aromatic compounds are commonly formed during 
the incomplete burning of coal, oil, gas and garbage as 
well as petroleum, solvents, pesticides and plastics.  
These compounds, although unsaturated, do not 
undergo normal reactions for linear unsaturated 
compounds.  This is related to the way in which their 
bonding electrons are spread evenly over the planar 
ring.  In addition to this, the thermodynamic stability of 
the benzene ring, shown in Figure 1.9, further increases 
its persistence within the biosphere and as such, aromatic hydrocarbon contamination of the 
environment has always been a big problem for industrialised countries in particular (Diaz 2006).  
Because of the wide range of useful substances derived from aromatic compounds, there is a huge 
global market for these chemicals that is increasing rapidly, therefore so too is the environmental 
burden they continue to pose. 
 
Naturally occurring aromatic hydrocarbons such as lignin can be catabolised by microorganisms 
(Diaz et al. 2001).  This general ability of bacteria to catabolise such compounds is a result of the 
   
 
Figure 1.9: A benzene ring consists of 6 carbons 
These are connected by delocalised electrons as though 
they were alternating single and double bonds.  The right 
hand diagram is a schematic representation of the 
delocalisation of electrons. 
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presence of aromatic chemicals in the environment from the recycling of plant derived material 
(Diaz 2006) and bacteria have evolved to utilise them as a carbon source.  This ability of bacteria to 
catabolise aromatic compounds can extend to simple industrially produced chemicals if they are 
structurally similar to a natural substrate.  In fact biodegradation of hydrocarbons by natural 
populations of microorganisms represents one of the primary mechanisms by which petroleum and 
other hydrocarbon pollutants are currently eliminated from the environment.  However, although 
ubiquitous in both terrestrial and marine environments, the fraction of the total bacterial population 
represented by hydrocarbon utilising bacteria varies dramatically between locations (Leahy and 
Colwell 1990). 
 
In addition, individual bacteria are only able to degrade a limited range of hydrocarbons, therefore 
the presence of mixed populations representing a broad spectrum of enzymatic capabilities is 
necessary to degrade complex mixtures of hydrocarbons (Leahy and Colwell 1990).  In situations 
where the aromatic compounds cannot be fully degraded by microorganisms, these toxic chemicals 
accumulate in the environment where they present a serious health risk to both humans and wildlife. 
 
 
1.2.2  Bioremediation 
Although these alien hydrocarbons can be removed from the environment by natural biological and 
physio chemical processes, this is generally a slow and unpredictable method of counteracting the 
damage caused by the massive increase in human release of aromatic compounds into the biosphere 
(Diaz et al. 2001).  In recent years bioremediation, that is the deliberate use and manipulation of 
detoxification abilities of living organisms, has become a useful and more commonly utilised 
method of removing harmful aromatic compounds from both terrestrial and aquatic environments, 
Figure 1.10 (Diaz 2006). 
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Although most organisms possess detoxification abilities of one kind or another, such as 
transformation, mineralization and immobilisation of pollutants, microorganisms, and particularly 
bacteria, have been the most frequently used for bioremediation strategies and are the best studied 
(Diaz 2006).  The combination of rapid growth rate, global abundance and high rate of mutations 
enables bacteria to evolve quickly and adapt to their ever changing environment, making them an 
ideal species for study and genetic manipulation (Diaz 2006).  It is hoped that a better 
understanding of microbial degradative pathways will enable us to use the enzymes involved to 
greater effect, or even manipulate them to encompass degradation of chemicals that are not natural 
substrates, thereby greatly reducing the negative environmental impact of aromatic compounds. 
 
In order to engineer a microbe that is capable of degrading a foreign substrate of our choosing, it is 
not possible simply to change a single enzyme.  Molecular pathways are so intricately balanced and 
the enzymes involved so inter dependent on one another that in order to equip a microorganism 
with the ability to degrade an aromatic compound that is not its natural substrate, rational and 
knowledgeable manipulation of both the host cell and the specific catabolic pathway involved is 
required (Diaz 2006).  It is for this reason that it is not enough to simply know about individual 
enzymes in isolation, knowledge about the way in which they interact with their environment and 
the molecules around them is vital.  A deeper understanding of different metabolic pathways could 
ultimately enable the engineering of novel hybrid pathways through the amalgamation of different 
Figure 1.10: Microbial degradation and bioremediation 
The main sources of environmental pollution arise from industrial activity and the combustion or 
accidental release of fossil fuels.  Microbial degradation of these aromatic compounds forms only part 
of the bioremediation process (Diaz 2006).  
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sections from several well understood pathways, resulting in catabolic expansion to new substrates 
and the construction of new routes of degradation (Diaz 2006). 
 
 
1.2.3  Microbial Methods of Degradation 
The benzene ring is the second most widely distributed unit of chemical structure in nature after 
glucosyl residues and bacteria have developed strategies for obtaining energy from many of these 
aromatic compounds (Diaz 2006), under either aerobic or anaerobic conditions (using alternative 
final electron acceptors such as nitrate, sulphate, and ferric ions).  It is a common feature of both 
aerobic and anaerobic degradation of aromatic compounds that structurally diverse compounds are 
degraded through many peripheral pathways to a relatively small number of intermediates, which 
can be further channelled via a few main pathways to the central metabolic machinery of the cell 
(Diaz 2006). 
 
In order for microorganisms to degrade aromatic compounds they need to be able to break the 
carbon carbon bonds within the molecule.  The method by which this is achieved in the peripheral 
pathways varies depending on the level of oxygen present.  Under anaerobic conditions bacterial 
enzymes catalyse the reductive hydrogenation of the ring, followed by the fragmentation of the 
cyclohexane ring skeleton but, under aerobic conditions the strategy used is oxidation of the ring 
followed by oxidative cleavage (Bugg and Lin 2001).  The enzymes that catalyse the aerobic 
reactions are termed oxygenases. 
 
 
1.2.4  Oxygenases 
An oxygenase involved in the aerobic catabolism of aromatic rings in bacteria follows one of two 
paths: either it performs the first phase of degradation by preparing the aromatic compounds for 
ring cleavage (Karlsson et al. 2002) or they are involved with the second phase of degradation, 
where they carry out the ring fission reactions themselves (Kita et al. 1999).  There are 2 main 
classes of oxygenase: mono oxygenases and dioxygenases (determined by whether they introduce 
an atom or a molecule of oxygen respectively), and it is the latter that are actually involved in the 
ring fission reactions, although some pathways also use dioxygenases to catalyse the insertion of 
two hydroxyl groups into the aromatic ring to produce a suitable ring fission substrate.  
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1.2.5  Dioxygenases 
Metabolism of aromatic rings by dioxygenases involves the introduction of two oxygen atoms into 
the substrate.  Experiments using heavy isotopes (O2
18) have shown that both oxygens come from a 
molecule of O2, rather than from O2 and H2O (Hayaishi et al. 1955). 
 
 
1.2.6  Cofactors 
Cofactors, often Fe
2+ or Fe
3+, are required by many dioxygenases to act as catalysts, enabling the 
enzyme to reach a high enough energy state to carry out the desired reaction.  This is due to the fact 
that the ground state of dioxygen (
3O2), which contains two unpaired electrons in the highest 
occupied π* orbitals, is spin forbidden to react with spin paired singlet species (Bugg 2003).  To 
reach the singlet excited state of dioxygen (
1O2), which contains a pair of valence electrons and is 
highly reactive towards alkenes and dienes, an additional 22 kcal/mol energy is required.  The 
dioxygenase is unable to access this excited state without a cofactor. 
 
 
1.2.6.1  Mechanism of Dioxygen Activation 
It is believed that there are three methods by which dioxygen can be activated; orbital overlap, 
single electron transfer and reaction with a substrate radical. 
 
Orbital Overlap with a metal ion occurs when a dioxygen complexes using unpaired π* orbitals to 
unpaired 3d orbital electrons of a transition metal.  This enables the reaction of a transition 
dioxygen with a singlet organic reagent.  However this can only occur if the overall number of 
unpaired electrons in the complex remains constant throughout. 
 
Single Electron Transfer is believed to occur due to transition metals found in dioxygenases and 
indeed many metallo enzymes having two consecutive available oxidation states, e.g. Fe
2+/Fe
3+, 
thus enabling the metal centre to transfer a single electron to bound dioxygen.  The 
3O2 oxygen  
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Figure 1.11: Activation of dioxygen by reduced flavin 
ground state forms a super oxide (O2
 ) if an additional electron is added to its electron cloud, which 
is then able to perform several 1
  or 2
  electron chemical reactions; this process is seen in catechol 
dioxygenases. 
 
Organic reagents are also able to act as stable radical intermediates in single electron transfer 
reactions.  For example, reduced flavin co factor found in flavoprotein hydroxylase enzymes is able 
to activate dioxygen via a single electron transfer forming a stable flavin semiquinone and 
superoxide, which then complex to form a hydroperoxide intermediate (Bugg 2003), see Figure 
1.11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reaction with a Substrate Radical: has been proposed in intradiol catechol dioxygenases (Que, Jr. 
and Ho 1996), where a bound catechol semiquinone intermediate attacks dioxygen to form a 
hydroperoxide radical, see Figure 1.12. 
 
 
 
 
 
Single electron transfer to dioxygen can also take place from organic reagents which can access a 
stable radical intermediate e.g.a reduced flavin cofactor is able to activate dioxygen via a single 
electron transfer to form a stable flavin semiquinone and superoxide, which then recombine to form a 
hydroperoxide intermediate.  Adapted from Bugg 2003.  
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Figure 1.12: Proposed activation mechanism for intradiol catechol cleavage 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2.6.2  Catechol Dioxygenases 
The hydroxyl groups of a compound can take various different conformations as shown in Figure 
1.13, which determines how they are cleaved by dioxygenases. 
 
 
 
 
Figure 1.13: Three isomeric forms of a 
dihydroxybenzene ring: 
ortho indicates that the substituents are 
adjacent e.g. at positions 1 and 2. 
meta indicates that the substituents are e.g. at 
positions 1 and 3. 
para indicates that the substituents are opposite 
e.g. at positions 1 and 4. 
ortho  meta  para 
Since the reaction of dioxygen via radical mechanisms is a spin allowed process, reaction with a substrate 
radical is an alternative possible mechanism. It has been proposed that a substrate activation mechanism of 
this kind occurs in the intradiol catechol dioxygenases, where a bound catechol semiquinone intermediate 
attacks dioxygen to form a hydroperoxide radical.  Adapted from Bugg 2003.  
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The mechanism of action of intradiol (cleavage occurs between the two 
hydroxyl groups) and extradiol (cleavage occurs adjacent to either of 
the two hydroxyl groups) dioxygenases.  Adapted from Bugg 2003. 
The substrate is oxygenated by the dioxygenase to form an intermediate dihydroxy aromatic 
compound, the ring of which is then cleaved proximal to one of the two hydroxyl groups (meta 
cleavage catalysed by extradiol dioxygenases) or between the two hydroxyl groups (ortho cleavage 
catalysed by intradiol dioxygenases) (Bugg and Lin 2001) Figure 1.14. 
 
The intradiol dioxygenases require Fe
3+ as a non haem cofactor and cleave the C C bond between 
phenolic hydroxyl groups in the ortho position.  The extradiol dioxygenases require Fe
2+ as a 
cofactor and cleave the C C bond adjacent to the phenolic hydroxyl groups in the meta position. 
 
It appears that the vast majority of metal 
based complexes designed for catechol 
oxidative cleavage perform intradiol 
cleavage, therefore it is likely that this is the 
kinetically favoured pathway under most 
conditions.  Extradiol reactions have proved 
much harder to reproduce in the laboratory, 
and appear to require facial tridentate ligand 
binding of the catechol mono anion, and the 
involvement of a proton donor, as well as 
being selective for Fe
2+.  This combination 
of requirements makes them less favourable in nature, as well as making them increasingly difficult 
to study in vivo (Bugg 2003). 
 
 
1.2.6.3  Cofactor Binding Sites 
The extradiol dioxygenase BhpC was purified and crystallised by Han et al. in 1995.  The structure 
obtained shows a funnel shaped cavity between two domains leading to the active site where the 
Fe
2+ cofactor was bound.  The cofactor ligation was found to be performed by three amino acids: 
His 146, His 210 and Glu 260 (His2Glu) (Han et al. 1995).  Whilst several other extradiol 
dioxygenase structures have been solved in recent years there is often limited similarity between 
their sequences, however the active site features are always very similar, and often conserved Fe
2+ 
ligands are used with the His2Glu motif being found in most extradiol dioxygenases to date as well 
as in some non haem Fe
3+ enzymes (Miller and Lipscomb 1996;Lin et al. 2001). 
 
Figure 1.14: Cleavage mechanism  
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X ray crystallography has shown that each family of ortho pathway dioxygenases have a specific 
set of amino acids for each co factor.  In intradiol dioxygenases the ligands that bind the co factors 
have been determined, with the non haem Fe
3+ ligated by four amino acid side chains: two 
imidazole side chains of histidine residues, and two phenolic side chains of a pair of tyrosine 
residues (His2Tyr2).  An H2O ligand was also found to create a five point trigonal bipyramidal 
structure (Lin et al. 2001). 
 
 
1.2.7  2,4’ Dihydroxyacetophenone Dioxygenase 
2,4’ dihydroxyacetophenone dioxygenase (DAD) was discovered when a strain of the gram 
negative, aerobic soil bacterium Alcaligenes was grown on a medium of 4 hydroxyacetophenone 
(Hopper 1986).  It is a homotetramer, with subunits each of 20.3 kDa, and it contains iron.  This 
iron is of unknown redox state (although the enzyme is colourless), and it is not lost during 
prolonged dialysis suggesting that it is tightly bound.  DAD was first purified and sequenced by 
Hopper et al in 1999, revealing a significant difference in sequence from other enzymes of its type 
(Hopper and Kaderbhai 1999).  The dad gene was cloned and found to encode 177 amino acids 
including 2 cysteines, although it is not known if they form a disulphide bond in the tertiary 
structure.  The sequence is shown below. 
Met V A N A I S E F W R D I R P I E S P F K P D A L P E A Y I 
P N A A T E D E R Y Y V P F T E T V A S R P L W I S P Q Q N R 
W C D I L L A R E A G L V N R H Y H P H E V F A Y T I S G K W 
G Y L E H D W T A T R G D F V Y E T P G E G H T L V A F E H E 
E P Met R V F F I V Q G P L I W L D E A G N S I G H F D V H D 
Y I A Met C R E H Y E K V G L G A D L V V T L F R Stop 
 
 
 
This enzyme is of particular interest because its mechanism of action is unlike that of any known 
dioxygenase and it bears little sequence homology to other dioxygenases (Hopper and Kaderbhai 
1999).  What makes it different is the fact that, unlike all other dioxygenases, which introduce two 
atoms of molecular O2 into the substrate and then cleave the aromatic ring, DAD introduces two 
atoms of molecular O2 into 2,4' dihydroxyacetophenone and cleavage then occurs at the side chain 
(Figure 1.15). 
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Figure 1.17: 2,4’ dihydroxyacetophenone dioxygenases reaction mechanism 
2,4’ dihydroxyacetophenone dioxygenase is classed as such because it inserts 2 atoms of molecular oxygen into its 
substrate, 2,4’ dihydroxyacetophenone.  This enzyme is unique amongst all known dioxygenases because cleavage occurs, 
not at the aromatic ring as normal, but at the side chain. 
 
2,4' dihydroxyacetophenone  O2   4 hydroxybenzoate    formate 
 
 
 
 
This is an alternative pathway to that utilised by microorganisms such as Pseudomonas, 
Arthobacter and  ocardia.  They use mono oxygenases to metabolise aromatic ketones such as 4 
hydroxyacetophenone by inserting O2 into the substrate, forming an ester that is then hydrolysed 
(Darby et al. 1987;Cripps et al. 1978). 
 
 
1.2.7.1  Sequence and Structural Similarity 
The dad gene was sequenced and several reading frames were found to be highly homologous to 
those in various Pseudomonas bacteria, but the functions of the corresponding proteins are not 
known.  However, it was also found that DAD shares sequence homology with cupin 2, a conserved 
barrel domain of the ‘cupin’ super family.  This suggests that DAD, as a homo tetramer, may form 
a β barrel structure.  
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Threading studies (Jones 2001) were carried out by G. Beaven, which found weak sequence 
homology (~20 %) between DAD and the ferredoxin like domains of several Rieske dioxygenases 
whose structures are known, the homology being strongest with naphthalene 1,2 dioxygenase 
(Karlsson et al. 2002).  It was found through size comparison that DAD corresponded with the 
[Fe2 S2] cluster of this enzyme.  However, it is known that this component functions solely to 
facilitate electron transfer and has no role in catalysis, raising the question of how DAD can 
catalyse a reaction if it consists almost exclusively of a structure with no catalytic function. 
 
It has been proposed that DAD may form ferredoxin like folds, similar to those found in ActVA 
Orf6 monoxygenase from Streptomyces coelicolor, and two novel haem degrading enzymes from 
Staphylococcus aureus, IsdI and IsdG for which structural models have been determined (Wu et al. 
2005) and a structural analysis is shown in Figure 1.16.  A ferredoxin fold is a common αβ protein 
fold with a signature βαββαβ secondary structure along its backbone.  Structurally, the ferredoxin 
fold can be regarded as a long, symmetric hairpin that is wrapped once around, so that its two 
terminal β strands hydrogen bond to the central two β strands, forming a four stranded, antiparallel 
β sheet covered on one side by two α helices.  ActVA Orf6 is part of a small class of mono 
oxygenases that catalyse the oxygenation of their substrates without the assistance of any prosthetic 
groups, metal ions or cofactors normally associated with the activation of molecular oxygen.  The 
crystal structure revealed the overall structure of ActVA Orf6 to be a ferredoxin like fold with a 
novel homodimeric assembly, indicating this structural configuration may function in an additional 
manner to that already known.  Hydrophobic interactions from the ß sheets stabilise the interface 
between the two subunits.  
 
28 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ActVA Orf6 has been shown to be structurally similar to IsdI and IsdG, although they show no 
significant sequence similarity to any other known haem oxygenases.  Their crystal structures (Wu 
et al. 2005) also show each subunit to form a ferredoxin like fold, suggesting a way by which an 
enzyme formed almost entirely of this fold can be catalytically active. 
 
Sequence alignments were conducted by G. Beaven using CLUSTAL W, showing that DAD shares 
only 18.9% identity to ActVA Orf6 and 15.1% to IsdG.  However, despite this low sequence 
identity to one another and DAD, structurally those crystal structures appear quite similar.  It is 
therefore possible that DAD forms similar ferredoxin folds within the tetrameric form. 
 
It is hoped that by determining the three dimensional structure, through the use of X ray 
crystallography, of both the native form of DAD and its complex with a substrate analogue, we will 
gain an improved understanding of its unusual catalytic mechanism and how this is determined by 
its structure. 
Figure 1.18: Structural analysis of IsdG and ActVA mono oxygenase families 
A, ActVA Orf6 homodimer with subunits shaded in blue and red. B, IsdG homodimer with subunits shaded in 
orange and green. C, IsdI homodimer with subunits shaded in aqua and pink. D, residues predicted to be involved 
in binding and oxidation of the substrate in ActVA Orf6 (blue) that are conserved in IsdG (green) and IsdI (pink). 
E, residues shown to be required for oxidation of haem in IsdG (green) and the equivalent residues in IsdI (pink). 
ActVAOrf6 residues that occupy a similar space as the catalytic residues of IsdG are shown in blue.  
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1.3  L threonine Dehydrogenase 
 
1.3.1  Amino Acids 
Amino acids are the building blocks of protein and there are 20 standard amino acids required to 
build the many proteins used in the growth, repair, and maintenance of our body tissues.  These 
amino acids are biosynthesized from other molecules, but organisms differ in which ones they can 
synthesise and which ones must be absorbed through their diet.  Those that cannot be synthesized 
by an organism are given the name essential amino acids.  For humans, the essential amino acids 
are isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine and 
these are obtained through our diet.  Another amino acid, histidine, is considered semi essential 
because the body does not always require dietary sources to obtain it as it is able to synthesise small 
amounts.  The remaining amino acids are alanine, arginine, asparagine, aspartic acid, cysteine, 
glutamic acid, glutamine, glycine, proline, serine, and tyrosine which we can synthesise. 
 
Foods of animal origin, such as meat, poultry, fish, eggs, and dairy products are the richest dietary 
sources of the essential amino acids; plant proteins have an amino acid composition that is generally 
nutritionally less favourable than animal proteins.  Metabolism of amino acids is determined by the 
proportion of amino acids required for protein synthesis (Friedman 1996).  Oxidation rates of amino 
acids are low until the amount consumed exceeds the amount needed for protein synthesis; 
oxidation then increases rapidly. 
 
 
 
 
Figure 1.19: The general structure of an amino acid 
This consists of an amino group and a carboxyl group co ordinated to the α carbon atom.  The R 
group is an organic side chain that differs between amino acids and confers their properties.  
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Alpha amino acids contain both amine and carboxyl functional groups bound to the same carbon 
(the α–carbon) and have the general formula H2NCHRCOOH, where R is an organic side chain, as 
shown in Figure 1.17.  It is this R group that determines the properties of one amino acid compared 
to another and can vary in size from a single hydrogen atom in glycine through a methyl group in 
alanine to a large heterocyclic group in tryptophan.  As both the amine and carboxylic acid groups 
of amino acids can react to form amide bonds, one amino acid molecule can react with another to 
form the peptide bond.  It is this polymerization of amino acids that creates complex proteins. 
 
Amino acids are chiral molecules, that is one monomer can exist as a mirror image of itself 
(enantiomers) and they are not super imposable, as shown in Figure 1.18 (Bada 1991).  In biological 
systems amino acids exists almost exclusively as the L enantiomer. 
 
 
 
 
 
 
 
1.3.2  Oxidoreductases and Dehydrogenases 
Because amino acids are structurally similar, organisms utilise a range of mechanisms to metabolise 
one to another.  For example, threonine can be metabolised to glycine in a two step enzymatic 
process involving L threonine dehydrogenase, which removes a hydrogen from threonine giving 2 
amino 3 ketobutyrate.  In the second step this intermediate is further cleaved in a CoA dependent 
reaction, catalysed by 2 amino 3 ketobutyrate CoA ligase, to produce glycine and acetyl coA. 
Figure 1.20: Amino acid enantiomers 
Amino acids are chiral molecules, therefore exist as enantiomers in either the D or L forms.  
These enantomers are mirror images of one another and cannot be superimposed.  Adapted 
from http://porpax.bio.miami.edu/.  
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Generally, the enzymes that transfer electrons from one molecule to another are called 
oxidoreductases.  These enzymes catalyze the oxidation reaction A + B
  → A
  + B.  In reality, free 
electrons do not exist as these reactions involve the transfer of hydrogen atoms.  Because most 
metabolic oxidation reactions involve removing hydrogen from the electron donor, these enzymes 
are called dehydrogenases.  Dehydrogenases transfer protons to an acceptor or coenzyme, i.e. small 
organic molecules, involved into enzymatic catalysis, such as nicotinamide adenine dinucleotide 
(NAD
+ or NADH), nicotinamide adenine dinucleotide phosphate (NADP
+ or NADPH), flavin 
adenine dinucleotide (FAD) or flavin mononucleotide (FMN).  The term oxidase is used only for 
the enzymes in which the oxidation reaction has molecular oxygen (O2) participating as the electron 
acceptor. 
 
 
1.3.3  L Threonine Dehydrogenase 
L threonine dehydrogenase (TDH) has been identified in all three domains of life i.e. eukarya, 
bacteria and archaea, from organisms such as a psychrophilic bacterium Cytophaga sp. KUC 1 
(Kazuoka et al. 2003), a hyperthermophilic archaeon Pyrococcus horikoshii (Machielsen and van 
der Oost 2006), E.coli K 12 (Boylan and Dekker 1981), humans (Edgar 2002), chicken liver 
mitochondria (Aoyama and Motokawa 1981) and goat liver mitochondria (Ray and Ray 1984).  The 
enzymes from E.coli and P. horikoshii (PhTDH) have been extensively characterised, although thus 
far Pyrococcus horikoshii (Ishikawa et al. 2007) and Flavobacterium frigidimaris are the only 
species from which the L threonine dehydrogenase enzyme had been crystallised and the three 
dimensional atomic structure determined (PDB codes 2DFV and 2YY7 respectively).  Although 
TDH is not restricted to liver mitochondria, in higher organisms it is most abundant in this tissue 
type (Aoyama and Motokawa 1981). 
 
L threonine dehydrogenase belongs to the family of oxidoreductases, specifically those acting on 
the >CHOH group of a donor molecule with NAD
+ or NADP
+ as the acceptor (EC 1.1).  These 
enzymes are divided into three classes; the short chain dehydrogenase family (subunits with 
approximately 250 residues), medium chain enzymes (with subunits of 350   375 residues) and 
long chain dehydrogenases (of greater than 385 residues per subunit) (Esposito et al. 2002).  It is to 
the medium chain family that the 350 amino acid long TDH from Thermococcus kodakaraensis 
belongs.  Typically enzymes in this family contain a catalytic zinc ion coordinated by three 
residues, often two Cys and one His, but variations occur and not all family members contain zinc,  
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nor do all have proven enzyme activity; for example ζ crystallin from a guinea pig eye lens lacks 
the ligands, the two metal ions and any measurable activity (Borras et al. 1989). 
 
L threonine dehydrogenase catalyses the NAD
+ dependent oxidation of L threonine to L 2 amino 
3 ketobutyrate, an intermediate in the metabolism of threonine to glycine (Potter et al. 1977), both 
of which are essential amino acids.  The dehydrogenase catalyses the first step in the threonine 
degradation pathway in several microorganisms that use L threonine as the main carbon and energy 
source.  The product 2 amino 3 ketobutyrate is further cleaved in a CoA dependent reaction, 
catalysed by 2 amino 3 ketobutyrate CoA ligase, to produce glycine and acetyl coA (Aoyama and 
Motokawa 1981).  TDH catalyses the first step of this reaction, shown in Figure 1.19. 
 
 
 
Figure 1.21: Metabolism of threonine by TDH 
 
 
 
L threonine dehydrogenase removes a hydrogen from threonine giving 2 amino 3 ketobutyrate.  This is the first 
step in a two step enzymatic reaction to convert threonine to glycine as shown in Schmidt et. al 2001.  
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TDH is recognised as catalysing the first step in this major route of threonine utilisation in both 
prokaryotes (Boylan and Dekker 1981) and eukaryotes (Dale 1978).  The importance of this 
pathway is illustrated by the fact that it accounts for 87% of the threonine catabolised in rat liver 
(Bird and Nunn 1983) and TDH activity is the only threonine catabolic reaction that is detected in 
chicken liver extracts (Aoyama and Motokawa 1981). 
 
Within the medium chain dehydrogenase family there exists a high degree of structural similarity 
between the enzymes, despite their low sequence similarity.  However, there are differences 
between the enzymes from higher plants and animals, which are typically dimeric for example that 
of horse liver alcohol dehydrogenase (ADH), and those of lower organisms like yeast, bacteria and 
archaea, which are tetrameric such as S. cerevisiae ADH.  This is illustrated in Figure 1.20. 
 
 
a)        b)  
 
 
Figure 1.22: Dimeric and tetrameric ADH 
 
 
 
 
Alcohol dehydrogenase exists as a dimer in higher organisms, as illustrated in a) by horse liver ADH, but exists as a 
tetramer in lower organisms, such as that shown in b) from Sulfolobus solfataricus.  Because TDH shares sequence identity 
with ADH, it is possible that threonine dehydrogenases will exhibit the same structural difference between species. 
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The monomers are similar comprising two domains; a catalytic domain and a nicotinamide cofactor 
(NAD
+) binding domain, which contains the α/β Rossmann fold characteristic of di nucleotide 
binding proteins (Rossman and Liljas 1974).  This six stranded parallel β sheet, flanked by α 
helices, has the relative strand order of 321456 (Murzin et al. 1995), as shown in Figure 1.21. 
 
 
Figure 1.23: Rossmann fold 
 
 
 
 
In dehydrogenases this fold often forms an extended β sheet between monomers A and B (and C 
and D) and in the tetramers the small helix α3, typically binding the structural zinc ion, forms 
contacts between the pairs of monomers: A and C (and B and D).  This can be clearly seen in 
structures like ADH from Sulfolobus solfataricus (SsADH) (Esposito et al. 2002), ADH from 
Saccharomyces cerevisiae (ScADH) (Leskovac et al. 1976) and TDH from Pyrococcus horikoshii 
(PhTDH) (Ishikawa et al. 2007). 
 
 
1.3.4  TDH from Thermococcus kodakaraensis 
 
1.3.4.1  Thermostability of Hyperthermophilic Proteins 
Thermophiles are now classified by their growth temperature: thermophiles above 55 ºC, moderate 
thermophiles above 65 ºC, extreme thermophiles above 75 ºC and hyperthermophiles above 90 ºC.  
Since their initial discovery in 1972 (Unsworth et al. 2007), many hyperthermophilic organisms 
This domain is found in many nucleotide binding proteins.  It consists of a parallel sheet formed by three 
extended parallel β strands, connected by α helices, forming a large sheet.  Adapted from http://www.rsc.org.  
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have been identified and the rate of discovery is increasing as recent developments in technologies 
enhance our ability to access the extreme environments they inhabit.  These environments, which 
until more recently were considered as being inhospitable to life, include volcanic areas rich in 
sulphur and ‘toxic’ metals and hydrothermal vents in the deep sea at extremely high pressures.  To 
date the highest temperature a hyperthermophile has been observed to grow is 121 ºC; this is a 
microorganism, designated strain 121, that was isolated from an active "black smoker” in the 
Northeast Pacific Ocean (Kashefi and Lovley 2003).  These developments are important because it 
is still yet to be understood what the underlying basis is for the extraordinary thermostability of 
these hyperthermophilic enzymes.  Should this be discovered then a great number of opportunities 
to make strategic use of their thermoactivity and thermostability present themselves (Adams and 
Kelly 1998). 
 
Hyperthermophilic enzymes are very similar to their mesophilic homologues, and this is supported 
by sequence alignments, amino acid content comparisons, crystal structure comparisons, and 
mutagenesis experiments (Vieille and Zeikus 2001).  One hypothesis used to explain the difference 
in structural stability at high temperatures is that the structures of hyperthermophilic enzymes are 
more rigid than their mesophilic counterparts at moderate temperatures and therefore rigidity is a 
prerequisite for high thermostability.  This hypothesis is supported by a growing body of 
experimental data that includes frequency domain fluorimetry and anisotropy decay (Manco et al. 
2000), hydrogen deuterium exchange (Bonisch et al. 1996;Jaenicke and Bohm 1998;Zavodszky et 
al. 1998), and tryptophan phosphorescence experiments (Gershenson et al. 2000).  For example, at 
20 ºC a much smaller fraction of the amide protons in Sulfolobus acidocaldarius adenylate kinase 
(53 %) are exchanged than in the porcine cytosolic enzyme (83 %), indicating that considerably 
more amide protons are involved in stable hydrogen bonds in the thermophilic enzyme.  
Temperatures of 80 ºC to 90 ºC must be reached before S. acidocaldarius adenylate kinase can 
show an exchange level comparable to that of the catalytically active mesophilic enzyme (Bonisch 
et al. 1996).  However, not all studies support this conclusion and more work on hyperthermophilic 
enzyme flexibility at various temperatures is needed to gain a better understanding of the role of 
conformational rigidity in protein stability. 
 
Hyperthermophilic enzymes have become model systems to study enzyme evolution, enzyme 
stability and catalytic mechanisms, protein structure function relationships, and biocatalysis under 
extreme conditions.  Not only that, they have the potential for use in a variety of industrial 
processes.  Enzymes like DNA polymerases and DNA ligases have applications as molecular 
biology reagents; Taq DNA polymerase from T. aquaticus was instrumental in the development of  
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PCR technology.  However, there is a very big difference between producing hyperthermophilic 
enzymes on the scale required for laboratory techniques and that required for large scale industrial 
processes.  Some amylases, glucosidases, pullulanases have applications (or potential applications) 
in starch processing, and many more are used in industrial processes such as paper pulp bleaching, 
chemical synthesis, cellulose degradation and ethanol production (Vieille and Zeikus 2001;Vieille 
and Zeikus 2001). 
 
It is hoped that by elucidating the three dimensional structures of hyperthermophilic enzymes it will 
be possible to determine the basis of their inherent properties of thermostability and optimal activity 
at high temperatures and the underlying atomic factors responsible.  These enzymes actually share 
the same catalytic mechanisms with their mesophilic homologues and when cloned and expressed 
into such hosts, hyperthermophilic enzymes usually retain their thermal properties, implying that 
these are genetically encoded.  Studies of primary sequences have failed to identify repeatable 
differences between hyperthermophilic and mesophilic enzymes; therefore it appears likely that no 
one mechanism is responsible for their thermostability.  Instead it is likely that a small number of 
highly specific alterations, which often do not obey any obvious rules, may be the source of this 
thermostability. 
 
Thus a concerted action of structural, dynamic and other physiochemical attributes are utilised to 
ensure the delicate balance between stability and functionality of proteins at high temperatures.  
These may include, but are certainly not limited to; charge clusters, networks of hydrogen bonds, 
optimization of packing, salt bridges, hydrophobic interactions, surface loop stabilization and 
reduction of the entropy of unfolding, each contributing to the overall thermostability (Unsworth et 
al. 2007).  Identifying these minor intrinsic differences that allow hyperthermophilic enzymes to 
maintain structural stability and activity at elevated temperatures is a major challenge, but one that 
can only be aided by the elucidation of the proteins’ tertiary and quaternary structures. 
 
 
1.3.4.2  Thermococcus kodakaraensis 
Thermococcales is composed of two major genera Thermococcus and Pyrococcus.  They are strictly 
anaerobic obligate heterotrophs that grow on complex proteinaceous substrates, and their growth is 
strongly associated with the reduction of elemental sulphur.  Alternatively, with a few exceptions, 
they are capable of gaining energy in the absence of elemental sulphur, by fermentation of peptides,  
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amino acids and sugars, forming acids, CO2 and H2 (Fukui et al. 2005).  The members of 
Thermococcus are ubiquitous in natural high temperature environments and are therefore 
considered to play a major role in the ecology and metabolic activity of microbial consortia within 
hot water ecosystems (Fukui et al. 2005). 
 
 
          
Figure 1.24: EM observation of Thermococcus kodakaraensis 
 
 
 
The anaerobic hyperthermophilic archaeon Thermococcus kodakaraensis (KOD1) was isolated 
from the sediment and water of a solfatara, at over 100 ºC, on the shores of Kodakara Island off the 
coast of Kagoshima, Japan (Figure 1.22) (Atomi et al. 2004).  The bacterium is of an irregular cocci 
shape, 1 2 µm in diameter, with several flagella.  It exhibits optimal growth at 95 ºC with a growth 
range from 65 ºC to 100 ºC, but is unable to grow at or above 105 ºC (Morikawa et al. 1994).  This 
species belongs to the order Thermococcales, comprising two major genera, Pyrococcus and 
Thermococcus (Itoh 2003), and a third genus Palaeococcus (Takai et al. 2000), which as obligate 
hetrotrophs are similar metabolically, growing on organic substrates usually in the presence of 
elemental sulphur.  Pyrococcus however, has a higher optimum growth temperature of 95 ºC 103 ºC 
compared to Thermococcus (Fukui et al. 2005).  The entire 2,088,737 bp genome of T. 
kodakaraensis has been sequenced and analysed (Fukui et al. 2005), making it one of the best 
characterized hyperthermophilic organisms.  An orthologue search was subsequently carried out on 
the genome, highlighting a DNA sequence corresponding to that of L threonine dehydrogenase 
(TDH; EC 1.1.1.103).  A study of the enzymatic properties of the gene product revealed the enzyme 
to be a true L threonine dehydrogenase of this archaeon (TkTDH) (Bowyer et al. 2008). 
 
This hyperthermophilic organism was discovered in a solfatara off the coast of Japan.  It is able to survive in temperatures 
up to 105ºC and its entire genome has recently been sequenced.  Photos taken from the T. kodakaraensis Genome Project.  
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The crystal structure of TkTDH from Thermococcus kodakaraensis has now been solved at a 
resolution of 2.4 Å revealing the detailed tertiary fold and quaternary structure of the molecule.  
Analysis suggests that the biologically active form of the molecule is a tetramer, in agreement with 
ADHs from lower life forms.  It was crystallised bound to the co factor NAD
+, identifying the 
active site and suggesting a possible mechanism of catalysis.  The TkTDH structure has been used 
to model a putative complex formed with 2 dimers of 2 amino 3 ketobutyrate CoA ligase, 
suggesting that 2 molecules of this dimeric protein bind one TkTDH tetramer.  This information can 
be used to further our understanding of the thermostability of hyperthermophilic proteins, 
particularly when compared to non thermophilic proteins. 
 
 
The following chapters present the results of structural studies on three diverse proteins.  The 
structure of BipD has been solved by X ray diffraction, giving insights into not only its structure 
and function, but also how it interacts with the tip of the type three secretion system needle, and 
assists the invasion of host cells.  The structure of TkTDH has also been determined by similar 
methods, allowing conclusions to be drawn as to how it interacts to form a complex with the next 
enzyme in the pathway and provides more evidence for the proposed catalytic mechanism of action.  
Studies are continuing on DAD and progress has been made in its expression and purification.  
Further crystallisation trials are being carried out to enable structure determination.  This work has 
not only elucidated specific protein structures, but also contributed to our general understanding of 
2 biochemical pathways.  
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Chapter 2 
 
Materials, Methods and  
X ray Crystallography 
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2.1  Molecular Biology 
 
2.1.1  DNA Vectors 
For over expression of both the BipD and DAD proteins, it was necessary to ligate the gene into a 
plasmid, which was then inserted into the appropriate bacterial strain.  A plasmid is an independent, 
circular, self replicating bacterial DNA molecule that carries only a few genes.  These occur 
naturally and the number of plasmids in a given cell generally remains constant from generation to 
generation.  Plasmids are autonomous molecules and exist in cells as extra chromosomal genomes 
(Liu and Shi 2000).  The genes they encode can endow the host organism with potentially 
advantageous characteristics and so can be used as DNA vectors.  One of the reasons that plasmids 
are used in molecular biology is that as well as being readily available, they are easy to manipulate 
and isolate.  The recombinant plasmids used today have all been engineered to contain a genetic 
element that provides a means by which those cells that possess it can be selected for. 
 
Figure 2.1: Restriction enzyme recognition sites of pET11a plasmid 
A pET vector is a bacterial plasmid designed to enable the quick production of a large quantity of any desired protein when activated. 
This plasmid (pictured below) contains several important elements   a lacI gene which codes for the lac repressor protein, a T7 
promoter which is specific to only T7 RNA polymerase (not bacterial RNA polymerase) and also does not occur anywhere in the 
prokaryotic genome, a lac operator which can block transcription, a polylinker, an f1 origin of replication (so that a single stranded 
plasmid can be produced when co infected with M13 helper phage), an ampicillin resistance gene, and a ColE1 origin of replication  
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The plasmid pET11a, shown in Figure 2.1, is the vector that has been used for both BipD and DAD 
protein expression in E.coli.  The plasmids used throughout this research have had ampicillin 
resistance conferred on them as a means of selecting which bacterial cells have successfully taken 
up the plasmid and retained it.  Ampicillin belongs to the penicillin group of beta lactam antibiotics, 
which function by preventing the cross linking of peptidoglycan chains in bacterial membrane 
synthesis.  This results in the membrane being ‘leaky’ and ultimately prevents successful bacterial 
cell growth.  The insertion of the β lactamase gene into the bacterial plasmid is responsible for 
ampicillin resistance because it encodes β lactamase, an enzyme capable of cleaving the ring in 
ampicillin and thereby inactivating it.  Transformed cells containing the plasmid with the β 
lactamase gene will be resistant to ampicillin and so will grow in the presence of the antibiotic, 
whereas non engineered cells will not. 
 
 
2.1.2  Restriction Endonucleases 
To cut the double stranded DNA of the gene of interest and the plasmid, ready for ligation, 
restriction endonucleases were necessary.  These enzymes function by scanning the length of a 
DNA molecule and once it encounters its particular recognition sequence; it will bond to the DNA 
molecule and make one cut in each of the two sugar phosphate backbones of the double helix 
(Andrews and Patel 1998).  The positions of these two cuts, both in relation to each other, and to the 
recognition sequence itself, are determined by the identity of the restriction endonuclease used to 
cleave the molecule. 
 
Different endonucleases yield different sets of cuts, but one endonuclease will always cut a 
particular base sequence the same way, no matter what DNA molecule it is acting on.  Once the cuts 
have been made, the DNA molecule will break into fragments.  These enzymes are part of a cell’s 
natural defence against foreign DNA, as well as a method of recognising and removing faulty DNA. 
 
Today we use restriction endonucleases to cut DNA at specific sites in order to intentionally 
introduce modifications.  There are several hundred known endonucleases, all of which function by 
recognising a specific base sequence in a strand of DNA and making a cut in each strand.  These 
recognition sites are usually palindromic and contain 4 6 base pairs.  There are three classes of 
endonucleases; Type I, II and III.  Type I and III are multi subunit enzymes that cleave with (Type 
I) or without (Type III) ATP (Williams 2003).  After recognising a specific sequence, the actual  
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cleavage is made away from the recognition site; Type I cuts 1 10 kb and Type III up to 100 base 
pairs away from the point of recognition.  This is not particularly helpful in molecular biology 
because it is not specific.  In contrast, Type II endonucleases are useful because they cleave DNA at 
a specified point within the recognition sequence, and these are the ones used in molecular biology 
(Andrews and Patel 1998). 
 
Cleavage is achieved by two distinct methods, leaving either ‘blunt’ or ‘sticky’ ended double 
stranded DNA.  Some enzymes cleave directly across the centre of the recognition site, giving rise 
to blunt ends.  The endonucleases used in the research detailed here were  deI and BamHI, both of 
which are Type II enzymes that leave cohesive (sticky) ends (Williams 2003).  They make a 
staggered cut, symmetrically placed either side of the centre of the palindromic recognition site, 
leaving a single strand of DNA overhanging the end of each fragment. 
 
   
BamHI  G G A T C C   deI  C A T A T G 
  C C T A G G  G T A T A C 
 
( ↑ = cut site) 
As with all enzymes, optimal activity is achieved at 37 ºC. 
 
 
2.1.3  DNA Ligase 
If restriction enzymes are the scissors of DNA manipulation, then DNA ligase is the glue.  It is a 
particular type of ligase that can join together DNA that has a break in both complementary strands.  
This enzyme is able to form covalent phosphodiester bonds between 3' hydroxyl ends and 5' 
phosphate ends of juxtaposed nucleotides, in an ATP dependant manner.  The alternative, a single 
strand break, is easily fixed by DNA polymerase using the complementary strand as a template but 
still requires DNA ligase to create the final phosphodiester bond to fully repair the DNA (Taylor 
and Hagerman 1990).  In this research T4 ligase (isolated from bacteriophage T4) has been used to 
insert DNA fragments of the bipd and dad genes, into the pET11a plasmid. 
 
The temperature at which ligation was carried out had to be kept constant at 16 ºC.  Although DNA 
ligase is most active at 25 ºC, the reaction temperature had to be kept low as homologous pairing of 
the sticky ends will not occur at high temperatures because hydrogen bonding is disrupted (Luo and 
↑  ↑ 
↓  ↓  
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Barany 1996).  The reaction was carried out over 4 hours to compensate for the low temperature 
and allow sufficient time for ligation to occur. 
 
Bacteriophage T4 DNA ligase is a single polypeptide with a M.W. of 68 kDa.  Maximal activity is 
obtained at pH 7.5   8.0. At pH 6.9 and pH 8.3 the enzyme exhibits 40 % and 65 % of its full 
activity respectively.  Mg
2+ is required and the optimal concentration is 10 mM.  Sulfhydryl 
reagents (DTT, 2 mercaptoethanol) are also required and NaCl in concentrations exceeding 200 
mM is inhibitory.  For intermolecular ligation, especially when the subtrate DNAs consist of large 
DNA molecules PEG (concentrations of 1 %   10 %) has been reported to stimulate the enzymatic 
activity (Takahashi et al. 1984). 
 
 
2.1.4  Primer Design and Polymerase Chain Reaction 
For over expression of BipD without the GST tag, primers for the bipd gene were designed, based 
on its sequence.  These oligonucleotides could then be used in PCR to clone many copies of the 
non tagged bipd gene sequence. 
 
The 5’ bipd sequence initially used was: 
ggacgcgcgctgaccgtgcgcgat 
G  R  A  L  T  V  R  D  
 
A trial 5’ primer was designed as shown here, including the recognition sequences for NdeI and 
XbaI: 
g tag cct |gga tct aga cat atg ggacgcgcgctgaccgtgcgcgat 
 
Tm = (1×AT) + (2×CG) 
Tm = (1×18) + (2×28) 
Tm = 18 + 56 
Tm = 74 °C 
 
But the melting temperature (Tm) of this sequence is too high for PCR, so some of the non coding 
bases at the beginning were removed: 
gga tct aga cat atg ggacgcgcgctgaccgtgcgcgat 
Tm = (1×AT) + (2×CG) 
Tm = (1×15) + (2×24) 
Tm = 15 + 48 
Tm = 63 °C 
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5’ end primer: 
gga tct aga cat atg gga cgc gcg ctg acc gtg cgc gat 
                 M   G   R   A   L   T   V   R   D 
 
Blue = NdeI, Green = XbaI 
 
The 3’ bipd sequence initially used was: 
5’ agctatctgcagatctga 3’ 
 
Reverse complement: 
tcagatctgcagatagct 
 
A 3’ end trial primer: 5’ to 3’ was designed as shown here, including the recognition sequences for 
NdeI and XbaI: 
g gcg caa gct tgg atc cgc cct a tcagatctgcagatagct 
 
Tm = (1×AT) + (2×CG) 
Tm = (1×18) + (2×23) 
Tm = 18 + 46 
Tm = 64 °C 
 
3’ end primer: 
g gcg caa gct tgg atc cgc cct a tcagatctgcagatagct 
 
reverse complement: 
agctatctgcagatctgatagggcggatccaagcttgcgcc 
 S  Y  L  Q  I Stop Stop 
 
Red= Hind III, purple = Bam HI 
 
Sequences ordered (both going 5’ to 3’): 
5’ end primer 
ggatctagacatatgggacgcgcgctgaccgtgcgcgat 
 
3’ end primer 
ggcgcaagcttggatccgccctatcagatctgcagatagct 
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2.1.5  Agarose Gel Electrophoresis 
This technique was used to separate DNA molecules by size, to visualise the products of ligation to 
verify they had been ligated, and following restriction enzyme digestion to check the DNA had been 
cut.  It was also used to quantitatively analyse the products of PCR as an estimate of yield. 
 
An agarose gel, containing ethidium bromide (EtBr), is poured (see appendix for method) and the 
negatively charged nucleic acid molecules move through the agarose matrix at different speeds, 
with an electric field (electrophoresis) (Brody et al. 2004).  The smaller molecules are able to move 
more easily through the matrix, and hence faster, than longer ones, and so migrate further down the 
gel. 
 
The advantage of this type of gel is that it is easily poured, does not denature the samples, and is 
physically firmer than polyacrylamide (used in SDS gel electrophoresis).  The samples can also be 
recovered if required.  The disadvantages are that gels can melt during electrophoresis, the buffer 
can become exhausted, and different forms of genetic material may run in unpredictable forms. 
 
The most important factor affecting the rate at which samples migrate through the gel is the length 
of the DNA molecule, smaller molecules travel further.  But conformation of the DNA molecule is 
also a factor.  For example, a DNA plasmid that has not been cut with a restriction enzyme may be 
in different conformations and therefore will move with different speeds (slowest to fastest): nicked 
or open circular, linearised, or supercoiled (Brody et al. 2004). 
 
Increasing the agarose concentration of a gel reduces the migration speed and enables separation of 
smaller DNA molecules.  The higher the voltage, the faster the DNA migrates, but this is limited by 
the fact that it heats up and ultimately causes the gel to melt.  High voltages can also decrease the 
resolution (Goedhart and Gadella, Jr. 2005). 
 
Gel electrophoresis can be used for the separation of DNA fragments of 50 base pairs up to several 
megabases (millions of bases).  However, it is normally used in a range of 100 bp to 20 kbp.  
Typical run times are about an hour.  Small nucleic acids are better separated by polyacrylamide 
gels, large DNA molecules are only able to move end on in a process called "reptation" and are 
more difficult to separate.  In general lower concentrations of agarose are better for larger 
molecules; it will exaggerate the distances between bands (Brody et al. 2004).  The disadvantage of  
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higher concentrations is the long run times (sometimes days).  Instead these gels should be run with 
a pulsed field electrophoresis (PFE), or field inversion electrophoresis. 
 
Loading buffers are added with the DNA in order to visualize it and sediment it in the gel well.  
Negatively charged indicators keep track of the position of the DNA and Orange G was used in this 
research.  The most common dye used for agarose gel electrophoresis is ethidium bromide, because 
it fluoresces under UV light when intercalated into DNA (or RNA).  By running DNA through an 
EtBr treated gel and visualizing it with UV light, distinct bands of DNA become visible (Goedhart 
and Gadella, Jr. 2005).  Alternatives to EtBr are available but were not used in this research. 
 
After electrophoresis the gel is illuminated with an ultraviolet lamp to view the DNA bands.  The 
EtBr fluoresces reddish orange in the presence of DNA.  The gels were viewed and photographed 
using a Gene Genius Bio Imaging System and GeneSnap from Syngene to produce a black and 
white photo, as shown in Figure 2.2. 
 
 
 
 
 
 
 
 
2.1.6  Bacterial Strains 
The host strain BL21(DE3) Escherichia coli was used for the expression of BipD and DAD and 
these cells were transformed using ‘maxiprepped’ DNA.  This strain is lysogenic for a λ prophage 
Figure 2.2: DNA agarose gel from electrophoresis 
The left hand lane shows a 1kb DNA marker and the other lanes show DNA strands of various sizes.  
The shorter strands have moved further down the gel than the longer ones and are visualized by 
staining with ethidium bromide viewed under ultraviolet light.  
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that contains an isopropyl β d thiogalactopyranoside (IPTG) inducible T7 RNA polymerase.  This 
viral polymerase is highly selective for its own promoters, which are not found to naturally occur in 
E. coli.  However, this polymerase is capable of efficiently transcribing almost any DNA sequence 
that is linked to a T7 promoter, even when inserted in to a foreign cell (Studier and Moffatt 1986).  
Transcription of the T7 RNA polymerase gene is controlled by the L8 UV5 lac promoter and the 
lac operon. 
 
The BL21(DE3)pLysS strain also carries the pACYC184 derived plasmid that encodes T7 
lysosyme, which selectively inhibits T7 RNA polymerase by binding to it (Moffatt and Studier 
1987).  This serves to suppress any basal expression of target DNA under the control of the T7 
promoter until over expression is induced by IPTG.  The accumulation of T7 lysosyme does not 
affect the growth of gram negative E. coli cells, presumably because it is unable to reach its 
substrate, the peptidoglycan cell wall, as it cannot penetrate the outer membrane (Studier 1991).  T7 
RNA polymerase can elongate RNA chains approximately five times faster than the host 
polymerase and, reportedly, specific mRNA produced by T7 polymerase can saturate the 
translational machinery of the E. coli cell to the extent that the rate of protein synthesis from this 
mRNA is primarily dependent on the efficiency of its translation (Moffatt and Studier 1987). 
 
The addition of IPTG to bacterial cultures is an established method of inducing expression of 
plasmid based genes for the production of recombinant proteins under the control of the lac 
promoter, because the most direct way to control the expression of a gene is to regulate its rate of 
transcription.  The lac operon is a set of genes and DNA regions that control the production of a 
protein and naturally it is controlled by the presence or absence of lactose and glucose.  In the 
absence of lactose, the repressor protein binds to the lac operator and prevents transcription.  
Binding of lactose to the repressor causes it to dissociate from the operator, enabling RNA 
polymerase to transcribe the gene.  IPTG mimics allolactose and switches on the lac operon, 
however the cell is unable to break down IPTG so the lac operon remains permanently on causing 
the cell to produce large quantities of the protein of interest. 
 
The advantage of using this IPTG inducible system to over express proteins is that the E. coli cells 
can undergo initial cellular growth and proliferation without the burden of producing the extra 
foreign protein.  This ensures that a suitable quantity of healthy E. coli cells are grown up to then 
over express the recombinant proteins in large amounts.  The competency of transformed cells will 
be maintained by conferring resistance to ampicillin.  
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2.2  Protein Purification 
 
2.2.1  Sonication 
Sonication is the act of applying sound (usually ultrasound) energy to agitate particles in a sample.  
In the context of this research an ultrasonic probe was used to disrupt the E.coli cell membranes 
with inaudible ultrasound (greater than about 18 kHz) causing the release of cellular contents, 
particularly soluble protein of BipD or DAD, into solution. 
 
Ultrasonication utilises the rapid sinusoidal movement of a probe within the liquid.  It is 
characterised by high frequency (18 kHz   1 MHz), small displacements (less than about 50 µm), 
moderate velocities (a few ms
 1), steep transverse velocity gradients (up to 4,000 s
 1) and very high 
acceleration (up to about 80,000 g) (Chaplin and Bucke 2007). 
 
 
2.2.2  Fractional Ammonium Sulphate Precipitation 
Fractional salt precipitation was the initial purification step carried out for both BipD and DAD to 
crudely remove some impurities from the soluble fraction obtained after sonication (once cell debris 
had been removed via centrifugation).  As increasing amounts of salt are added, different proteins 
will precipitate out of solution.  Ammonium sulphate is most commonly used for this technique 
because it does not have any deleterious effects on protein structure, is highly water soluble and 
inexpensive. 
 
An amount of (NH4)2SO4 sufficient to cause 15 % saturation was fully dissolved in the sample and 
the homogenous solution centrifuged at 18,000 rpm for 30 minutes to remove any precipitation.  
The pellet was resuspended, and a volume of the supernatant retained for analysis.  A further 15 % 
(NH4)2SO4 was added and the protocol repeated in a step wise manner until 75 % saturation was 
reached.  SDS gel electrophoresis was used to ascertain at what (NH4)2SO4 concentration the 
protein of interest precipitated out and this pellet sample was retained. 
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2.2.3  Dialysis 
Following ammonium sulphate precipitation, the sample contains a high salt concentration, which 
could hinder chromatography purification by ion enxchange.  Dialysis is used to separate molecules 
in solution by the difference in their rates of diffusion through a semi permeable membrane.  In this 
situation, salts will to move out of the dialysis tubing, in to the surrounding solution where the 
(NH4)2SO4 concentration is lower. 
 
The solution, containing many different kinds of molecules, is placed into semi permeable dialysis 
tubing, such as a cellulose membrane with pores, and sealed.  The sealed dialysis tube is placed in a 
container of 20 mM TRIS and molecules small enough to pass through the tubing move out of the 
dialysis tube, in to the lower concentration solution.  Larger molecules such as proteins, that have 
dimensions significantly greater than the pore diameter, are retained inside the dialysis tube.  
Typically the solution was dialysed over 48 hours. 
 
 
2.2.4  Chromatography 
Chromatography is the principle of separating substances by their different characteristics.  There 
are several characteristics by which proteins can be differentiated, as illustrated in Figure 2.3 
(Amersham Biosciences 2007a), which can be combined to maximise purification. 
 
 
  Figure 2.3: Chromatography types 
Proteins can be separated by size, hydrophobicity, charge, affinity and reversed phase.  More than one 
technique can be combined to maximise purification of a sample.  Adapted from Novagen instruction manual.  
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2.2.4.1  Ion Exchange Chromatography 
In this instance the protein of interest is separated from other proteins based on ionic charge.  
Because amino acids contain both the active groups of an amine and a carboxylic acid they can 
carry either a positive or a negative charge (or be neutral) and so are called zwitterions.  At a certain 
pH known as the isoelectric point, the peptide carries no net electrical charge.  The exact value is 
specific to each different amino acid.  Ion exchange chromatography separates proteins according to 
their net charge.  For example, if a protein has a net positive charge at pH 7, then it will bind to a 
column of negatively charged beads, whereas a negatively charged protein would not.  By changing 
the pH so that the net charge on the protein is negative, it too will be eluted. 
 
A sample containing a mixture of proteins is introduced into a sample loop and a buffered aqueous 
solution used to carry the sample from the loop onto a column that contains some form of stationary 
phase material.  This is typically a resin or gel matrix consisting of agarose or cellulose beads with 
charged functional groups covalently bonded to them.  The stationary phase surface of the 
chromatography column displays ionic functional groups that interact with analyte ions of opposite 
charge.  The column is washed to remove any unbound molecules, then the bound protein is eluted 
systematically by varying pH and/or ionic strength of the buffer solution.  These changes interfere 
with the electrostatic interactions between the bound protein and the stationary phase material, 
causing the protein to be released from the column.  Ion exchange chromatography retains analyte 
molecules based on ionic interactions.  This type of chromatography is further subdivided into 
cation exchange chromatography and anion exchange chromatography: 
 
Cation exchange chromatography retains positively charged cations because the stationary phase 
displays a negatively charged functional group such as phosphoric acid. 
 
Anion exchange chromatography retains negatively charged anions using positively charged 
functional group such as a quaternary ammonium anion. 
 
 
2.2.4.1.1  Q sepharose™ Anion Exchange Chromatography Column 
This column was chosen for intermediate purification because it is suitable for use at pH 8 (where 
both BipD and DAD are stable and are anionic).  The 6 % matrix of cross linked agarose contains a  
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strong quaternary ammonium anion, providing a binding capacity of 120 mg/ml (Amersham 
Biosciences 2007c). 
 
 
 
 
 
 
 
2.2.4.1.2  Hi Trap Q XL Anion Exchange Column 
It was found necessary to ‘polish’ the DAD sample before crystallisation to remove the few 
remaining trace contaminants, and this was achieved through the use of a 1 ml Hi Trap Q XL 
column.  This contains long chains of dextran coupled to a robust, 6 % highly cross linked agarose 
matrix.  The dextran chains increase the exposure of the Q charged groups, resulting in very high 
loading capacities (Amersham Biosciences 2007c). 
 
 
2.2.4.2  Gel Filtration Chromatography 
This technique separates proteins by their size, or hydrodynamic volume, using what amounts to a 
molecular sieve.  Typically a gel medium, usually porous beads of polyacrylamide, dextran or 
agarose, is used and filtered under low pressure; these media are also known as the stationary phase.  
Unlike ion exchange chromatography, these compounds contain very few charged groups to avoid 
unwanted electrostatic interactions that would interfere with size separation.  A buffered aqueous 
solution is used to transport the sample through the stationary phase, in a similar manner to other 
chromatography columns.
Figure 2.4: Structure of sepharose cross linked agarose media 
Sepharose media are based on chains of agarose, arranged in bundles and with different degrees 
of intra chain cross linking (Figure 12), to give a range of rigid, macroporous matrices with good 
capacity and low non specific adsorption.  Adapted from Novagen instruction manual.  
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The flow rate is often slow for gel filtration to allow time for better separation of similar sized 
proteins and hence higher resolution.  Longer columns also improve resolution because they 
provide a greater distance over which the proteins can separate.  Smaller molecules are able to pass 
through the porous beads, whereas larger proteins are excluded and forced to travel through the 
interstitial spaces.  For this reason, smaller molecules take longer to travel through the column 
because effectively they have a greater volume available to them than larger molecules, as 
illustrated in Figure 2.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.4.2.1  Superdex™ 200 Gel Filtration Chromatography Column 
Superdex 200 is a spherical composite of dextran and cross linked agarose, thereby combining the 
separation power of Sephadex™ with high physical and chemical stability of cross linked 
Superose™ 6.  The particles are approximately 13  m in size and can separate molecules in the 
range of 10 kDa – 600 kDa.  This column was used as a secondary step for purification of BipD and 
DAD after anion exchange, at a flow rate of 0.5 ml/min (Amersham Biosciences 2007b). 
 
Figure 2.5: Gel filtration 
 
This technique works on the principle of separating protein molecules according to their size. 
1) many porous beads are tightly packed into the column, with only small interstitial spaces. 
2) a buffer solution containing the mixture of proteins is introduced to the column, small molecules (shown in 
orange) are able to permeate the beads. 
3) molecules diffuse in and out of the beads, becoming separated from the medium and larger sized molecules. 
4) larger molecules are unable to enter the beads and so pass down the column much more quickly by moving 
through the interstitial spaces. 
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2.2.4.3  Affinity Chromatography 
Unlike gel filtration and ion exchange chromatography, affinity chromatography does not rely on 
the physical difference between proteins in a mixture, but instead on a unique characteristic of the 
protein of interest.  It is based on highly specific biological interactions; such as that between 
antigen and antibody, enzyme and substrate, or receptor and ligand.  This is a reversible interaction 
between a protein and a specific ligand coupled to a chromatography matrix.  Affinity 
chromatography combines the size fractionation capability of gel permeation chromatography with 
the ability to design a stationary phase that reversibly binds to a known subset of molecules.  In this 
instance an affinity column for the GST tag on the BipD protein was used.  Affinity 
chromatography is a unique method by which proteins can be purified because a protein can be 
separated from a mixture on the basis of its biological function or individual chemical structure.  
Purification that would otherwise be time consuming, difficult or even impossible using other 
techniques can often be achieved with affinity chromatography.  The appropriate ligand is 
immobilised on the column and reversibly binds its substrate as a protein mixture flows through the 
column. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: Affinity chromatography 
 
This technique utilises a specific interaction between the protein of 
interest and a ligand, to purify it from the protein mixture. 
1) the ligand is immobilised on the affinity medium. 
2) a mixture of proteins are loaded onto the column and the one sthat 
is specific to the ligand will bind (reversily) to the affinity medium. 
3) once all the non bound proteins has been washed off, the protein 
of interest can be eluted.  
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2.2.4.3.1  GSTrap Affinity Chromatography Column 
Immobilised glutathione is bound to the affinity medium.  The solution containing the protein 
mixture was loaded and the GST BipD fusion protein captured on the column.  Impurities are 
removed by washing.  Instead of eluting the protein immediately, thrombin was added to the 
column to cleave the GSTag from BipD.  BipD and thrombin could then be washed from the 
column and the GST was later eluted using reduced glutathione. 
 
 
2.2.4.3.2  Benzamidine Affinity Chromatography Column 
To separate the thrombin and BipD, it was necessary to use another affinity column.  The 
benzamidine column uses p aminobenzamidine immobilised on cross linked agarose to bind 
thrombin.  The mixture was loaded on to the column and BipD flowed straight through whilst the 
thrombin bound.  This was later eluted with a solution of TRIS and p aminobenzamidine. 
 
 
2.2.5  Concentration 
10 kDa vivaspins from VWR biomarker were used to concentrate larger volumes of protein 
solution.  ddH2O was first loaded into the tube and centrifuged at 3,000 rpm until all the H2O had 
passed through the membrane.  The protein was then loaded in and centrifuged until it reached the 
appropriate volume.  Frequent pipetting is required to combat concentration polarisation and 
maintain a reasonable flow rate. 
 
10 kDa centricons were used to concentrate small volumes of protein.  These were loaded into a 
standard fixed angle centrifuge and centrifuged at 5,000 rpm until the required volume was 
obtained.  Both vivaspins and centricons work by forcing small molecules, such as H2O and salt, 
through a membrane and away from the protein, leaving the protein in a smaller volume of H2O. 
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2.2.6  SDS PAGE Gel Electrophoresis 
This technique is used to separate proteins, based on their size, and compare them to fragments of 
known molecular weight.  Sodium dodecyl sulphate (SDS) is an anionic detergent that denatures 
proteins by "wrapping around" the polypeptide backbone, binding to proteins fairly quantitatively in 
a mass ratio of approximately 1.4:1.  In so doing, SDS confers a negative charge to the polypeptide 
in proportion to its length, i.e. the denatured polypeptides become "rods" of negative charge cloud 
with equal charge or charge densities per unit length.  It is usually necessary to reduce disulphide 
bridges in proteins before they adopt the random coil configuration necessary for separation by 
size: this is achieved using β mercaptoethanol.  Denaturing SDS PAGE separations therefore ensure 
that migration is determined by molecular weight and not by intrinsic electrical charge of the 
polypeptide.  The proteins were run in an electric field through a polyacrylamide gel, which acts as 
the separating mesh. 
 
A discontinuous system has been used in this research where a non restrictive large pore gel 
(stacking gel) is layered on top of a separating gel.  Each type of gel is made using a different buffer 
and the tank buffers are different again from the gel buffers.  The resolution obtained in a 
discontinuous system is much greater than that obtained with a continuous system (see appendix for 
method).  Once the gel has been stained, it is possible to see the bands of protein and compare the 
protein of interest against a molecular weight marker to determine its size. 
 
 
 
 
Figure 2.7: An SDS gel 
SDS gel electrophoresis is an analytical technique for visualising the protein 
content of a solution.  The first lane contains a marker with fragments of known 
molecular weights.  The protein of interest can be run along side the marker and 
the bands compared to ascertain their sizes.  
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2.3  Crystallisation 
 
In order to use X ray crystallography as a method of obtaining structural data from a protein 
molecule, it is first necessary to grow a crystal of the protein.  The use of a protein crystal results in 
many copies of the protein molecule being repetitively packed to form an ordered structure, 
sometimes up to 1mm in each dimension but often much smaller.  This depth allows the X rays to 
be diffracted; and recording and analysis of the resultant data to give an average structure of the 
protein taken from all the molecules present in the crystal.  The crystal lattice can be described in 
terms of its unit cell, which is the smallest and simplest volume element from which the entire 
crystal can be constructed by repeated lattice translations.  This is illustrated in Figure 2.8.  The unit 
cell itself can be further broken down into the asymmetric unit.  This is the largest aggregate of 
molecules that possesses no crystallographic symmetry elements, but which can be juxtaposed onto 
other identical entities by symmetry operations.  In the Figure below, the individual molecule makes 
up the asymmetric unit, whilst the unit cell comprises of both molecules related by a symmetry 
operation.  This is then repeated throughout the crystal to form the lattice. 
 
 
 
 
 
 
 
The way in which X rays are diffracted by the electron density within crystalline structures can be 
explained by Braggs law nλ=2dsinθ.  This supposes that a crystal lattice comprises multiple parallel 
layers or planes of molecules with constant interplanar spacing.  An X ray beam will only be 
diffracted when the rays reflected by successive planes emerge from the crystal in phase with one 
Figure 2.8: Crystallographic unit cell and lattice 
The protein molecules pack together with the smallest repeating arrangement forming the unit cell, left.  This unit 
cell is then repeated throughout the crystal, forming the crystalline lattice.  
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another.  If they emerge out of phase, the waves destructively interfere with each other, causing 
graded reflections through to no reflection at all.  See Figure 2.9. 
 
 
 
Figure 2.9: Bragg’s Law 
 
 
 
 
Once a protein has been purified, the solution is used to set up 24 well crystallisation trays.  The 
well solution is an aqueous precipitation solution that does not denature the protein and is made up 
to about 1 ml total volume, and the crystallisation of biological macromolecules is achieved using a 
solution of the protein in precipitant as a hanging drop of about 4 µl.  This is usually 2 µl of protein 
and 2 µl of well solution.  This drop is pipetted onto a siliconised glass cover slip, which is inverted 
and held in place over the well by grease, as shown in Figure 2.10 (Torrii Lab 2008).  This is 
termed the hanging drop crystallisation method, the most common technique used for crystallising 
proteins. 
 
Bragg’s law provides the conditions under which X ray diffraction can occur.  This diagram schematically illustrates 
interference between waves scattering from two adjacent rows of atoms in a protein crystal.  This diagram was 
adapted from www.hasdeu.bz.edu.ro/softuri/fizica/mariana/Atomica/Bragg/home.html.  
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Figure 2.10: Hanging drop crystallisation method 
 
 
 
 
Once sealed by a cover slip, the well becomes a closed system.  Vapour diffusion of water from the 
protein drop into the well solution is driven by the difference in concentration between the two 
solutions.  This continues until equilibrium is reached.  During this process, the concentration of 
both the protein and precipitant in the drop slowly increase until the protein solution reaches a 
supersaturated state.  At this point, nucleation occurs and subsequently the growth of protein 
crystals. 
 
Proteins differ from small molecules only in the degree of supersaturation required to induce 
crystallisation or to allow a useful rate of crystallisation.  The supersaturation of a solution of 
protein may be increased in several ways such as; cooling, allowing water to evaporate, variation of 
the pH and the addition of an ionic solute, e.g. salt.  Using evaporation to form protein crystals is 
much like that observed when working with common salt or sugar.  As the water evaporates the 
protein solute begins to form crystals when the supersaturation reaches a point that the amount of 
water available can no longer support the high concentrations of protein.  However, for small 
molecules this could be achieved by heating the solution until the water has boiled off.  This method 
is obviously not appropriate for protein crystallisation, as proteins often denature above 40 ºC.  
Figure 2.11 (Read 2005) shows a crystallisation phase diagram.  The protein and precipitant 
concentrations must be such that they fall into the nucleation region, where the formation of 
molecular clusters occurs.  As the protein concentration then falls, due to some protein molecules 
now forming the protein crystal, the concentrations drop into the metastable region where crystals 
grow. 
The hanging drop contains protein and precipitant, and reservoir only contains the precipitant 
solution.  Vapour diffusion within the well causes the drop to become saturated with protein and 
at this point, nucleation of crystals occurs.  Adapted from www.bio.davidson.edu/.  
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A crystallisation tray is used to vary the conditions in each of the wells in order to determine the 
optimal conditions for growing crystals.  Factors such as protein concentration, pH and solute 
composition and concentration can be varied.  Because different pH levels (how acidic or basic a 
solution is) change the structural attributes of the amino acids that make up proteins, changes in pH 
can cause a protein to crystallise.  Organic solvents also aid the precipitation of protein from 
solution, and a commonly used water soluble polymer is polyethylene glycol (PEG).  It is 
commercially available in a range of molecular masses, such as PEG 300 through to PEG 8000. 
 
Using an ionic solute such as salt creates another problem.  Ionic materials, such as sodium 
chloride, or common salt, dissolve readily in water.  Because of the strong electric field around 
these ions, Na
+ and Cl
 , a large number of water molecules are loosely bound around the ions in a 
sphere of hydration.  This is because the water molecule itself is an electric dipole, with one end 
slightly positively charged and the other end negatively charged.  The net effect of adding salt to a 
protein solution is to reduce the amount of water that is free to keep the protein molecules in 
solution, a process called ‘salting out’.  Thus, the degree of supersaturation of the protein solution is 
Figure 2.11: A crystal growth phase diagram 
This illustrates the effect of varying precipitant and protein concentration.  Proteins fail to crystallise in the unsaturated 
region (blue).  In the nucleation region (peach) nuclei will form and in the metastable region (cream) these will grow into 
crystals.  If the crystallisation conditions overshoot the nucleation region, that result will be precipitation of the protein 
(brown) to an amorphous substance.  Adapted from http://kenividilaseris.wordpress.com.  
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effectively increased, and crystallisation becomes more likely.  Some examples of protein crystals 
are shown in Figure 2.12. 
 
a)          b)     
Figure 2.12: Protein crystals 
 
 
 
2.3.1  Crystal Freezing 
To minimise radiation damage to the crystal whilst it is in the X ray beam, the crystals are first 
frozen.  There are 2 mains ways by which this can be achieved; using liquid nitrogen on the 
cryostream at 100K or liquid ethane.  To freeze a crystal on the cryostream, a crystal is picked with 
a loop from the hanging drop and placed in a drop of mother liquor from that well.  If the mother 
liquor does not contain some sort of cryo protectant, such as glycerol or PEG 550, this can be added 
in a stepwise manner so as not to disrupt the crystal by rapidly altering its environment.  For 
example, if a 30% glycerol concentration is desired, 3 4 small drops of glycerol can be pipetted next 
to the drop of mother liquor and each one mixed in separately, allowing time for the crystal to 
adjust to its new environment.  The crystal is mounted and rapidly exposed to the cryostream, 
instantly freezing it.  It is then stored in a vial of liquid nitrogen prior to exposure to the X ray 
beam.  To freeze the crystal in liquid ethane, the crystal is transferred to a cryo protectant is the 
same manner as described above, but is frozen by first being immersed in liquid ethane, then liquid 
nitrogen before being stored.  The higher heat capacity of liquid ethane may allow faster cooling 
rates. 
 
 
Protein crystals grow in very many shapes and sizes, sometimes many grow in one drop, in others there is only a single crystals.  This is 
determined by the protein and precipitant concentrations used, the conditions under which crystallisation occurs and how long they 
crystals are left to grow.  a) shows a single crystal of TkTDH with dimensions of approximately 0.7 mm x 0.1 mm x 0.1 mm.  b) shows 
several smaller SeMet BipD crystals of irregular shapes.  
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Figure 2.13: An X ray crystallographic diffraction pattern 
2.4  Protein X ray Crystallography 
 
This is a method by which a model of a protein molecule can be made, as it is not possible to see it 
directly with visible light (electromagnetic radiation with wavelengths (λ) 400 700 nm).  This is 
because in order to ‘see’ something, the object being viewed must be larger than the λ of light.  
Individual atoms within a protein molecule can therefore not be seen because the distance between 
these atoms is only about 0.15 nm (1.5 Å) and it is X rays that have wavelengths of around this 
magnitude.  However, X rays cannot be focused by lenses as visible light can.  To get around this 
problem, the direction and intensity of diffracted X rays are measured (as diffraction patterns) at 
different angles around the protein crystal.  Computer programs can then be used to analyse this 
data and construct a model of the molecule based on the observed data. 
 
 
2.4.1  Data Collection 
Data is collected from the protein crystal by firing X rays at it from different angles (often 180º at 
1º intervals).  The X rays diffracted by the electron clouds are recorded for each angle as diffraction 
patterns.  The spots created by an X ray striking the detector are called reflections, the darker it is 
the greater the intensity of the X ray beam that struck the detector (Figure 2.13). 
 
 
 
 
This 1º oscillation diffraction pattern is from 2,4 dihydroxyacetophenone dioxygenase.  The crystal diffracts the 
source beam into many distinct rays, each of which produces a reflection (spot) on the detector.  The position and 
intensity of these reflections contains the information necessary to reconstruct a model of the molecule. 
  
 
62 
 
2.4.2  Data Processing 
The first step in data processing is to convert the images within a dataset to a list of reflections 
indexed by their position or Miller indices (h,k,l), intensity estimates (I) and the standard error of 
those intensities (SIGI).  All of this information is recorded in a reflection file (.mtz).  The program 
chosen to perform this function was MOSFLM (part of the CCP4 suite), although other commonly 
used programs include XDS and HKL2000.  Although the basic principles behind these programs 
are similar, the methods utilised by each do differ.  Firstly the unit cell for the particular crystal 
must be determined.  This is done by measuring the intensity and position of a number of 
reflections, typically 100 200 from each image.  This information, along with the detector distance, 
X ray wavelength and detector type, is to construct the Bravais lattices and lattice type in reciprocal 
space. 
 
The crystallographic unit cell dimensions are described by the length of three edges (a, b, c) and 
three angles (α, β, γ).  The values of these dimensions will determine which of the seven crystal 
systems the unit cell falls into.  Combinations of these seven crystal systems (cubic, tetragonal, 
orthorhombic, rhombohedral, hexagonal, monoclinic and triclinic) coupled with the four lattice 
centerings (P   primitive, C   centred, F – face centered and I   internal) gives rise to 14 possible 
Bravais lattice types shown in Figure 2.14. 
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Figure 2.14: The 14 Bravais lattices 
These are the distinct lattice types which when repeated can fill the whole space.  There are 14 in three dimensional 
space, consisting of 7 crystal systems (cubic, tetragonal, orthorhombic, rhombohedral, hexagonal, monoclinic and 
triclinic) coupled with the 4 lattice centerings (P   primitive, C   centred, F – face centered and I   internal)  
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The Bravais lattices only describe how the unit cell can be translated in three dimensions to obtain 
crystal morphology; the point group provides information on how the asymmetric unit is positioned 
within the unit cell.  The possible symmetry operations that can be imposed on protein crystals are 
translations, rotations and screw axes (rotations and translations combined).  The combination of 
these possible symmetry operations of the point groups with the Bravais lattices, results in a total of 
65 allowed space groups relevant to protein crystallography.  More space groups are possible, but 
because proteins consist of L amino acids, many of the symmetry operations are not possible in 
protein crystals.  Each space group is represented by a symbol such as P43212, with the letter at the 
beginning being the lattice type (in this example primitive) and the numbers representing the 
symmetry operations within the unit cell. 
 
Once the reflection spots have been picked by MOSFLM, autoindexing can be used choose a space 
group with the highest symmetry.  Typically the solution with the highest symmetry and lowest 
penalty is chosen, as can be seen from Figure 2.15 where I4 is chosen over C2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.15: Crystallographic space group prediction by MOSFLM 
MOSFLM uses the positions of the reflections, along with the beam position, to predict a space group for the data.  This can be more 
accurately determined by refining the cell so that it picks a space group best fitted to all the data.  
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After the initial indexing solution has been picked, it can be further refined by comparing 
predictions across user defined images to try to find the "best" cell that fits the whole dataset.  Often 
this is carried out using at least 2 segments of 2 images 90 º apart.  This solution can be tested by 
predicting the positions of spots based on the images used to refine the cell, which should closely 
match the positions of actual observed reflections.  If this is the case then integration can be carried 
out to convert all the observed spots into a list of measured reflections.  Integration extracts 
intensity values for all of the reflections from each image in the dataset by summing up pixel values 
for each spot.  From the indexing parameters that were previously determined and refined, 
MOSFLM knows where to look on each image for all of the hkl reflections that are observed.  The 
success of the integration can be measured by viewing the summary file to ensure the "RESID" is 
below 0.15, the "WRESID" is close to 1.0 and the "I/sgI_out" is around 2. 
 
The program Sortmtz can be used to sort all the reflections before using Scala to scale all the 
equivalent symmetry related reflections together.  By integrating the images, the intensities of 
typically 100,000 hkl reflections that have been extracted are combined to leave only the 20,000 or 
so of these that are unique.  Many of the original observations will actually be separate 
measurements of the same hkl reflection or of symmetry related hkl reflections.  All the redundant 
intensity measurements of the hkl reflections can be merged into single, averaged values for the 
intensity of each symmetrically unique reflection hkl.  This is achieved by the program calculating a 
scale factor for each image and applying it the data to create uniformity in intensity across all 
images.  The log file gives a good indication of the quality of the data (Figure 2.16); particularly 
useful are the values for mean (I/sd), multiplicity, completeness and Rmerge.  The Rmerge value is a 
measure of the deviation in intensity between all the observed symmetry related reflections, which 
result from the range of symmetry elements in the space group.  Freidel’s law states that if the 
correct space group for the crystal has been chosen, the intensity of these reflections should be 
identical.  The program Truncate is run with Scala to convert any small negative intensities to 
positive values and then convert all data into mean structure amplitudes. 
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2.4.3  Phase Determination 
As well as knowing the position and intensity of the diffracted X ray reflections, it is also necessary 
to know the phase of the wave diffracted from the electron cloud of the molecule, but this 
information is lost during X ray crystallography.  Knowledge of the phases is necessary to make use 
of the reflection data collected because both are required to compute an image of the molecule. 
 
The recorded reflections can be described as complex three dimensional waves, which result from 
the superposition of the X ray waves scattered by the protein’s electron density, and can be 
described by a structure factor Fhkl: 
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This equation is used to relate the electron density in real space ρ (x, y, z) to the reflections 
measured in reciprocal space, after correcting for unit cell volume (V).  Fhkl is a periodic function 
describing a complicated wave and consists of a frequency, amplitude ׀Fhkl׀ and phase αhkl: 
 
Fhkl=|Fhkl| e
2πiαhkl 
 
Figure 2.16: An exert from the log file produced by Scala 
This table illustrates the statistics used as a measure of data quality.  The Mn (I/sd) should be about 2 and the 
Rmerge low, ideally below 0.1.  This indicates good data that has processed well.  
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The amplitude ׀Fhkl ׀ can be obtained directly from the diffraction data because it is directly 
proportional to the square root of the measured intensity Ihkl for the reflection hkl.  However, the 
phase angle of each reflection is unknown and is required to calculate ρ (x,y,z), and so obtain the 
positions of individual atoms in the protein molecule.  It is therefore necessary to obtain some phase 
information in order to determine a protein structure. 
 
If the structure of a similar protein has already been solved, then it can be used in molecular 
replacement to provide estimates of the phases for the new model.  The idea behind this method is 
to find the rotation and translation values that position the model structure in the experimental unit 
cell so as to give the highest correlation between observed diffraction measurements and those 
calculated from the model.  This method was used for the structure determination of TkTDH.  
However, because both BipD and DAD are novel proteins with no similar structures previously 
solved, this strategy is not an option and multiwavelength anomalous diffraction data must be 
collected from derivatives of these proteins, in order to calculate the phases. 
 
 
2.4.3.1  Molecular Replacement 
Molecular replacement involves borrowing the phases from a previously solved model and applying 
them to the unknown structure as an estimate of the phases.  This is perhaps the simplest method by 
which phases can be determined for structure determination, so long as a similar known structure is 
available with at least 40 % sequence or structural similarity to the unknown structure.  Molecular 
replacement becomes progressively more difficult as the sequence identity between the known and 
unknown proteins is reduced, or the completeness of the model decreases.  This method involves 
using the known model to determine the position (translation) and orientation (rotation) of the 
unknown molecule in the crystallographic unit cell. 
 
There are two main methods by which molecular replacement can be achieved.  Traditional 
molecular replacement methods are based on the properties of the Patterson function, which is the 
Fourier transform of the experimental intensities.  From this can be generated a Patterson map; a 
vector map with peaks at the positions of vectors between atoms in the unit cell and is thus unique 
to the protein.  Programs that use this method include MOLREP (Vagin and Teplyakov 1997). 
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However more recent programs, such as PHASER (McCoy 2007), use maximum likelihood based 
methods to perform molecular replacement, and this was the program of choice.  Molecular 
replacement requires searching in six dimensions, so to simplify this, the rotation and translation 
functions are performed separately.  The rotation function must first be solved to have any chance 
of solving translation function, because intermolecular vectors are determined by orientation as well 
as position.  When searching for more than one monomer in the asymmetric unit, PHASER will 
first search for one and once it has found it will fix it in position, before searching for the next 
monomer. 
 
The Log Likelihood Gain (LLG) used in PHASER, is a measure of the probability that the data 
would have been measured, given the model, so it allows us to compare how well different models 
agree with the data.  In the case of molecular replacement, the model consists of the atomic 
coordinates plus rotation and/or translation operators applied to those coordinates.  The LLG is the 
difference between the likelihood of the model and the likelihood calculated from a Wilson 
distribution, so it measures how much better the data can be predicted with your model than with a 
random distribution of the same atoms.  The LLG allows comparison of different models against the 
same data set, but the LLG values for different data sets should not be compared with each other. 
 
 
2.4.3.2  Anomalous Diffraction Phasing 
Multiwavelength anomalous diffraction (MAD) phasing requires the presence of one or more atoms 
with X ray absorption in the energy range for which X ray intensity data is to be measured 
(normally around 1Å).  The absorption edges of C, N, O, S and H are far away from the accessible 
energy range and are not generally useful for MAD phasing. However, elements with atomic 
numbers between roughly 20 and 40, or that are greater than 60, have accessible absorption edges.  
These include the transition metals, as well as atoms such as selenium, that can be artificially 
introduced into macromolecules.  MAD phasing experiments carried out in this project used BipD 
in which methionine residues were replaced by selenomethionine (SeMet BipD). 
 
The X ray diffraction experiment consists of measuring X ray intensity data at several different 
wavelengths at or near the absorption edge of the anomalous scattering atoms.  Changing the 
wavelength changes the intensities of the individual reflections and the differences in intensities can  
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be used to directly calculate the phase angle for each reflection.  In this research the experiments 
were carried out on beamlines at the ESRF, Grenoble. 
 
Once experimental data is available, the next step is to locate the anomalous scattering selenium 
atoms.  For structures with only a few such atoms, the locations can usually be determined by 
inspection of the appropriate Patterson function.  However if the structure has many anomalous 
scattering atoms then the Patterson function is too complicated for manual interpretation.  Another 
approach is based on automated interpretation of the Patterson function in combination with 
difference Fourier techniques.  This technique is the basis for the program SOLVE, which scales 
data, solves Patterson functions, calculates difference Fourier’s, looks at a native Fourier to see if 
there are distinct solvent and protein regions, and can score partial MAD and multiwavelength 
isomorphous replacement (MIR) solutions to build up a complete solution.  The resultant electron 
density map can then be improved using RESOLVE, by using a statistical approach to combine the 
experimental X ray diffraction information with knowledge about the expected characteristics of an 
electron density map of a macromolecule. 
 
 
2.4.4  Refinement and Model Building 
Once an electron density map has been generated, it can be refined using programs such as 
REFMAC (Vagin et al. 2004), CNS (Brunger et al. 1998) and PHENIX (Adams et al. 2002), and 
model building carried out using programs such as TURBO FRODO and COOT (Emsley and 
Cowtan 2007).  Through a series of alternate refinement and manual model building steps, the 
experimental model can be modified to better fit the experimental data, and this is monitored by 
comparing the Rfree value with the Rfactor.  The Rfree is calculated using 5 10 % of the total 
reflections, which are not used in the refinement and thus provide an unbiased assessment of each 
refinement step.  Both figures should be low, indicating good model agreement, and there should 
only be a small difference between the values, indicating good agreement between the observed 
data and the refined data model. 
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2.4.4.1  Refinement 
Refinement is the iterative process of optimising the agreement between the observed structure 
factor amplitudes from the diffraction data and those calculated from the atomic model, also taking 
into consideration chemical parameters such as bond angles and length.  A balance is reached 
between the weight carried by the experimental data versus that of known chemical parameters, 
depending on the quality and resolution of the experimental data; the better it is the less 
supplementary restraints are required to ensure a good model is produced. 
 
Atoms are able to exist in a variety of energy states, resulting in many local energy minima as well 
as the global minimum, which is where the atoms should be.  This problem can be solved through 
the use of programs like CNS and PHENIX, which are able to overcome the energy barrier through 
the use of a technique called simulated annealing.  Annealing is a physical process in which a solid 
is heated until all atoms randomly arrange themselves in a liquid phase and is then slowly cooled, 
enabling the atoms to reach the lowest possible energy state.  Simulated annealing is a 
computational simulation of this annealing process and increases the probability of finding a more 
optimal position for an atom.  These local minima can also be overcome by manual model building.  
Refinement programs such as CNS and PHENIX are also able to refine atomic positions with the 
help of constraints and restraints.  For example the occupancy of a particular atom can be set or 
constrained to a specific value during refinement.  This is usually set a 1.0 (or 100 %), but for 
TkTDH the occupancies of the NAD
+ atoms were set at 0.5 to best account for the fact that only 50 
% for the co factor binding sites were occupied.  Restraints are more flexible, for example bond 
angles and lengths are usually restrained to a particular range of values as opposed to being given a 
single set value. 
 
Once the model had been refined a few times and therefore represented a better fit with the 
experimental data, another refinement program, REFMAC, was used.  These programs not only 
differ in their user interface, but also in their method of parameter refinement. REFMAC uses the 
method of maximum likelihood in which atom positions are selected that maximise the probability 
of the model.  REFMAC can be used to refine group B factors, ligand occupancy and NCS 
restraints.  In the final rounds of refinement the NCS restraints are relaxed and eventually removed 
altogether, as the model is now good enough to be refined without these. 
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Refinement programs produce files containing the coordinates of each atom (.pdb) as well as Fo Fc / 
2Fo Fc maps, which record the electron density and difference density (.mtz or .map).  These are 
used by model building programs to manually adjust the model. 
 
 
2.4.4.2  Model Building 
The graphics program COOT was used for the majority of model building in these structures, 
although TURBO FRODO was also utilised in some instances.  The aim of such programs is to 
better fit the model to the observed electron density by making manual alterations not carried out 
during refinement.  The 2Fo Fc electron density map depicts a molecular surface net extended over 
the atoms in the molecule, as shown in Figure 2.17. 
 
 
Figure 2.17: Electron density from a 2Fo Fc map 
 
 
The Fo Fc map is used to aid model building by highlighting areas of positive and negative density.  
Positive density implies that the contribution of the observed intensities (Fo) to ρ is greater than that 
of the calculated structure factors (Fc), therefore the unit cell contains more electron density than 
implied by the current model and requires the movement of atoms towards this area to increase the 
electron density.  This often occurs if atoms are absent from a part of the model where they should 
actually be present.  The converse is true for negative density, and suggests that atoms must be 
moved away from this area, i.e. they are not actually there in the protein.  Figure 2.18 illustrates part  
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of the model incorrectly built, showing negative density where a residue should not be, and positive 
density where a residue should be. 
 
 
Figure 2.18: Positive and negative Fo Fc difference electron density 
 
 
 
COOT was first used to mutate the initial model sequence (determined by the search model) to the 
correct sequence for the protein structure being determined.  It could then be used to overcome local 
energy minima in the model by manual intervention in real space to move residues into predicted 
locations, guided by the electron density and difference maps, as illustrated in Figure 2.19. 
 
 
   
Figure 2.19: Modified residue in electron density 
 
 
The picture on the left show the electron density before refinement and the picture on the right shows the 
improved density after refinement.  
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Once the model was a reasonable fit with the electron density, ligands were modelled in as 
necessary, i.e. for TkTDH density was observed for NAD
+.  The RCSB PDB database was used to 
obtain the atomic coordinates (.pdb file) for NAD
+.  This data was then fed into the online program 
PRODRG, which generated a dictionary file for the ligand (.cif file).  These files could then be read 
into COOT and the ligand modelled into the appropriate density in each monomer.  The ligand and 
protein model .pdb files were merged and the.cif file used to refine the ligand.  Lastly, waters were 
added to the model. 
 
 
2.4.5  Validation and Structural Analysis 
Once the Rfactor and Rfree were as low as could be achieved, the online validation server Procheck 
(Laskowski et al. 1993) was used to assess the validity of the model.  Parameters such as bond 
lengths were checked and the deviation of the peptide bonds φ (phi) and ψ (psi) from the standard 
angles shown on a Ramachandran plot (Figure 2.20). 
 
 
Figure 2.20: Ramachandran plot showing the peptide bond angles Phi and Psi  
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Residues in the most favoured regions lie in the red areas and include those angles that best fit the 
standard bond angles.  Others lie in the additional allowed regions (yellow) and generously allowed 
regions (beige).  Those residues that lie in the disallowed region are those whose φ and ψ angles 
deviate significantly from the standard angles.  Other factors that were validated were the B factors, 
cis peptides and water molecules. 
 
Analysis was carried out using malign (Wheeler and Gladstein 1994) and alscript (Barton 1993) to 
align the primary sequences.  Structural figures were prepared using CueMol, PyMOL (DeLano 
2008) and CCP4MG (Potterton et al. 2004). 
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Chapter 3 
 
Structural studies of 
Burkholderia pseudomallei 
Invasion Protein D from 
Burkholderia pseudomallei 
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3.1  Introduction 
 
Translocator proteins like BipD are part of the type III secretion apparatus used by bacteria to insert 
selected proteins into the cells of host organisms in order to infect the target cell and replicate.  
BipD is expressed by the gram negative saprotroph Burkholderia pseudomallei, the causative agent 
of melioidosis.  This is a serious infectious disease of both animals and humans, endemic to tropical 
and subtropical regions particularly Southeast Asia and Northern Australia (Gan 2005).  Most 
commonly this disease manifests itself clinically as abscesses, pneumonia and, at worst, as a fatal 
septicaemia, but actually has a complex spectrum of clinical manifestations making it difficult to 
diagnose and treat effectively (Aldhous 2005).  B. pseudomallei is known to infect most cell types 
and it appears able to evade, and perhaps actively interfere with, the host’s immune system (Gan 
2005).  BipD may also be involved in the bacterium’s ability to escape from endocytic vesicles 
through actin polymerisation and the formation of protrusions, facilitating cell to cell spread 
(Stevens et al. 2004). 
 
Melioidosis does not tend to affect Western visitors to endemic countries, so consequently research 
into the bacterium attracts relatively little funding.  However the West’s awareness of B. 
pseudomallei has increased in recent years since being identified and labelled as a potential 
biological terrorist weapon, thanks to which research into the organism is now being promoted at 
the US National Institute of Allergy and Infectious Diseases through its biodefence initiative 
(Aldhous 2005). 
 
The BipD protein is a component of the B. pseudomallei type III protein secretion system (TTSS) 
where it is a translocator protein that transports bacterial effector proteins across the plasma 
membrane into a host cell.  These then subvert or inhibit the cell’s processes for the benefit of the 
bacterium.  It is thought BipD is located at the tip of the secretion needle and may act as a ‘plug’ to 
regulate the secretion of effector proteins, and as a ‘sensor’ to tell the bacterium when to secrete 
them. 
 
B. pseudomallei strains containing mutated BipD exhibit reduced virulence but this does not 
eliminate the development of fatal melioidosis, indicating that it is part of a system, rather than 
acting alone (Stevens et al. 2004).  It is hoped that by elucidating the structure of BipD we will 
better understand how this specific TTSS functions, potentially offering a target for prophylactic 
drugs against melioidosis.  There are several known homologues of BipD in TTSS of other bacteria  
 
77 
 
so knowledge of its structure will also contribute to a better understanding of how these TTSS 
function generally, maybe offering up potential targets against other diseases. 
 
 
3.2  BipD Expression and Purification Protocol 
 
3.2.1  DNA Manipulation 
The initial BipD expressed was a GST fusion protein, but later problems during purification 
necessitated the design of the bipd gene without the GST tag.  Agarose gel electrophoresis was used 
throughout to provide qualitative analysis of DNA samples (see appendix for method). 
 
 
3.2.2  Transformation 
JM109 cells were used to obtain the bipd plasmid for small scale plasmid purification (although 
BL21(DE3) were later used for overexpression).  20  l JM109 competent cells from the  80ºC 
freezer were thawed on ice.  bipd DNA was mixed with the cells and left on ice for 5 minutes.  
These were then heat shocked by immersing in 42 ºC water for 1 minute then put back on ice.  1 ml 
Luria Bertani growth medium (LB) was added to the cells and they were grown at 37 ºC for 1 hour 
on a shaker. 
 
The sample was centrifuged at 13,000 rpm for 3 minutes and 900  l supernatant discarded.  The 
pellet was resuspended in the remaining 100  l and spread onto an ampicillin agar plate (see 
appendix for method).  This was left to grow overnight at 37 ºC.  4 colonies were picked from the 
plate and used to inoculate 4 separate 10ml bottles of LB + 5  l ampicillin.  These were grown 
overnight at 37 ºC.  The cultures were centrifuged at 14,000 rpm for 5 minutes and the supernatant 
discarded. 
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3.2.2.1  Plasmid Purification 
A plasmid purification kit (QIAprep Spin Miniprep Kit) was used to extract the DNA.  The pelleted 
bacterial cells were resuspended in 250  l Buffer P1 (containing RNase A) and transferred to a 
microcentrifuge tube.  250  l lysis Buffer 2 was then added and the tube gently inverted 4 6 times 
to mix, after which the solution turned blue.  350  l Buffer N3 was added and the tube immediately 
inverted 4 6 times to mix.  The microcentrifuge tube was centrifuged for 10 minutes at 13,000 rpm. 
 
The resultant supernatant was decanted into a QIAprep spin column and centrifuged for 60 seconds.  
The flow through was discarded and the column washed using 0.5 ml Buffer PB to remove trace 
nuclease activity.  The column was centrifuged for 60 seconds at 13,000 rpm and the flow through 
discarded.  0.75 ml Buffer PE was used to again wash the column and it was centrifuged for 60 
seconds at 13,000 rpm.  The flow through was discarded and the column again centrifuged for 60 
seconds.  The column was placed in a microcentrifuge tube and the DNA eluted by adding 50  l 
H20 to the centre of the column, leaving them to stand for 60 seconds then centrifuging for 60 
seconds. 
 
 
3.2.2.2  Quantitative Analysis of DNA 
A Pharmacia Biotech Ultrospec 3000 spectrophotometer was used to scan the DNA sample.  A peak 
of 0.116 absorbance was observed at a wavelength of 260 nm, indicating 5.28 µg bipd DNA 
present.  Any remaining liquid was evaporated off. 
 
 
3.2.2.3  Primer Design 
The bipD gene sequence is shown below: 
CGGACCGGGTACATTTCCCCTCTAGAATAATTTTGTTTAACTTTAAGAAGGAGATATACATATGGG
ACGCGCGCTGACCGTGCGCGATTGGCCGGCGCTCGAGGCGCTCGCGAAGACGATGCCGGCCGATGC
CGGCGCGCGGGCGATGACCGACGACGATCTGCGCGCAGCGGGCGTCGATCGCCGCGTGCCGGAGCA
AAAGCTCGGCGCGGCGATCGACGAATTCGCGTCGCTCCGGCTGCCCGATCGGATCGACGGGCGCTT
CGTCGATGGCCGCCGCGCGAACCTCACGGTGTTCGATGATGCACGCGTGGCGGTGCGCGGCCACGC
GCGCGCGCAGCGCAACCTGCTCGAGCGCCTGGAAACCGAGCTCCTGGGCGGCACGCTGGACACCGC
GGGCGACGAAGGCGGCATCCAGCCGGACCCGATCCTTCAGGGGCTCGTCGACGTGATCGGCCAGGG
CAAATCCGATATCGATGCGTACGCAACGATCGTCGAGGGGCTGACGAAGTACTTCCAGAGCGTCGC 
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CGACGTGATGAGCAAGCTGCAGGACTACATCTCGGCGAAAGACGACAAGAACATGAAGATCGACGG
CGGCAAGATCAAGGCGTTGATCCAGCAGGTCATCGACCATCTGCCGACGATGCAGTTGCCGAAAGG
GGCCGACATCGCGCGCTGGCGCAAGGAGCTCGGCGATGCCGTCTCGATCAGCGATTCGGGCGTCGT
GACGATCAATCCGGACAAGCTGATCAAGATGCGCGATTCGCTGCCCCCTGACGGCACGGTGTGGAC
ACCGCGCGCTACCAGGCCTGGAACACCGCGTTCTCCGGGCAGAAGGACACATCCAGAACGATGTGC
AGACGCTCGTCGAAAATACTCGCACCAGACTCGAACTTCGACATCTGGTCAGTGCTGAGCGGCGCG
ATCTCGACGCTCACGACACGCAGAGCTATCTGCAGATCTGATAGGCGATCGCTGCTACAAGCCGAA
GAGCTGAATGCTGCTGCACGCTGACATACTAGCATACCTGGCTCTACGTCTGAGGGATTTTGCTGA
GAGACTATCCGGATTCCGCAAGCCGCGTACGGCTACCAGCTATGCTACGATCAGGTACGTCAGATG
ACTGAGCCATGTGATTCTACCGCGCTAGTCTGCATACGCAATCGTAGCTACGGTAACCGTCACTGA 
 
 
Translating to: 
Met G R A L T V R D W P A L E A L A K T Met P A D A G A R A Met T 
D D D L R A A G V D R R V P E Q K L G A A I D E F A S L R L P D R 
I D G R F V D G R R A N L T V F D D A R V A V R G H A R A Q R N L 
L E R L E T E L L G G T L D T A G D E G G I Q P D P I L Q G L V D 
V I G Q G K S D I D A Y A T I V E G L T K Y F Q S V A D V Met S K 
L Q D Y I S A K D D K N Met K I D G G K I K A L I Q Q V I D H L P 
T Met Q L P K G A D I A R W R K E L G D A V S I S D S G V V T I N 
P D K L I K Met R D S L P P D G T V W T P R A T R P G T P R S P G 
R R T H P E R C A D A R R K Y S H Q T R T S T S G Q C Stop 
 
Primers were designed for the bipd gene.  The oligonucleotide sequences chosen were: 
5’ end primer (Tm 63 ºC) 
ggatctagacatatgggacgcgcgctgaccgtgcgcgat 
 
3’ end primer (Tm 64 ºC) 
ggcgcaagcttggatccgccctatcagatctgcagatagct 
 
These sequences were run through the online program webcutter (http://rna.lundberg.gu.se/cutter2/) 
to ascertain if they contained restriction endonuclease cleavage sites for BamHI, HindIII, NdeI, 
XbaI.  None of those endonucleases were predicted to cut the BipD sequence. 
 
 
3.2.2.4  Polymerase Chain Reaction 
PCR was used to amplify up the bipd gene.  1 l of DNA (100 ng/ l) was mixed with; 1  l bipd 1 
primer, 1  l bipd 2 primer, 5  l Mg free buffer, 3  l MgCl2 25 mM, 1  l PCR mix nucleotides and 
38  l H2O making a total volume of 50  l.  0.25  l Taq polymerase was added and centrifuged.  The 
following method was programmed and the sample inserted:  
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Programme 1:  94 ºC for 1 min 
Programme 2:  segment 1: 94 ºC for 1 minute (melt) 
    segment 2: 55 ºC for 1 minute (anneal)        30 cycles 
    segment 3: 72 ºC for 3 minutes (polymerisation) 
Programme 3:  72 ºC for 10 minutes to complete all replication 
Programme 4:  4 ºC for 24 hours. 
 
The 50  l DNA was cleaned using a QIAquick PCR purification kit.  250  l of Buffer PB was 
added to the 50  l PCR sample and mixed.  This was transferred to a QIAquick column, centrifuged 
for 60 seconds at 13,000 rpm and the flow through discarded.  0.75 ml Buffer PE was used to wash 
the column and it was centrifuged for 60 seconds.  The DNA was eluted into an microcentrifuge 
tube by adding 30  l elution buffer, leaving it to stand for 60 seconds then centrifuging for 60 
seconds.  The univap was used to evaporate off any remaining liquid. 
 
 
3.2.2.5  DNA Digest 
The DNA was resuspended in 10  l H2O and digested using the restriction endonucleases Nde1 and 
BamH1.  The pET11a plasmid was also digested using the restriction enzymes independently as 
controls to check for a successful digest. 
 
  vol DNA  BSA  H2O  Nde1  Buffer D  BamH1 
BipD  5  1  1  1  1  1 
pET11a (N)  1  1  6  1  1  0 
pET11a (B)  1  1  6  0  1  1 
 
 
The samples were set up as shown here but initially without the BamH1.  These were incubated at 
37 ºC for 2 hours after which BamH1 was added to the appropriate samples.  They were then 
incubated for a further 2 hours and an agarose gel run to check that the digest was successful. 
 
 
] 
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3.2.2.6  DNA Ligation 
The ligations were set up using a 1:8 ratio of plasmid to insert: 1 l digested DNA, 1  l double cut 
pET11a plasmid, 1  l ligase, 1  l buffer, 1  l BSA and 5  l H2O.  This was left for 4 hours at 16 ºC. 
 
 
 
 
 
 
 
3.2.2.7  Large scale Preparation of Plasmid 
The plasmid containing the insert coding for BipD was used to transform BL21 E.coli cells, as 
described above and these were plated onto an ampicillin agar plate and grown overnight at 37 ºC.  
A single colony was picked and used to inoculate 5 ml LB with ampicillin and grown overnight at 
37 ºC.  The cells were harvested by centrifugation at 14,000 rpm for 15 minutes and the supernatant 
discarded. 
 
The bacterial cell pellet was resuspended in 10 ml lysis Buffer P1 and 10 ml Buffer P2 was mixed 
in by gentle repeated inversion.  This was incubated at room temperature for 5 minutes.  10 ml of 
chilled Buffer P3 was added and the solution immediately mixed before being incubated on ice for 
20 minutes.  The sample was centrifuged at 14,000 rpm for 30 minutes.  The supernatant containing 
the plasmid DNA was removed and centrifuged for a further 15 minutes. 
 
A QIAGEN tip 500 was equilibrated by applying 10 ml Buffer QBT and allowing the column to 
empty by gravity flow.  The supernatant was then applied and allowed to enter the resin by gravity 
flow.  The QIAGEN tip was washed with 2x30 ml Buffer QC to ensure the removal all 
Figure 3.1: An agarose gel showing a plasmid ligation sample 
Lane 12 (highlighted) shows 2 fragments, the plasmid at the top of the gel and the 
insert further down, indicating that the ligation was successful.  
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contaminants and the DNA eluted using 15 ml Buffer QF.  The DNA was precipitated by the 
addition of 10.5 ml isopropanol and centrifuged at 8,000 rpm for 30 minutes.  The DNA pellet was 
washed with 10 ml room temperature 70 % ethanol and centrifuged at 8,000 for 15 minutes.  The 
supernatant was discarded and the pellet allowed to air dry overnight. 
 
The DNA was dissolved in 1ml autoclaved H2O and centrifuged for 1 minute at 13,000 rpm to 
remove any particles.  Quantitative analysis at 260 nm showed a quantity of 396  g DNA.  It was 
then dried in the univap, resuspended in 396  l H2O to a concentration of 1  g/ l and frozen.  The 
DNA was sequenced and the correct sequence confirmed. 
 
 
3.2.3  Protein Expression 
 
3.2.3.1  Protein Expression of Seleno methionine Protein 
Because crystals of the native protein had already been grown, it was necessary to express a 
selenomethionine derivative to enable structure determination by anomalous X ray diffraction.  At 
that time no homologues of BipD had been sequenced, hence structure determination required a 
heavy atom derivative to calculate the phases of the X rays as they diffract from the protein crystal.  
This was achieved through the incorporation of selenium atoms. 
 
A starter culture of BipD (with the GST tag for the SeMet protein and without for the native 
protein) was grown up overnight in 10ml with ampicillin (always at a final concentration of 100 
µg/ml unless otherwise stated), at 37 ºC.  1 L LB medium was inoculated with a 10ml starter culture 
and ampicillin and grown at 37 ºC to mid log phase with an optical density of approximately 0.6 
OD600.  At this stage the culture was decanted into a sterile (ethanol washed) 1000 ml Beckman 
centrifuge bottle and centrifuged at 7,000 rpm for 20 minutes. 
 
Ampicillin and 12 ml of 20 % sterile glucose was added to 1 L of sterile M9 minimal medium (see 
appendix for method) and 20 ml removed for later use. 
 
Once the LB culture had been centrifuged, the supernatant was discarded and the pellet resuspended 
in 20 ml M9 media and kept on ice for 1 hour.  This was then used to inoculate the 1 L of M9  
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minimal medium and incubated at 37 ºC for 45 minutes, during which time the cells are starved of 
many nutrients including methionine.  The subsequent addition of 10 ml amino acid mix 1, 10 ml 
amino acid mix 2, 1 ml vitamins and 4 ml seleno – L – methionine (see appendix for methods) 
forces the cells to use selenomethionine and leads to the incorporation of it in place of methionine.  
This culture was grown for 20 minutes at 37 ºC then heat shocked by shaking in a 42 ºC water bath 
for 25 minutes, followed by 5 minutes on ice water.  A final concentration of 0.3 M IPTG was used 
to induce BipD expression and the culture was grown at 16 ºC for 48 hours to encourage slow 
induction of protein and avoid the formation of inclusion bodies. 
 
 
3.2.3.2  Over expression of Native Protein 
It was attempted to grow further native BipD crystals to improve the resolution of X ray data 
collected.  A starter culture of BipD was grown up overnight in 10ml and ampicillin, at 37 ºC.  1 L 
LB medium was inoculated with a 10 ml starter culture and ampicillin and grown at 37 ºC to mid 
log phase with an optical density of approximately 0.6 OD600.  It was induced with filter sterilised 
IPTG to a final concentration of 0.5 M and grown overnight at 37 ºC, Figure 3.2. 
 
 
3.2.3.3  Harvest Cells 
The 1L bacterial cell culture was centrifuged at 7,000rpm for 1 hour and the supernatant discarded.  
The bacterial cell pellet was resuspended in 20 ml 50 mM TRIS pH 8. 
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3.2.3.4  Sonication 
To remove soluble fractions (including the BipD protein) from the cell, sonication was used to 
disrupt the cell membrane and allow the contents to spill out.  The sample was put on ice and 
sonicated in a Soniprep 150 sonicator for 10 cycles of 30 seconds ON and 90 seconds OFF, then 
centrifuged at 18,000 rpm for 1 hour to remove the cell debris.  The supernatant was separated off 
and the pellet resuspended in 5 ml 50 mM TRIS pH 8.  SDS gel electrophoresis was used to confirm 
the induction of BipD and indicate whether it was present as soluble or insoluble protein. 
 
 
3.2.4  Crude Purification 
 
3.2.4.1  Ammonium Sulphate Precipitation 
This is a crude method by which a soluble protein can be separated from the initial cell mixture 
because different ammonium sulphate concentrations cause different proteins to precipitate out of 
solution.  Impurities are precipitated out by raising the ammonium sulphate concentration up to the 
Figure 3.2: SDS gel showing pre and post IPTG induced samples 
The gel shows no induction of BipD in the uninduced cells, or in lane 5, but over 
expression of the protein in lanes 3 and7.  
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point at which BipD just remains soluble, and then to raise the concentration again to the point 
beyond which very little BipD remains in solution. 
 
Steps of 15 % (NH4)2SO4 addition were used to determine the precipitation points.  It is known that 
55 % saturation requires 0.35 g/ml (NH4)2SO4, so for a volume of 25 ml supernatant, 2.38 g was 
added.  This was mixed well then centrifuged at 18,000 rpm for 40 minutes to remove the 
precipitate.  A sample of both the pellet and supernatant was taken for SDS gel electrophoresis (see 
appendix for method).  After the supernatant had been separated from the pellet a further 2.38 g 
(NH4)2SO4 was added taking the saturation to 30 %.  This was again centrifuged and the above steps 
repeated until 75 % saturation was achieved.  Analysis by SDS gel electrophoresis showed that 
BipD precipitated out at 45 % ammonium sulphate saturation (data not shown). 
 
 
3.2.4.2  Dialysis 
Dialysis is necessary to remove the high salt content present in the sample as a result of ammonium 
sulphate precipitation.  1m of 12kDa pore dialysis tubing was boiled for 10 minutes with NaHCO3 
and EDTA to remove any residual heavy metal impurities.  The 45 % pellet was resuspended in 10 
ml 50 mM TRIS pH8 and pipetted into the dialysis tubing.  Any air was removed and the tubing 
sealed at both ends.  It was immersed in 2 L 20 mM TRIS pH 8 and left stirring for 48 hours at 4 ºC. 
 
 
3.2.5  Column Purification (with the GST fusion protein) 
All buffers used in column purification were degassed. 
 
 
3.2.5.1  GSTrap Affinity Chromatography 
The column was washed with dH2O, binding buffer and elution buffer to remove any contaminants 
(see appendix for methods).  A 2 ml sample of BipD was diluted with 3 ml binding buffer and 
loaded onto the column at 0.5 ml/min using an Akta Prime machine and washed with binding buffer  
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to remove contaminants.  1.6 mg thrombin dissolved in 5 ml binding buffer was then loaded onto 
the column and left for 20 hours to allow it to cleave the GST – BipD bond. 
 
The column was washed with 30 ml binding buffer to remove the BipD and thrombin from the 
column.  The bound GST was eluted with 30 ml 50 mM TRIS containing 10 mM reduced L 
glutathione pH 8. 
 
 
3.2.5.2  Removal of Thrombin 
The purification of BipD from thrombin was achieved by buffer exchange to 20 mM TRIS pH 8 
containing 500 mM NaCl and passage through a 1 ml Amersham Biosciences benzamidine column.  
Pure BipD was eluted and the thrombin eluted from the column with 20 mM TRIS containing 500 
mM NaCl and 10 mM p aminobenzamidine. 
 
 
3.2.6  Column Purification (with no GST tag) 
 
3.2.6.1  Q Sepharose Anion Exchange Column 
The column was washed with 1 M KCL then equilibrated with 50 mM TRIS pH8.  The post 
dialysis BipD was diluted to 60 ml and loaded onto the column at 3 ml/min.  It was washed to 
remove any non specific binding then a KCl gradient 0 M – 0.8 M was set up over 950 ml to elute 
the protein, which was collected in 10 ml fractions.  A gel was run to determine the BipD content 
and the appropriate fractions pooled.  This was buffer exchanged and concentrated to 5 ml using a 
10 kDa Vivaspin. 
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3.2.6.2  Superdex 200 Gel Filtration Column 
The column was washed and equilibrated with 140 mM NaCl and 50 mM TRIS pH 8.  A 1 ml 
protein sample was loaded onto the column at 0.5 ml/min and 2 ml fractions collected over an 8 
hour time period.  A gel was run to determine in which fractions the protein was present. 
 
 
 
3.3  Crystallisation 
 
The final yield of SeMet protein was approximately 30 mg/l of culture.  For crystallization this was 
concentrated to 6 mg/ml using a 10 kDa vivaspin ultracentrifugation spin column. 
 
Crystallisation screens were set up by the hanging drop method, based on conditions used 
previously to obtain crystals of the native protein.  Within 3 weeks promising crystals were 
observed and following optimisation of the crystallisation conditions good quality crystals, up to 
1mm in length, Figure 3.3, were obtained under these conditions; [SeMet BipD] = 4 mg/ml, 20 25 
% PEG 4000, 5 mM nickel chloride, 0.1 M glycine, 0.1 M sodium cacodylate (pH 5.0 5.5) (Erskine 
et al. 2006).  After 4 weeks growth, crystals were picked, cryo protected with 30 % (v/v) glycerol 
and mounted in mohair loops or litholoops (Molecular Dimensions) for freezing in liquid ethane 
and storage under liquid nitrogen. 
 
   
Figure 3.3: BipD protein crystals 
Crystals were grown by the hanging drop method with a concentration of 4 mg/ml SeMet BipD in 20 25 % PEG 4000, 5 mM 
nickel chloride, 0.1 M glycine, 0.1 M sodium cacodylate (pH 5.0 5.5).  The largest of these crystals measured 0.5mm in the 
longest dimension, and grew after 4 weeks.  
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3.4  Structure Determination 
 
The structure determination of BipD was carried out by Dr Peter Erskine and Dr Jon Cooper. 
 
3.4.1  Data Collection and Processing 
The SeMet BipD crystals were taken to the European Synchrotron Radiation Facility (ESRF) in 
Grenoble where they were found to diffract to a resolution of 2.1 Å using the ID23 1 beamline.  A 
dataset, Figure 3.4, was collected at the selenium peak wavelength and processed using MOSFLM 
(Leslie 2006), SCALA (Evans 2006) and other programs in the CCP4 suite (CCP4 1994). 
 
 
 
 
This indicated the crystals belonged to the monoclinic space group P21 and had cell dimensions of 
a=53.5 Å, b=56.2 Å, c=84.2 Å, β= 94.5 Å.  Use of the Matthews Coefficient program in CCP4 
suggested 2 monomers of BipD were present per crystallographic asymmetric unit, with a solvent 
content of 35 %. 
Figure 3.4: X ray diffraction image for BipD 
185 images were collected at 1º intervals at the ESRF.  The crystal diffracted to 2.1 Å resolution.  
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Since attempts at SAD phasing using the above data were unsuccessful, multi wavelength 
anomalous dispersion (MAD) X ray data were collected from another crystal using beam line 
BM16.  Data to a resolution of 3.0 Å were collected at the selenium fluorescence peak wavelength 
(0.9794 Å), followed by a remote dataset (0.9077 Å) and lastly an inflection point dataset (0.9796 
Å).  The data were processed as above and the relevant statistics are shown in Table 2. 
 
 
3.4.2  Refinement and Model Building 
Six out of the 12 expected selenium sites were located by use of the program SOLVE/RESOLVE 
(Terwilliger and Berendzen 1999), which produced an excellent electron density map as shown in 
Figure 3.5.  Segments of polypeptide were fitted to the map using the automatic map fitting 
program MAID (Levitt 2001) and were rebuilt using TURBO FRODO (Biographics, Marseille) and 
WinCOOT (Emsley and Cowtan 2007).  Thus one monomer with the correct sequence of BipD was 
built into the map and a copy of this model was then fitted by visual inspection to the electron 
density for the second subunit in the asymmetric unit. 
 
Dataset  Peak  Remote  Inflection  SAD 2.1 Å dataset 
ESRF beam line  BM16  BM16  BM16  ID23 1 
λ (Å)  0.9794  0.9077  0.9796  0.9794 
Resolution (Å)  40.0 3.0 (3.2 3.0)  40.0 3.0 (3.2 3.0)  40.0 3.0 (3.2 3.0)  38.7 2.1 (2.2 2.1) 
Rmerge (%)  8.5 (16.2)  8.3 (17.8)  8.4 (21.2)  8.6 (41.1) 
Completeness (%)  99.4 (100.0)  99.6 (100.0)  99.7 (100.0)  97.5 (93.4) 
Average I/σ(I)   25.0 (11.3)  26.7 (12.1)  26.9 (11.1)  10.4 (2.8) 
Multiplicity   9.9 (10.1)  9.8 (10.0)  9.8 (10.0)  3.7 (3.5) 
Values for the outer resolution shell of each dataset are shown in parentheses 
Rmerge=Σh|(Ihi–Ih)|/Σi (Ihi) where Ih is the mean intensity of the scaled observations Ihi. 
Table 2: Statistics for BipD datasets 
A 2.1 Å SAD dataset was collected, but this was insufficient for structure determination, so a MAD dataset 
was collected from a different crystal on a different beamline. 
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A further 3 selenium sites were located from an anomalous difference Fourier and used in phasing.  
Model building was assisted by the use of the density modification program DM (Cowtan 1994) to 
extend the experimental MAD phases to higher resolution.  The model was refined using the 2.1 Å 
resolution dataset from the other crystal by use of the programs SHELX 97 (Sheldrick and 
Schneider 1997) and CNS (Brunger et al. 1998), interspersed with rounds of manual rebuilding and 
solvent fitting.  The Rfree reflection set was chosen using SHELXPRO (Sheldrick and Schneider 
1997) in thin resolution shells to avoid bias between the working and test sets due to the presence of 
non crystallographic symmetry.  Except for the initial round of refinement in which rigid body 
constraints were applied to both monomers in the asymmetric unit, non crystallographic symmetry 
(NCS) restraints were not used. 
 
Figure 3.5: A section of the electron density map for part of helix 8 
Approximately 80 % of the model was built using data from the crystal used in the MAD collection, which diffracted 
to 3 Å.  This was then refined using the 2.1 Å dataset from the other SeMet BipD crystal from which the SAD dataset 
was collected.  The fit is very good in most regions, although it remains poor for some residues at the N and C termini 
and the loop region between residues 112 and 128, despite extensive efforts to rebuild them throughout the refinement 
process.  This disorder in the loop region may however have functional significance.  
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Figure 3.6: A Ramachandran plot for the BipD model 
The final model has 88.8 % of its residues within the ‘most favoured’ regions of the Ramachandran plot, by 
PROCHECK criteria, and 99.6 % of residues lie within the so called ‘generously allowed’ boundary.  The 
remaining 0.4 % of residues (indicated by labelled red squares) are in parts of the molecule with poor electron 
density and hence their conformations are poorly defined.  The black triangles indicate glycine residues.  
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Figure 3.7: A dimer of BipD forming the crystallographic asymmetric unit 
Figure 3.8: Schematic of the BipD protein molecule’s topology 
The central black dot indicates where both monomers associate with approximate 2 fold symmetry by contacts involving helices 4 
(front) and 8 (back).  It is yet to be determined whether this is a biologically functional structure. 
 
α helical segments shown in pink and β strand regions shown in green.  The loop region linking helices 
α3 and α4 is shown dashed since this region is poorly defined by the electron density map.  
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The refinement statistics of the final model, Figure 3.7, are shown in Table 3.  The Ramachandran 
plot for this model is shown in Figure 3.6. 
 
Rfactor (%)  22.6 
Rfree (%)  29.9 
Number of reflections  28,488 
RMSD bond lengths (Å)  0.004 
RMSD 1 3 distances (Å)  0.017 
RMSD bumps (Å)  0.014 
RMSD chiral tetrahedral (Å)  0.024 
RMSD planar groups (Å)  0.022 
Mean B factor for main chain atoms (Å
2)  43.0 
Mean B factor for side chain atoms (Å
2)  46.5 
Mean B factor for whole chain (Å
2)  44.7 
 
Table 3: Refinement statistics for the BipD structure 
All data between 10.0 Å and 2.1 Å resolution with no σ(I) cut off were used in the 
refinement except for 5 % of the data which were reserved for the R free set.  Note that 
residues in the highly disordered loop between residues 112 and 128 were omitted from 
the average B factor calculations. 
 
 
 
3.5  Structure Analysis 
 
3.5.1  General Structure Analysis 
The final model was refined using data between 2.1 Å and 10.0 Å and has an Rfactor of 22.6 % and 
an Rfree of 29.9 % (Table 3).  These slightly high figures may be attributed in part to the disorder of 
the loop region between residues 112 – 128 and at the N and C termini.  The asymmetric unit 
contained 2 BipD molecules and 681 water molecules, as shown in Figure 3.7.  By the PROCHECK 
criteria (Laskowski et al. 1993) 88.8 % of the residues in the final structure lie within the ‘most 
favoured’ regions of the Ramachandran plot and 99.6 % lie within the ‘generously allowed’ 
boundary.  The remaining 0.4 % of residues are in parts of the molecule with poor electron density 
and therefore their conformations are poorly defined (Figure 3.6). 
 
The overall structure, Figure 3.9, is appreciably extended and consists mainly of a bundle of 
antiparallel α helical segments with two three stranded β sheets regions, one being at the end of the 
bundle and one being at the side. 
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This model is consistent with an earlier far UV circular dichroism (CD) spectra for BipD, carried 
out on the protein before crystallisation and shown in Figure 3.10.  Analysis of this spectra showed 
an estimated α helix content of 66 % and 4 % β sheet (X ray analysis determined a content of 59 % 
α helix and 4 % β sheet). 
 
 
 
 
 
 
Figure 3.9: A ribbon model of the BipD structure 
Figure 3.10: A CD spectrum for BipD 
The longest helices (α2, α3, α4 and α8) form a 4 helix bundle and the remaining tertiary structure (3 alpha helices and 2 beta 
sheets) is formed by the region linking the last two helices of the 4 helix bundle. 
This indicates the predominance of α helices in the structure of BipD.  To record 
the spectrum, the protein was diluted to 0.15 mg/ml in 20 mM phosphate buffer 
(pH 7.6).  This spectrum is in agreement with the crystallographic model.  
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3.5.2  Tertiary Structure 
The overall topology of BipD is illustrated by the schematic diagram in Figure 3.8.  The first 20 30 
residues of the protein were not clearly defined in the electron density map.  In one subunit of the 
asymmetric unit, residues 36 43 were clearly seen to form a short α helix (helix 1) but in the other 
molecule this region is less well defined and adopts a slightly different conformation.  This can be 
seen in Figure 3.11. 
 
 
 
 
 
 
 
The polypeptide chain then goes on to a longer helical region (helix 2) from residue 47   63, which 
is followed by a slightly irregular β hairpin involving residues 64   81 (β1 and β2 in Figure 3.8).  
The hairpin region is followed by another α helix (helix 3) that extends from residue 82 – 111 and 
runs antiparallel to helix 2.  The majority of the next 20 residues were found to be poorly defined in 
the electron density map, indicating a disordered region within the crystal, but which may be of 
functional biological significance. 
 
Residue 128 is the N terminal beginning of a very long α helix (helix 4), which extends almost the 
full length of the protein molecule and ends with residue 170.  It runs antiparallel to helix 3 and 
leads into a β hairpin formed by residues 171 – 183 (β3 and β4 in Figure 3.9).  This is followed by a 
short region of helix formed by residues 184 – 196 (helix 5) running antiparallel to helix 4. 
 
Figure 3.11: Superposition of both molecules of BipD in the asymmetric unit 
The structurally conserved regions of both monomers both superimpose with an rms C
α deviation of 0.6 Å, 
emphasising the similarity of their conformations.  The only regions where the structures diverge (N and C 
termini and the loop between helices 3 and 4) are poorly defined by the electron density map.  
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Residues 197 – 203 form an extended region (β5) of which at least 3 residues take part in a three 
stranded β sheet involving a β hairpin formed by residues 220 – 230 (β6 and β7 in Figure 3.9).  
There is a short region of helix formed by residues 209 – 216 (helix 6), which connects the first 
strand of the β5 sheet with the start of the hairpin region (β6 and β7).  The topology of this region in 
the molecule has some parallels with a Greek key motif with one of the outer β strands replaced by 
a helix (helix 6). 
 
Helix 7 is formed by residues 233 – 241 and runs antiparallel to helix 5.  It leads in to a short β 
strand region formed by residues 246 – 250 (β8), which forms a three stranded β sheet with the β 
hairpin formed by residues 171 183 (β3 and β4).  The final α helix (helix 8) extends for 50 residues 
from 251 – 301, running the whole length of the protein molecule.  This helix is a highly conserved 
region of the protein family, with sequence identities of 60 % in IpaD and 52 % in SipD, suggesting 
that it plays an important role in the function of the type III secretion system. 
 
 
 
 
 
 
 
 
Figure 3.12: Sequence alignment of BipD with its homologues IpaD and SipD 
The BipD sequence has 26 % identity and 36 % similarity with IpaD (from S.flexneri), and 27 % identity and 39 % similarity 
with SipD (from S. typhimurium).  The amino acids are coloured according to the scheme: cyan – basic, red – acidic, green – 
neutral polar, pink – bulky hydrophobic, white – Gly, Ala and Pro, yellow – Cys.  The secondary structure elements are 
indicated below the alignment and have been numbered according to the scheme in Figure 3.9.  
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3.5.3  Quaternary Structure 
It was found that in the crystallographic asymmetric unit, two molecules of BipD associate to form 
a dimer via extensive contact at the C terminal end of helix 8 and N terminal end of helix 4 of both 
subunits.  This is despite gel filtration of purified BipD (~3 mg/ml) on a calibrated Superdex 75 
column at pH 7.5, which established that it has a Ve/Vo ratio of 1.17, which corresponds to 
monomeric protein. 
 
 
 
 
 
 
 
 
The area of contact between the two monomers involves helix 8 pairing up with the same helix 
from the other monomer in an antiparallel manner, and the same for helix 4, Figure 3.13.  Although 
gel filtration had indicated that BipD was monomeric in solution, the fact that these extensive 
contacts are being formed between helix 8, the most highly conserved region of the molecule, 
implies that the dimer may be biologically relevant, possibly forming at higher protein 
concentrations. 
 
Figure 3.13: Specific contacts involved in dimer formation 
Two monomers of BipD within the asymmetric unit associate to form a putative dimer.  Here helix 8 (pale 
blue and green) can be seen paired together, with helix 4 in the background.  The most extensive contacts 
are formed by helix 8 where residues at the C terminal end are strongly conserved in BipD, IpaD and 
SipD, suggesting that the dimer may be biologically relevant.  
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The residues of helix 8 involved in this contact region extend from Asn288 to Leu200, comprising 
approximately 3 turns of the helix, where 8 consecutive residues 287   294 (DNLVKVLS) are 
conserved between BipD, IpaD and SipD.  This region forms an interface dominated by van der 
Waals contacts between aliphatic side chains, although there are some water mediated contacts too.  
These findings, combined with the known sensitivity of the protein to deletions in the region 
(Picking et al. 2005), suggest that the dimer observed in the X ray structure may be a functionally 
important form of the molecule.  However, the interface lacks specific direct interactions such as 
hydrogen bonds or salt bridges between the monomers. 
 
There are other stretches of conserved sequence in helix 8 that are not involved in dimer formation.  
It is therefore possible that these regions are involved in binding partner proteins in the translocon.  
In the dimer, the quaternary contacts involving helix 4 from each BipD monomer are of a similar 
nature (i.e. involve small hydrophobic or neutral polar side chains) and extend over approximately 
four turns of the helix between Pro128 and Asp143.  The sequence conservation in this region is 
poorer than for helix 8 and likewise the interface between helix 4 from each monomer lacks specific 
hydrogen bonds and salt bridges. 
 
 
3.6  Discussion 
 
3.6.1  Movement of BipD Through the TTSS Needle 
It is known that chaperones are required to assist the passage of proteins through the secretion 
needle, probably by partially or fully unfolding them so that they will fit through (Yip and 
Strynadka 2006).  However, the elongated shape of the BipD molecule indicates that it may be able 
to pass though the pore of the needle with minimal unfolding. 
 
The core 4 helix bundle of the molecule is formed by the longest helices 2, 3, 4 and 8.  The region 
formed by residues 171   250 (i.e. helices 5, 6 and 7 and both of the 3 stranded β sheets) is 
effectively an extensive elaboration of the loop linking helices 4 and 8.  If the region formed by 
residues 171 – 250 were to unfold or swing away from the four helix bundle, the diameter of the 
molecule would be reduced to approximately 25 Å, narrow enough to fit through the interior pore of  
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the needle.  Epitope mapping studies of IpaD (Turbyfill et al. 1998) indicate that residues in the 171 
– 250 region of BipD could have considerable flexibility. 
 
However, recent work carried out on the conformational stability and differential structural analysis 
of BipD and its homologues (Espina et al. 2007) has shown that BipD has only one thermal 
unfolding transition.  It is also suggested that the intramolecular coil of BipD may be somewhat 
different from that of IpaD and SipD because it exhibits spectral characteristics between that of a 
double  and triple stranded coil.  This suggests the possibility that even if IpaD is able to unfold, 
BipD may not necessarily be able to.  The N terminal domain of BipD is much longer than seen in 
homologues, with more of a loop than a turn.  The loop appears to form a stronger interaction with 
the coiled coil, accounting for the apparent triple stranded coiled coil.  Because the N terminal 
domain is so much different to that of IpaD and SipD and has different structural characteristics, it 
may indicate a unique biological function for this region of the protein.  Figure 3.14 (Johnson et al. 
2006) shows a ribbon diagram of IpaD (green) superposed on Bacillus subtilis FliS (purple, 1VH6) 
demonstrating the opened four helix bundle of this chaperone and suggesting a possible unfolded 
conformation for IpaD.  As a homologue, it has been suggested that BipD may unfold in the same 
manner, although this has not been demonstrated. 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
IpaD is shown in green, with the proposed unfolding helix 
bundle shown in dark green.  A similar region from the 
chaperone of Bacillus subtilis FliS, has been superimposed on the 
structure in purple.It has been proposed that the four helix bundle 
of IpaD and BipD are able to unfold in the same conformation 
shown for the chaperone of Bacillus subtilis FliS, allowing it to 
move through the pore of the secretion needle. 
Figure 3.14: An unfolded chaperone superimposed on IpaD  
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The structure for BipD (green), solved at pH 5.8 was aligned with IpaD (blue), solved at pH 7.5 and it can been seen that significant 
conformational difference exist between the two structures.  Most noticeably, helix α4 of BipD is much straighter than that of IpaD, 
and therefore closer to the beta sheet around helix α6.  This my play some role in it’s functionality. 
3.6.2  The Effect of pH Changes 
It is known that the Ipa/Mxi/Spa TTSS of Shigella is necessary for lysis of the endosome 
membrane, once the bacterial cell has been engulfed by the host cell (High and Dobberstein 
1992;Fernandez Prada et al. 2000;Sansonetti 2001).  The fact that B. pseudomallei contains a 
homologous TTSS implies that it may use a similar mechanism to escape from endosomes.  
Consistent with this idea, it has been reported that B. pseudomallei mutants lacking putative 
components of the Bsa secretion and translocation apparatus (BsaZ and BipD, respectively) are 
confined to endosomes with intact membranes following infection of J774.2 murine macrophage 
like cells (Stevens et al. 2005). 
 
It is known that some proteins, such as hemaglutinin undergo a pH induced conformational change 
exposing a fusigenic peptide that facilitates entry of the influenza virus into the target cell 
(Bullough et al. 1994).  The environment provided by the endocytic vesicle is around pH 5.0 and 
this is similar to that at which the BipD crystals grew (pH 5.8 following mixing of the protein in 
50mM Tris pH 8.0 with the well solution of 0.1 M cacodylate pH 5.0 – 5.5), suggesting that the 
structure observed in our X ray analysis may be very close to that which occurs in the endosome as 
the pH is lowered.  IpaD was crystallised at pH 7.5, well above the acidic environment of the 
endosome.  Alignment of the BipD structure (pH 5.8) and IpaD structure (pH 7.5) reveals that 
although the 2 proteins are structurally similar, there are marked difference, which could be 
accounted for by pH induced conformational changes, Figure 3.15. 
 
 
Figure 3.15: Alignment of BipD and IpaD at different pH 
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Studies of Shigella effector proteins found that IpaD only associated with liposomes at high 
concentrations and that the affinity for liposomes was increased by lowering the pH below 5.0.  
Whilst pH dependant denaturation of any soluble protein might be expected to expose hydrophobic 
regions and increase its binding to membranes, the fact that we know BipD is involved in lysing the 
endosome cell membrane implies that this may have some biological relevance. 
 
All of the secondary structure elements in BipD have a high density of acidic and basic residues as 
shown in Figure 3.16, suggesting that as the pH is lowered in the endosome, protonation of 
carboxylate groups may cause repulsion of the positively charged basic groups and hence 
conformational change.  This is especially true for the smallest exposed helices 1, 6 and 7, which 
have a very high abundance of acidic and basic residues. 
 
 
 
 
 
 
 
 
Perhaps these regions are the most vulnerable to pH induced unfolding in the endosome which 
could trigger association of the protein with the membrane. In contrast the longest and most 
conserved helix (helix 8) has by far the lowest density of acidic or basic residues. 
 
 
Figure 3.16: The electrostatic surface of the BipD dimer 
The two monomers of BipD in the asymmetric unit associate with 2 fold symmetry contacts involving helices 4 and 8.  
The region of contact is highly negatively charged as shown by the large area of red.  
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3.6.3  BipD as a Translocon Plug 
IpaD has been isolated from the tip of intact TTSS embedded in the bacterial membranes and on 
isolated needles even prior to secretion induction (Espina et al. 2006).  Coupled with the fact that 
even short deletions (5 residues) in the C terminus of IpaD completely abolish the invasive 
phenotype and pore insertion (Picking et al. 2005), these observations led to suggestions that IpaD 
may play a role in regulating insertion of the IpaB/IpaC translocon pore from the tip of the S. 
flexneri needle (Blocker et al. 2003) and the secretion of effector proteins.  Deletion of the first 20 
residues of IpaD prevents its secretion, suggesting that these residues somehow act as a secretion 
signal (Picking et al. 2005).  Unfortunately this region of BipD was not defined by the electron 
density map. 
 
Removal of residues between 20 and 120 of IpaD reduced contact mediated haemolysis of red 
blood cells but had no effect on invasion (Picking et al. 2005).  Since deletions beyond residue 120 
eliminate both haemolysis and invasiveness this suggested that the C terminal region of the 
molecule is most important for its function as a molecular plug.  All deletions (except for the first 
20 residues) resulted in an increase in IpaD secretion.  Deletion of just a few residues at the C 
terminus also eliminated both haemolysis and invasiveness and also results in even greater levels of 
IpaD secretion suggesting that this region is also involved in transport regulation. 
 
The equivalent part of BipD was not defined in the electron density map in spite of it being a 
strongly conserved region.  It is possible that the extreme C terminal region of the protein may only 
become ordered in the presence of the partner proteins BipB and BipC.  There is evidence that IpaD 
regulates the relative rates of IpaB and IpaC transport and the reduction in haemolytic activity of 
IpaD mutants correlates with the reduced incorporation of IpaB and IpaC into erythrocyte 
membranes (Picking et al. 2005).  Thus BipD is likely to play a similar role in regulating transport 
of BipB and BipC as well as their final integration into the target cell membrane. 
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3.7  Further Efforts at Structure Analysis 
 
Based on the results of our structural investigation reported here, mutagenesis studies of BipD are 
required to define the roles of conserved and structurally important residues identified thus far.  In 
addition, further investigation of the oligomerisation state of BipD is required, particularly as it 
appears to fulfil a variety of roles and may exist in different states depending on its current function.  
The proposed pH dependent conformational changes in the wild type and mutant BipD protein 
could be analysed by use of CD spectroscopy.  In parallel with ultra structural studies of the 
Burkholderia type III secretion system and other detailed studies of its protein components (e.g. the 
needle protein BsaL recently analysed by NMR (Zhang et al. 2006), the structure reported here will 
contribute towards a more detailed understanding of this remarkable molecular machine. 
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Chapter 4 
 
Structural studies of 2,4’ 
Dihydroxyacetophenone 
dioxygenase from 
Alcaligenes sp. 
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4.1  Introduction 
 
Dioxygenases catalyse the incorporation of both atoms of oxygen from O2 into a single substrate 
(Hayaishi et al. 1955;Hayaishi et al. 1955), a reaction that frequently involves the cleavage of a C C 
bond (Bugg and Lin 2001;Bugg and Lin 2001).  2,4’ dihydroxyacetophenone dioxygenase from 
Alcaligenes sp. is of particular interest because the way in which it catalyses the cleavage of the 
aromatic compound 2,4’ dihydroxyacetophenone to yield 4 hydroxybenzoate and formate is 
achieved in a unique manner, unlike any other known dioxygenase (Hopper and Kaderbhai 
1999;Hopper and Kaderbhai 1999). 
 
 
Figure 4.1: Reaction catalysed by 2,4’ dihydroxyacetophenone dioxygenase 
 
 
 
Aromatic compounds are responsible for much of today’s pollution and are commonly formed by 
industrial process during the incomplete burning of coal, oil, gas and garbage, as well as petroleum, 
solvents, pesticides and plastics.  The majority of these chemicals are not naturally degraded and so 
persist in the environment for many years.  The use of microorganisms to catabolise these 
compounds is known as bioremediation and is becoming a useful tool for removing hazardous 
chemicals from the land and water.  By determining how the oxygenases and dioxygenases of 
microorganisms actually function to degrade aromatic compounds, it could then be possible to 
manipulate these enzymes to degrade compounds other than their natural substrates and remove 
aromatic pollutants from the environment. 
 
2,4' dihydroxyacetophenone dioxygenase acts by cleaving the side chain of 2,4’ dihydroxyacetophenone , yielding 4 
hydroxybenzoate (left) and formate (right).  This differs from other dioxygenases that cleave the aromatic ring itself.  
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The oxidative cleavage of an aromatic hydrocarbon ring is achieved by oxygenases; either by 
inserting the required oxygen atoms into the ring, thus preparing it for fission, or catalyzing the ring 
fission reaction themselves and cleaving the ring open.  There are two classes of oxygenases, mono 
oxygenases and dioxygenases, both of which can perform the above tasks but are differentiated by 
the number of oxygen atoms they insert into the aromatic hydrocarbon.  Usually mono oxygenases 
are involved in hydroxylation reactions; preparing the aromatic ring for cleavage by inserting a 
single atom of oxygen into the molecule.  However, when hydrolyzing aromatic ketones they have 
been shown to insert a single atom of oxygen into the substrate to form an ester, which is then 
hydrolysed.  The remaining atom from dioxygen is reduced to water (Tanner and Hopper 2000).  
Dioxygenases are involved in both the hydroxylation and fission reactions.  The usual prerequisite 
for this oxidative cleavage is that the ring contains two hydroxyl groups, para or ortho to each other 
(Harwood and Parales 1996).  Depending where the hydroxyl groups are positioned on the ring, the 
dioxygenase can utilize one or other of three different pathways (Harpel and Lipscomb 1990). 
 
In order to engineer a microbe capable of degrading a foreign substrate of our choosing it is not 
possible simply to change a single enzyme.  Molecular pathways are so intricately balanced and the 
enzymes involved so inter dependant that in order to equip a microorganism with the ability to 
degrade an aromatic compound other than its natural substrate, rational and knowledgeable 
manipulation of both the host cell and the specific catabolic pathway involved is required (Diaz 
2006).  It is for this reason that it is not enough to know about individual enzymes in isolation, 
knowledge about the way in which they interact with their molecular environment is vital. 
 
Through the use of techniques such as bacterial over expression, purification and X ray 
crystallography, it is hoped that it will be possible to elucidate the three dimensional structure of 
DAD.  By achieving this it would then be possible to better understand the novel mechanism by 
which this dioxygenase functions and, it is hoped, a better understanding of microbial degradative 
pathways and detailed atomic knowledge of the enzymes involved.  This will enable their use to 
greater effect to reduce the negative environmental impact of aromatic and for the production of 
chemicals by biotransformations. 
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4.2  DAD Expression and Purification Protocol 
 
4.2.1  DNA Manipulation 
During this project we had problems with the existing glycerol stocks of DAD in pET11a in BL21 
(DE3) E.coli cells.  This necessitated preparing the dad plasmid, which was then used to transform 
more BL21(DE3) E.coli cells using 0.5 µl of plasmid.  This was carried out in the same manner as 
already described for BipD on pages 77 82. 
 
 
4.2.2  Protein Expression 
 
4.2.2.1  Native Protein Over expression 
The dad gene had been previously cloned into a pET11a expression vector in E.coli after efforts 
with the original pλ1 cyt vector proved unfavourable for the expression of a selenomethionine 
derivative.  15 µl of 2,4’ dihydroxyacetophenone dioxygenase BL21 Escherichia coli from a 15 % 
glycerol stock was spread on an LB agar plate (yeast extract, NaCl, tryptone, bacterio agar) 
containing ampicillin (50 µg/ml) and left to grow overnight.  All bacterial growth was performed at 
37 ºC unless otherwise stated.  A single colony was then selected and used to inoculate 10 ml sterile 
LB media of the same antibiotic strength, which was grown to mid log phase of OD600 0.6, 
measured using a Pharmacia Biotech Ultrospec 3000 spectrophotometer.  5 ml of the culture was 
removed for later use as a starter culture and the remaining 5 ml induced with a final concentration 
of 0.5 M filter sterilised Isopropyl β D 1 thiogalactopyranoside (IPTG) and left to grow overnight. 
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A 300 µl sample of culture was then examined by 12.5 % SDS PAGE gel electrophoresis at 25 mA 
to check the successful over expression of DAD.  Once this had been confirmed, thereby 
establishing the presence of the pET11a DAD construct, the 5 ml starter culture was used to 
inoculate 4 × 100 ml flasks of LB of the same antibiotic strength, which were induced with ITPG at 
OD600 0.6.  However, it was found that induction by this method resulted in 95 % of the DAD 
protein being expressed as insoluble inclusion bodies, shown in Figure 4.1.  In an effort to avoid 
this, a heat shock method was used to grow the E.coli.  4 × 100 ml flasks of LB of the same 
antibiotic strength were grown to mid log phase then grown for 25 minutes at 42 ºC in the hope that 
this would induce chaperone production, which would re fold the denatured protein.  The culture 
was then chilled in ice water for 5 minutes, induced with a final concentration of 0.3 mM IPTG and 
grown in an incubator at 16 ºC for 48 hours.  However, this method too produced DAD mainly as 
inclusion bodies. 
 
It was then decided to use Novagen Overnight™ Express Instant TB Medium to try to over express 
DAD as soluble protein.  A 1 L batch of Overnight™ Express Instant TB Medium was made by the 
addition of 1 L H2O and 10 ml glycerol to the 60 g sachet.  This was then autoclaved and made up 
to the same antibiotic strength.  The media was induced with a 5 ml culture that had previously been 
checked for induction in the manner earlier described.  Figure 4.3 shows that although this method 
Figure 4.2: SDS gel showing sample protein contents 
Cultures 7 and 8 were sonicated, as later described, and then centrifuged 
to separate the cell supernatant and pellet.  SDS gel analysis revealed the 
presence of DAD in both samples as being mainly in the cell pellet, 
implying that the dioxygenase is expressed as insoluble inclusion bodies.  
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still produces some inclusion bodies, there is a sizeable fraction of soluble protein to be worked 
with.  The cells were harvested after 24 hours total induction time. 
 
4.2.2.2  Seleno methionine Protein Over expression 
To express a selemomethionine derivative of DAD, the Novagen Overnight™ Autoinduction 
System 2 was used, but this method produced only inclusion bodies.  So instead we once again tried 
the heat shock method of expression.  A starter culture was grown, as previously described, and 
used to inoculate 1 L LB medium, which was grown at 37 ºC to mid log phase.  The cells were then 
centrifuged for 20 minutes and the pellet resuspended in 10 ml M9 minimal media and kept on ice 
for a maximum of 1 hour.  A 1 L flask of M9 minimal media, containing 10 ml 40 % glucose 
solution and 1.5 ml ampicillin, was inoculated with the 10ml solution and incubated at 37 ºC for 45 
minutes.  Amino acids (with selenomethionine replacing methionine) and vitamins were added and 
the culture grown for a further 20 minutes (see appendix for methods).  The flask was put in a 
shaking water bath at 42 ºC for 25 minutes, then stood in ice water for 5 minutes before being 
induced with a final concentration of 0.3 mM IPTG.  The culture was grown at 16 ºC for 48 hours, 
before being harvested and purified as described for the native protein. 
 
 
4.2.3  Harvest Cells 
The cells were decanted into a 1 L Beckman centrifuge tube and harvested by centrifuging at 7,000 
rpm for 20 minutes.  The supernatant was discarded and the cell pellet resuspended in 20 ml buffer 
containing 50 mM TRIS at pH 8. 
 
 
4.2.4  Sonication 
The cells were disrupted by sonication for 2 repeats of 12 cycles, 30 seconds on, 90 seconds off, 
separated by a 10 minute cooling period on ice.  This was centrifuged at 18,000 rpm for 60 minutes 
to remove cell debris.  SDS gel analysis showed that although native DAD was still present as 
insoluble inclusion bodies in the pellet, this time it was also present in at least equal, if not greater 
quantities, of soluble protein in the supernatant (Figure 4.3).  
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4.2.5  Crude Purification 
 
4.2.5.1  Ammonium Sulphate Precipitation 
Ammonium sulphate precipitation was carried out on the supernatant, initially at 30 % saturation 
(0.2 g/ml) to remove some of the impurities.  4 g ammonium sulphate was dissolved in the 20 ml 
sample and then centrifuged at 18,000 rpm for 40 minutes.  The supernatant was removed and a 
sample taken for SDS analysis, then the pellet resuspended in 5 ml 50 mM TRIS for SDS analysis.  
Ammonium sulphate precipitation was then carried out at 45 % saturation by the addition of a 
further 2 g ammonium sulphate to the supernatant and centrifugation for 40 minutes at 18,000 rpm.  
Samples were taken and SDS analysis showed the presence of a very large amount of DAD in the 
45 % pellet (Figure 4.4). 
 
Figure 4.3: SDS gel showing soluble protein content of samples 
The test culture samples taken from, the Novagen Overnight™ 
Express Instant TB Medium culture were analysed by SDS gel.  The 
test culture grown in LB (uninduced) and induced with IPTG shows 
over expression of DAD.  The culture grown in the Instant TB medium 
shows massive over expression of DAD in the pellet, probably present 
as insoluble inclusion bodies.  However, there is an even greater 
quantity of DAD present as soluble protein in the cell supernatant.  
This soluble protein was then purified.  
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4.2.5.2  Dialysis 
The pellet was resuspended in 20 ml of 50 mM TRIS buffer.  1 m of dialysis tubing was boiled in 
H2O containing sodium bicarbonate and EDTA for 10 minutes then washed in ddH2O.  The sample 
was dialysed in 2 L 50 mM TRIS pH 8 for 48 hours, and then centrifuged at 14,000 rpm for 20 
minutes and the pellet discarded. 
 
 
4.2.6  Column Purification 
 
4.2.6.1  Q Sepharose Anion Exchange Column 
A Q sepharose
TM anion exchange column was equilibrated with degassed 50 mM TRIS pH 8 until a 
stable base line (280 nm) was observed at 4 ºC.  The sample was diluted to 70 ml in 50 mM TRIS 
and loaded onto the column at a flow rate of 1.5 ml/min (0.5 sensitivity) until all unbound protein 
had been washed off.  A stable base line was then re established.  The bound proteins were then 
eluted on a salt gradient of 0 M – 0.8 M KCl over 950 ml at a flow rate of 1.5 ml/min and 10 ml 
Figure 4.4: SDS gel showing the results of ASP 
Ammonium sulphate precipitation (ASP) at 30 % and 45 % was 
carried out on the cell supernatant containing soluble DAD to 
remove some of the impurities.  It was found that DAD did not 
precipitate out at 30 %, but remained soluble in the supernatant.  
At 45 % DAD did precipitate out and was retained in the pellet.  
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fractions were collected.  The peak fractions were analysed by SDS PAGE and those containing 
DAD were pooled and concentrated using a 50 ml amicon with a cut off membrane of 10 kDa.  The 
concentrate was centrifuged at 4,000 rpm for 20 minutes and the pellet removed. 
 
 
4.2.6.2  Superdex 200 Gel Filtration Column 
A Superdex
TM 200 gel filtration column was washed with 1 M KCl then equilibrated with 50 mM 
TRIS, 200 mM KCl pH 8 until a stable base line was observed at 4 ºC.  Five separate 1 ml aliquots 
of protein solution were loaded onto the column at a flow rate of 1 ml/min (0.2 sensitivity) in five 
separate column runs.  4 ml fractions were collected and the peak fractions analysed by SDS 
PAGE.  Those fractions containing DAD were pooled and concentrated to 10 ml and centrifuged at 
4,000 rpm for 20 minutes and the pellet discarded.  Figure 4.5 shows the purity of DAD after anion 
exchange and gel filtration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2.6.3  Hi Trap Q XL Anion Exchange Column 
In order to remove the remaining contaminants, a Hi trap Q XL anion exchange column was used.  
The column was equilibrated with 50 mM TRIS pH 8 and the 10 ml sample loaded at 0.5 ml/min 
(0.2 sensitivity).  The protein was eluted in steps; 0.15 M KCl, 0.3 M KCl and 0.5 M KCl, and 
collected in 2 ml fractions. 
Figure 4.5: SDS gel showing protein content 
Even after the sample had been run on the Q 
sepharose anion exchange column and Superdex 200 
gel filtration column, contaminants were still present.  
To try to remove these, the sample was run on a Hi 
Trap Q XL anion exchange column. 
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It was found that DAD eluted at 0.3 M KCl (Figure 4.6).  The fractions were pooled and 
concentrated using 10 kDa vivaspins and 10 kDa centricons to a volume of 600 µl.  This was 
spectrophotometrically assayed to reveal a final concentration for the native protein of 5.8 mg/ml 
(absorbance at 10 times dilution = 1.342, extinction coefficient = 2.3).  This was diluted by 2 to 
give 1.2 ml 2.9 mg/ml as it was felt that a protein concentration of around 3 mg/ml would be most 
suitable for crystallisation.  The SeMet DAD was concentrated to 4.3 mg/ ml for crystallisation. 
 
 
4.3  Crystallisation 
 
4.3.1  Native DAD Protein 
A crystal screen was set up based around the condition used by G. Beaven with the freeze dried 
protein provided by Dr D.J. Hopper of the University of Aberystwyth, although it did take 2 years 
for a crystal to grow.  The mother liquor contained 0.7 ml 0.1 M TRIS/HCl, pH 8 and 14 % PEG 
8000 and these conditions were varied: 
 
 
 
Figure 4.6: SDS gel showing the sample purity 
After the DAD sample had run through the Hi trap anion 
exchange column, most of the contaminants were 
removed.  Fractions 4 6 were pooled and used in 
crystallisation screens.  
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7.0        9.0 
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650µl H2O 
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pH 7.0 
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pH 9.0 
100µl glycerol 
200µl PEG 8K 
600µl H2O 
0.1M TRIS/HCl 
pH8.0 
14% PEG 8K 
 
 
0.1M TRIS/HCl 
pH8.0 
14% PEG 8K 
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pH 7.0 
100µl glycerol 
400µl PEG 8K 
450µl H2O 
100µl TRIS/HCL 
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100µl glycerol 
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450µl H2O 
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pH 9.0 
100µl glycerol 
400µl PEG 8K 
400µl H2O 
0.1M TRIS/HCl 
pH8.0 
14% PEG 8K 
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pH8.0 
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pH 7.0 
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pH 9.0 
No glycerol 
200µl PEG 8K 
750µl H2O 
100µl TRIS/HCL 
pH 9.0 
No glycerol 
200µl PEG 8K 
700µl H2O 
0.1M TRIS/HCl 
pH 7.8 
14% PEG 8K 
0.1M TRIS/HCl 
pH 8.2 
14% PEG 8K 
50µl TRIS/HCL 
pH 7.0 
No glycerol 
400µl PEG 8K 
550µl H2O 
100µl TRIS/HCL 
pH 7.0 
No glycerol 
400µl PEG 8K 
500µl H2O 
50µl TRIS/HCL 
pH 9.0 
No glycerol 
400µl PEG 8K 
550µl H2O 
100µl TRIS/HCL 
pH 9.0 
No glycerol 
400µl PEG 8K 
500µl H2O 
0.1M TRIS/HCl 
pH8.0 
14% PEG 8K 
1µ 100mM 
formate in drop 
0.1M TRIS/HCl 
pH8.0 
14% PEG 8K 
1µ 100mM 
formate in drop 
 
 
 
Crystallisation conditions were screened using both Molecular Dimensions screens MD 1+2 and 
Jena Biosciences JB screens 1 10.  24 well plates were set up using the hanging drop vapour 
diffusion method at room temperature.  A 1 ml reservoir was used, with a 5 µl drop containing 2.5 
µl reservoir and 2.5 µl protein.  Small, cubic crystals of native protein, approximately 15 µm in 
diameter, were observed in 5 different conditions after 10 months (Figure 4.7), suggesting the 
enzyme may have undergone a degree of proteolysis before crystallisation could occur.  These 
conditions were found in screens JB1 (PEG 400 – 3000 based) and JB6 (ammonium sulphate 
based). 
 
JB1  A3  15% w/v PEG 400, 200mM HEPES sodium 
salt pH 7.5, 200mM magnesium chloride  JB6  A1  500mM ammonium sulphate, 1.0M lithium 
sulphate, 100mM sodium citrate 
  B3  30% w/v PEG 400, 100mM MES sodium salt 
pH 6.5, 100mM sodium acetate    B1  1.5M ammonium sulphate, 15% w/v glycerol, 
100mM Tris HCl pH 8.5 
  B6  30% w/v PEG 400, 100mM Tris HCl pH 8.5 
200mM sodium citrate       
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The crystals were mounted using Litholoops (Molecular Dimensions) and cryoprotected in the 
mother liquor with 10 % (v/v) glycerol.  These were then frozen in a cryostream at 100 K and stored 
in liquid nitrogen. 
 
 
   
 
 
 
4.3.2  Selenomethionine DAD Derivative 
It was found that the SeMet DAD forms a precipitate in the native enzyme crystallisation 
conditions, so crystallisation trials have been set up in the same way as described above, using 
Molecular Dimensions screens MD 1+2 and Jena Biosciences JB screens 1 10, as well as the 
optimisation conditions being screened for the native protein.  To date no crystals have been 
observed. 
 
 
4.4  Preliminary X ray Diffraction Analysis of Native 
DAD 
 
The native crystals were taken to the ESRF (Grenoble, France) where the microfocus beamline 
ID23 2 was used to screen them.  The only crystal to diffract to a reasonable resolution was that 
grown in condition JB1 B3, 30 % w/v PEG 400, 100 mM MES sodium salt pH 6.5, 100 mM 
sodium acetate.  A dataset was collected to 3.1 Å resolution (Figure 4.8).  2 sets of 45 images were 
collected with 1° oscillations and an exposure time of 1 second per image. 
Figure 4.7: Crystals of DAD protein 
 
These crystals of DAD protein grew under two different screen conditions (JB1 PEG 400 based, and JB6 Ammonium 
sulphate based) and appeared between months 10 12 after the hanging drops were set up.  Both crystals were very small, 
not greater than 0.1mm in any dimension. 
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Figure 4.8: DAD diffraction data collected to 3.1 Å resolution 
 
An image and one quadrant of a diffraction image obtained using beamline ID23 1 at ESRF 
(Grenoble, France) from a crystal of DAD, showing diffraction spots to 3.1 Å resolution.  
 
117 
 
Initial data processing, carried out using MOSFLM (Leslie 2006), SCALA (Evans 2006) and other 
programs in the CCP4 suite (CCP4 1994), indicated that the crystal belonged to the space group 
F23 and had unit cell parameters of a=b=c=180.1 Å, α=β=γ=90º (Table 4).  The processed datasets 
extend to 3.1 Å resolution with an Rmerge of 10.5 %, and completeness of 99.9 % and multiplicity of 
5.3.  The program Matthews_coef (CCP4 1994) was used to determine the likely number of 
molecules present in the asymmetric unit from which it was estimated that 2 monomers per 
asymmetric unit would give a solvent content of 59 %. 
 
Beamline  ID23 2 
Wavelength (Å)  0.976 
Space group  F23 
Unit Cell Parameters 
a=b=c (Å)  180.1 
Resolution(Å)  104.3 3.1 (3.3 3.1) 
Rmerge
* (%)  10.5 (55.8) 
Completeness (%)  99.9 (100.0) 
Average I/σ  13.0 (3.0) 
Multiplicity  5.3 (5.5) 
Number of observed reflections  47183 (7078) 
Number of unique reflections  8894 (1297) 
Wilson’s B factor (Å
2)  68.3 
Matthew’s coefficient  3.00 
Solvent content (%)  59.00 
Number of molecules in the 
asymmetric unit  2 
Table 4: Data collection and processing statistics for native DAD. 
 
 
 
 
Attempts were made to solve the structure using the program ACORN (CCP4 1994) and a 1.1 Å 
dataset collected from the freeze dried DAD crystal, however this was unsuccessful.  MrBUMP 
(CCP4 1994) was also used to search for a homologue and perform molecular replacement.  The 
homologue found was a novel manganese containing cupin from Thermotoga maritime (PDB code 
1VJ2), but this only displayed 29 % sequence homology with DAD and is about 40 residues shorter, 
therefore no processable solution could be found.  Because no homologous structure exists, 
molecular replacement cannot be used for phasing of the data, therefore structure determination will 
proceed when a SeMet DAD crystal can be obtained and a MAD dataset collected. 
 
Values in parenthesis are for the outer resolution shell. 
* Rmerge = ΣhΣi |(Ihi-Ih)| / ΣhΣi (Ihi) 
where Ih is the mean intensity of the scaled observations Ihi.  
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Chapter 5 
 
Structural studies of 
L threonine Dehydrogenase 
from Thermococcus 
kodakaraensis 
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5.1  Introduction 
 
The anaerobic hyperthermophilic archaeon Thermococcus kodakaraensis (KOD1) was isolated 
from the sediment and water of a solfatara, at over 100 ºC, on the shores of Kodakara Island off the 
coast of Kagoshima, Japan.  The entire 2,088,737 bp genome of T. kodakaraensis has been 
sequenced and analysed (Fukui et al. 2005), making it one of the best characterized 
hyperthermophilic organisms.  An orthologue search was subsequently carried out on the genome, 
highlighting a DNA sequence corresponding to that of L threonine dehydrogenase (TDH; EC 
1.1.1.103).  TDH has been identified in all three domains of life i.e. eucarya, bacteria and archaea, 
from organisms such as a psychrophilic bacterium Cytophaga sp. KUC 1 (Kazuoka et al. 2003), a 
hyperthermophilic archaeon Pyrococcus horikoshii (Machielsen and van der Oost 2006), E.coli K 
12 (Boylan and Dekker 1981), humans (Edgar 2002), chicken liver mitochondria (Aoyama and 
Motokawa 1981) and goat liver mitochondria (Ray and Ray 1984).  The enzymes from E.coli and 
P. horikoshii (PhTDH) have been extensively characterised, although thus far Pyrococcus 
horikoshii and Flavobacterium frigidimaris are the only species from which the L threonine 
dehydrogenase enzyme had been crystallised and the three dimensional atomic structure determined 
(PDB codes 2DFV and 2YY7 respectively) (Ishikawa et al. 2007).  Although TDH is not restricted 
to liver mitochondria, in higher organisms it is most abundant in this tissue type (Aoyama and 
Motokawa 1981). 
 
L threonine dehydrogenase belongs to the family of oxidoreductases, specifically those acting on 
the >CHOH group of a donor molecule with NAD
+ or NADP
+ as the acceptor (EC 1.1).  It is to the 
medium chain family that the 350 amino acid long TkTDH belongs.  Typically enzymes in this 
family contain a catalytic zinc ion and structural zinc ion.  L threonine dehydrogenase catalyses the 
NAD
+ dependent oxidation of L threonine to L 2 amino 3 ketobutyrate, an intermediate in the 
metabolism of threonine to glycine (Potter et al. 1977), both of which are essential amino acids.  
The dehydrogenase catalyses the first step in the threonine degradation pathway in several 
microorganisms that use L threonine as the main carbon and energy source.  The product 2 amino 
3 ketobutyrate is further cleaved in a CoA dependent reaction, catalysed by 2 amino 3 ketobutyrate 
CoA ligase, to produce glycine and acetyl coA (Aoyama and Motokawa 1981). 
 
Within the medium chain dehydrogenase family there exists a high degree of structural similarity 
between the enzymes, despite their low sequence similarity.  However, there are differences 
between the enzymes from higher plants and animals, which are typically dimeric for example that  
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of horse liver alcohol dehydrogenase (ADH), and those of lower organisms like yeast, bacteria and 
archaea, which are tetrameric such as S. cerevisiae ADH. 
 
Since their initial discovery in 1972 (Unsworth et al. 2007), many hyperthermophilic organisms 
have been identified and the rate of discovery is increasing as recent developments in technologies 
enhance our ability to access the extreme environments they inhabit.  These environments, which 
until more recently were considered as being inhospitable to life, include volcanic areas rich in 
sulphur and ‘toxic’ metals and hydrothermal vents in the deep sea at extremely high pressures.  To 
date the highest temperature a hyperthermophile has been observed to grow at is 121 ºC; this is a 
microorganism, designated strain 121 that was isolated from an active "black smoker” in the 
Northeast Pacific Ocean (Kashefi and Lovley 2003).  These developments are important because it 
is still yet to be understood what the underlying basis is for the extraordinary thermostability of 
these hyperthermophilic enzymes.  Should this be discovered then a great number of opportunities 
to make strategic use of their thermoactivity and thermostability present themselves. (Adams and 
Kelly 1998). 
 
Hyperthermophilic enzymes are very similar to their mesophilic homologues, and this is supported 
by sequence alignments, amino acid content comparisons, crystal structure comparisons, and 
mutagenesis experiments (Vieille and Zeikus 2001).  One hypothesis used to explain the difference 
in structural stability at high temperatures is that the structures of hyperthermophilic enzymes are 
more rigid than their mesophilic counterparts at moderate temperatures and therefore rigidity is a 
prerequisite for high thermostability. 
 
It is hoped that by elucidating the three dimensional structures of hyperthermophilic enzymes it will 
be possible to determine the basis of their inherent properties of thermostability and optimal activity 
at high temperatures and the underlying atomic factors responsible.  These enzymes actually share 
the same catalytic mechanisms with their mesophilic homologues and when cloned and expressed 
into such hosts, hyperthermophilic enzymes usually retain their thermal properties, implying that 
these are genetically encoded.  Studies of primary sequences have failed to identify repeatable 
differences between hyperthermophilic and mesophilic enzymes; therefore it appears likely that no 
one mechanism is responsible for their thermostability.  Instead it is likely that a small number of 
highly specific alterations, which often do not obey any obvious rules, may be the source of this 
thermostability.  Thus a concerted action of structural, dynamic and other physicochemical 
attributes are utilised to ensure the delicate balance between stability and functionality of proteins at 
high temperatures.  These may include, but are certainly not limited to; charge clusters, networks of  
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hydrogen bonds, optimization of packing, salt bridges, hydrophobic interactions, surface loop 
stabilization and reduction of the entropy of unfolding, each contributing to the overall 
thermostability (Unsworth et al. 2007).  Identifying these minor intrinsic differences that allow 
hyperthermophilic enzymes to maintain structural stability and activity at elevated temperatures is a 
major challenge, but one that can only be aided by the elucidation of the proteins’ tertiary and 
quaternary structures. 
 
The crystal structure of TkTDH from Thermococcus kodakaraensis has been solved at a resolution 
of 2.4 Å revealing the detailed tertiary fold and quaternary structure of the molecule.  Analysis 
suggests that the biologically active form of the molecule is a tetramer, in agreement with ADHs 
from lower life forms.  It was crystallised bound to the co factor NAD
+, identifying the active site 
and suggesting a possible mechanism of catalysis.  The structure has been used to model the 
putative complex formed with 2 amino 3 ketobutyrate CoA ligase (KBL), suggesting that 2 
molecules of this dimeric protein bind one TkTDH tetramer. 
 
 
5.2  TDH Expression and Purification Protocol 
 
The DNA cloning, protein expression and purification of TkTDH was carried out by Q. Bashir and 
colleagues at the University of Punjab, Pakistan (Bowyer et al. 2008). 
 
 
5.2.1  Cloning of TkTDH 
The Tk TDH gene (TK0916) from the genomic DNA of T. kodakaraensis was amplified by PCR 
and ligated into the pTZ57R/T cloning vector using T4 DNA ligase (Fermentas).  The recombinant 
pTZ tdh plasmid was digested with Nco1 and EcoR1 and the Tk TDH gene ligated with pET 8c, 
giving the recombinant pET tdh plasmid that was then used to transform E.coli DH5α competent 
cells.  Recombinant pET tdh plasmid was then purified from E. coli DH5α and transformed into the 
expression strain E.coli BL21 (DE3). 
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5.2.2  Expression and Purification 
Expression of the un tagged, full length TkTDH protein was undertaken on the 1 litre scale in LB 
medium and, following growth of cultures to mid log phase, expression of the gene was induced 
with 0.2 mM IPTG at 37 °C for a further 4 hours.  Cells were harvested by centrifugation at 6,000 x 
g for 10 minutes at 4 °C and washed with 50 mM Tris HCl (pH 8).  The cell pellet was resuspended 
in the same buffer and the protein was purified by a series of steps involving lysis of the cells by 
sonication, removal of the insoluble material by centrifugation (15,000 x g for 30 minutes at 4 °C) 
and heating of the soluble fraction to 85 ºC for 20 minutes to precipitate further impurities which 
were removed by centrifugation at 15,000 x g for 30 minutes at a temperature of 4 °C. This was 
followed by anion exchange chromatography using a Resource Q column (Amersham Biosciences, 
United Kingdom) which was equilibrated with 50 mM Tris HCl buffer at pH 8. Proteins were 
eluted with a linear gradient of 0 to 1.0 M sodium chloride in 50 mM Tris HCl buffer at pH 8. 
Fractions with TDH activity were dialyzed against 50 mM Tris HCl buffer pH 8 containing 2 M 
ammonium sulphate and applied to a hydrophobic interaction chromatography column (Resource 
ISO, Amersham Biosciences, United Kingdom) equilibrated with 50 mM Tris HCl buffer at pH 8 
containing 2 M ammonium sulphate. The bound proteins were eluted with a linear gradient from 2.0 
to 0 M ammonium sulphate in 50 mM Tris HCl buffer at pH 8.  
 
Purified enzyme was stored in 50 mM Tris HCl at pH 8 and was found to have a subunit molecular 
mass of 38,016 Da by mass spectrometry.  It was found to be tetrameric by gel filtration, thereby 
making it similar to the TDHs from E.coli, P.horikoshii, P.furiosus and Cytophaga sp. 
 
 
5.3  Crystallisation 
 
Many crystallisation and optimisation trials were set up before suitable conditions were found.  
Crystallisation trials were set up at room temperature using the hanging drop vapour diffusion 
method on 24 well plates, and conditions were initially screened using both Molecular Dimensions 
screens MD 1+2 and Jena Biosciences JB screens 1 10.  A 1ml reservoir was used, with a 5µl drop 
containing 2.5 µl reservoir and 2.5 µl protein.  Crystals of TkTDH grew in 0.1 M sodium citrate pH 
5.6, 2 M ammonium sulphate and 0.2 M sodium / potassium tartrate (screen MD2 well 29).  Three 
rounds of optimisation screens were set up to refine the crystallisation conditions, as frequently it  
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was found that fractured crystals formed as illustrated by Figure 5.1, leading to twinned data that 
proved too difficult to process. 
 
 
Figure 5.1: Multiple TDH crystal 
 
 
 
Several optimisation screens were set up in the presence of 5 % (v/v) glycerol and it was found that, 
in general, crystals from these trays were less fractured in appearance and grew as single crystals. 
 
 
Figure 5.2: TDH crystal 
Initially the TDH crystals grown by the hanging drop method were very 
fractured or grew as multiple crystals in the absence of glycerol, regardless 
of the crystallisation precipitant and additives. 
The addition of 5 10 % glycerol to the TDH crystallisation conditions helped the crystals grow 
as less fractured, single crystals, enabling the collection of a good quality data set. 
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It was expected that TkTDH requires Zn
2+ ions for structural reasons, and possibly for catalytic 
purposes, based on our knowledge of alcohol dehydrogenase structures (Guy et al. 2003).  As it was 
unclear whether zinc would have remained bound to TkTDH throughout the purification, zinc 
chloride was added to some crystallisation trays to a final concentration of 0.1 mM.  Single crystals 
of TkTDH eventually grew in 0.05 M sodium citrate pH 5.6, 2.4 M ammonium sulphate, 0.1 M 
sodium / potassium tartrate, 5 % (v/v) glycerol and 0.1 mM zinc chloride (Figure 5.2).  In all cases 
TkTDH at a concentration of 3.4 mg/ml was used. 
 
 
5.4  Structure Determination 
 
5.4.1  Data Collection and Processing 
The crystals were mounted using Litholoops (Molecular Dimensions) and cryoprotected in the 
mother liquor with 10 % (v/v) glycerol.  These were then frozen in a cryostream at 100 K and stored 
in liquid nitrogen.  The crystals were taken to the European Radiation Synchrotron Facility (ESRF) 
in Grenoble, France, where a dataset was collected to 2.4 Å resolution (Figure 5.3) using beamline 
ID14 3.  190 images were collected with 1° oscillations and an exposure time of 30 seconds per 
image with 3 passes per image. 
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Figure 5.3: TDH diffraction data collected to 2.4 Å 
An image and one quadrant of a diffraction image obtained using beamline ID14 3 at ESRF 
(Grenoble, France) from a crystal of TDH, showing diffraction spots to 2.4 Å resolution.  
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The data were processed using MOSFLM (Leslie 2006;CCP4 1994), SCALA (Evans 2006) and 
other programs in the CCP4 suite (CCP4 1994).  However, the determination of the space group 
was ambiguous and varied depending on the number and angular range of the images chosen for 
autoindexing.  When using images 1 and 90, the preferred space group prediction was C2. 
 
 
Figure 5.4: MOSFLM C2 space group prediction 
 
 
It was attempted to process the data in C2, then later I222, but in both cases MOSFLM was unable 
to predict the spots correctly. 
 
 
Figure 5.5: Section of MOSFLM spot prediction in C2 space group 
Initial prediction for the TDH crystal using diffraction images at 1º and 90º indicated C2 as the most probably space group. 
As can be seen from the image, in the C2 space group MOSFLM is unable to 
correctly predict spots.  The coloured squares should align with the diffraction 
spots, but this is clearly not the case in this example.  
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However, when indexing using images 1, 45 and 90, the preferred space group prediction was P4. 
 
 
Figure 5.6: MOSFLM P4 space group prediction 
 
 
This gave much better predictions and the data was processed in P4 and the data scaled, giving an 
Rmerge of 0.154. 
 
 
Figure 5.7: Section of MOSFLM spot prediction in P4 space group 
 
 
Using 3 diffraction images to index the TDH crystal, the space group predicted was P4, as opposed to C2 when using only 2 images. 
As can be seen from the image, in this space group MOSFLM is able to 
correctly predict spots because the coloured squares accurately coincide 
with the diffraction spots.  
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5.4.2  Molecular Replacement 
Matthews_coef (CCP4 1994) was used to predict the number of molecules present in the 
asymmetric unit.  It was expected TkTDH would exist as a homotetramer because many other 
ADHs and PhTDH do, so homotetramers of approximately 150000 Da were searched for and it was 
predicted that there were 3 in the asymmetric unit, giving a solvent content of 47.34 % (when the 
data was processed in P43). 
 
 
Figure 5.8: TDH matthews coefficient prediction 
 
 
 
The first TDH crystal structure was recently solved (Ishikawa et al. 2007), providing a molecular 
replacement model for our structure.  That TDH comes from the hyperthermophilic archaeon 
Pyrococcus horikoshii and shares 80 % sequence homology with this TDH from Thermococcus 
kodakaraensis.  A 5 % free R flag data set was picked in thin shells using Dataman.  Shells were 
used instead of a random selection as non crystallographic symmetry (NCS) existed in the model. 
 
MOLREP was used in molecular replacement with a single monomer from 2DFV as the search 
model looking for 3 homotetramers, but was unable to find a solution.  PHASER was then used as 
an alternative and found a solution with a Log Likelihood Gain (LLG) of 105.  In order to be more 
accurate with the space group, PHASER was set to run with alternative space groups, meaning that 
it tried P4, P41, P42 and P43, then picked the most promising solution and performed full molecular 
The program predicted the presence of three homotetramers of TDH in the 
crystallographic asymmetric unit, based on a molecular weight of 150 kDa.  
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replacement in that space group.  This resulted in P43 being the most promising space group as 
shown below. 
 
  P4  P41  P42  P43 
Rmerge  0.154  0.115  0.116  0.115 
LLG  105  160  No solution  5055 
 
 
Still searching for 3 homotetramers, PHASER was used to find a molecular replacement solution 
for all choices of alternative space group as detailed below. 
 
 
  P4  P41  P42  P43  P4322  P422  P4212  P4122  P41212  P4222  P42212  P43212 
Rmerge  0.154  0.115  0.116  0.115  0.118  0.118  0.111  0.118        0.118 
LLG  105  160 
No 
solution  5055  780   4.98   4.21  165  125   82   54  521 
 
 
P4322 had the highest LLG of the higher symmetry space groups so a round of rigid body 
refinement was carried out using Refmac 5.  However, this gave an Rfactor of 0.66, so this seemed 
unlikely to be the correct solution. 
 
As there was no obvious solution from the molecular replacement solutions found so far (searching 
for a number of homotetramers), P2 was tried.  This had the lowest Rmerge so far (0.103) and the 
highest LLG (12030), so it was decided to try the higher space groups within P2.  It was also 
decided to search for monomers in the asymmetric unit.  Initially 12 monomers were searched for, 
as this was the most favourable solution given by the Matthews coefficient, but PHASER was 
unable to find 12 monomers.  It did however find 8 monomers. 
 
  P2  P21  P222  P2221  P22121  P212121 
Rmerge  0.103  0.106  0.111  0.111  0.111  0.111 
LLG  12030  10310  10763  21182  low  24276 
 
 
As can been seen in the table above, P212121 gave the best solution.  However, after a round of rigid 
body refinement in Refmac, Rfactor = 0.42 and Rfree = 0.45.  This seemed very high but a round of 
restrained refinement in Refmac was performed, giving Rfactor = 0.29 and Rfree = 0.34.  These 
statistics seemed reasonable, but when the model was viewed in COOT it was found that many of 
the peptide bonds were broken and it was not a good model. 
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No good molecular replacement solution had been found and there was no significant difference 
between the statistics to distinguish a clear solution.  However, with a molecular replacement model 
of 80% sequence similarity to TkTDH, it seemed likely that this was indeed just a case of finding 
the correct space group.  Eventually it was looking at the HKLview for P2 and P4 in detail that 
helped to finally determine the space group. 
 
It was clear from the P4 hk0 view that any given reflection was rotated 90° about the z (l) axis, 
suggesting P4 as opposed to P2.  The 0kl and h0l views showed systematic absences every 2
nd 
reflection along the h and k axis and every 4
th along the l axis, suggesting P41212 or P43212.  It could 
also be clearly seen from the hk0 view that there was a clear diagonal mirror plane suggesting P422 
over P2.  Pointless (CCP4 1994) was also run and this predicted P422 with the data processed in 
both P2 and P4. 
 
Having established that the point group was likely to be 422, and knowing that in previous runs of 
PHASER, P43 was preferred over P42 or P41, a molecular replacement solution was searched for in 
P4322 and P43212.  Initially 8 monomers were searched for, based on previous runs.  However, no 
solutions were found for either space group and both stopped after finding 4 monomers.  
Matthews_coef was run again, searching for 1 homotetramer of 150000 Da, which for both space 
groups suggested there were 4 monomers in the asymmetric unit.  PHASER was again run in P4322 
and P43212, this time searching for 4 monomers in the asymmetric unit. 
 
 
  P4322  P43212 
  8 monomers  4 monomers  8 monomers  4 monomers 
Matthews coefficient  1.75  3.50  1.75  3.50 
Solvent Content  29.79%  64.90%  29.79%  64.90% 
Log Likelihood Gain  No solution  No solution  No solution  15485 
 
 
Thus P43212 was found to be the correct space group, based on the molecular replacement, giving 
an Rmerge of 0.148 and a log likelihood gain (LLG) of 15485.  The corresponding unit cell 
dimensions are a = b = 124.5 Å, c = 271.1 Å. 5 for P43212. 
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  P2 0kl  P2 0kl   
 
   
  P2 h0l  P2 h0l   
 
   
  P2 hk0  P2 hk0   
 
Figure 5.9: HKL view of TDH crystals in P2 space group 
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  P4 0kl  P4 0kl   
 
     
  P4 h0l  P4 h0l   
 
     
 
  P4 hk0  P4 hk0   
 
Figure 5.10: HKL view of TDH crystals in P4 space group 
 
The 0kl and h0l views showed systematic absences every 2
nd reflection along the h and k axis and every 4
th along the l axis, suggesting 
P41212 or P43212.  It could also be clearly seen from the hk0 view that there was a clear diagonal mirror plane suggesting P422 over P2.  
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Data collection and processing information for TkTDH is shown in Table 5 
 
Beamline  ID14 3 (ESRF) 
Wavelength (Å)  0.931 
Space group  P43212 
Unit cell parameters 
a=b (Å)  124.5 
c (Å)  271.1 
Resolution(Å)  73.9 2.4 (2.5 2.4) 
Rmerge
* (%)  11.4 (60.0) 
Completeness (%)  100 (100) 
Average I/σ  18.2 (4.8) 
Multiplicity  15.1 (14.8) 
Number of observed reflections  1001694 (141093) 
Number of unique reflections  66425 (9511) 
Wilson’s B factor (Å
2)  51.3 
Matthew’s coefficient  3.50 
Solvent content (%)  64.90 
Number of molecules in the asymmetric 
unit  4 
 
Table 5: Data collection and processing statistics for TkTDH 
 
 
 
5.4.3  Model Building and Refinement 
Initially rigid body refinement was carried out in Refmac to 2.6 Å, giving an Rfactor = 0.43 and Rfree 
= 0.43.  Using COOT, residues in the model that differed between PhTDH and TkTDH were 
mutated to the correct residues and restrained refinement was done using Refmac, giving Rfactor = 
0.26 and Rfree = 0.32.  The difference between Rfactor and Rfree was greater than the allowed 5 %, and 
when viewed in COOT, it was found that the model was broken in many places. 
 
As it appeared Refmac was not refining this structure well, it was decided to try using CNS instead.  
Refinement was carried out with data to a resolution of 2.4 Å, using CNS (Brunger et. al., 1998).  
Three rounds of simulated annealing up to 4000ºC and rigid body refinement with tight NCS 
restraints between the four subunits, interspersed with model building in COOT, were carried out.  
During the third round, group B factors were also refined.  Two rounds of rigid body refinement 
were then carried out using PHENIX (Adams et. al., 2002) with several cycles of tight NCS 
restraints, lower temperature simulated annealing and translational symmetry restraints, again 
interspersed with model building.  The final seven rounds of restrained refinement were carried out 
Values in parenthesis are for the outer resolution shell.  * Rmerge = ΣhΣi |(Ihi Ih)| / ΣhΣi (Ihi) 
where Ih is the mean intensity of the scaled observations Ihi.  
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using REFMAC 5 (CCP4 1994), with medium NCS restraints.  490 water molecules were added 
and the co factor NAD
+ was built into the electron density using COOT and the structure rebuilt 
using both the 2Fo Fc and Fo Fc maps.  The final Rfactor and Rfree values are 22.0 % and 27.6 %, 
respectively, and the diffraction data and crystallographic refinement statistics are summarised in 
Table 6. 
 
Resolution Range (Å)  73.9   2.4 (2.5 2.4) 
Space group  P43212 
Rfactor (%)  22.0 
Rfree (%)  27.6 
Subunits per asymmetric unit  4 
Number of non hydrogen protein atoms  10672 
Number of water molecules  490 
Wilson’s B factor (Å
2)  42.6 
Average B factor (Å
2)  43.0 
RMSD bond lengths (Å)  0.038 
RMSD bond angles (deg.)  2.968 
Matthew’s coefficient  3.50 
Solvent content (%)  64.90 
Rmerge
* (%)  14.6 (59.0) 
Completeness (%)  100 (100) 
Average I/σ  14.8 (2.7) 
Multiplicity  14.5 (11.8) 
Table 6: Refinement statistics for TkTDH 
 
 
 
Unfortunately the lobe loop regions of helix α3 are very disordered in our model, and the electron 
density is poor.  This high degree of disorder is likely due to the absence of a structural zinc ion, 
which is expected to stabilise the region.  All other areas of the model shown strong electron density 
and the model fits the map well, as illustrated in Figure 5.11. 
 
Values in parenthesis are for the outer resolution shell.  * Rmerge = ΣhΣi |(Ihi Ih)| / ΣhΣi (Ihi) 
where Ih is the mean intensity of the scaled observations Ihi.  
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a)   
 
b)   
Figure 5.11: Electron density for the TkTDH model 
 
 
 
 
 
The figures of the structure were prepared using Pymol.  Areaimol (CCP4 1994) was used to 
calculate the surface area for an individual monomer, a dimer and the biological tetrameric protein.  
Buried surface areas were calculated using CNS (Brunger et al. 1998), and COOT (Emsley and 
Cowtan 2007) was used to generate RMS deviations and align subunits. 
In general there is very good electron density for the TkTDH model, as can be seen in a) for the area around 
residue 188.  However, the electron density around the flexible loop region of α3, as can be seen in b) around 
residue 100.  This is most likely probably due to the loops’ flexibility in the absence of a structural zinc ion. 
2Fo Fc = 1.5σ (blue), Fo Fc =  2σ (red) / 2σ (green) 
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5.5  Structure Analysis 
 
5.5.1  Primary Structure Similarity 
The gene encoding L threonine dehydrogenase, identified in the genome sequence of T. 
kodakaraensis (TkTDH), indicates that the protein comprises 350 amino acid residues.  The protein 
has a molecular mass of 38,016 Da per monomer, as determined by electrospray mass spectrometry.  
As well as displaying high sequence similarity with other characterised TDHs from 
hyperthermophiles; P. abyssi (88 % identity), P. furiosus (88 % identity) and P. horikoshii (87 % 
identity) as determined by a BLAST search, TkTDH is homologous to other TDHs and some 
ADHs, as shown in Figure 5.12. 
 
 
 
 
 
 
This alignment compares TkTDH with TDHs and ADHs from a variety of other organisms.  TkTDH displays 87.4% sequence identity 
with PhTDH (Pyrococcus horikoshii), 87.6% identity with PaTDH (Pyrococcus abyssi), 51.0% identity with TtTDH (Thermoanaerobacter 
tengcongensis), 42.8% identity with EcTDH (Escherichia coli), 26.3% identity with Horse Liver ADH, 28.5% identity with SsADH 
(Sulfolobus solfataricus), 26.9% identity with CbADH (Clostridium beijerinckii), 24.9% identity with TbADH (Thermoanaerobacter 
brockii), 26.7% identity with ApADH (Aeropyrum pernix), 25.9% identity with ScADH (Saccharomyces cerevisiae) and 9.6% identity 
with FfADH (Flavobacterium frigidimaris). 
 
The conserved cysteine residues thought to co ordinate the structural zinc ion are shown in bright green, the conserved Cys and His and 
Glu residues thought to co ordinate the catalytic zinc ion are shown in bright blue and the conserved GxGxxG NAD
+ binding motif is 
shown in pink.  The four hydrophobic residues that form a cluster in some medium chain dehydrogenases are shown in green.  The α 
helical and β strand secondary structure is shown diagrammatically beneath the sequences. 
 
Figure 5.12: TkTDH sequence alignment  
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Amongst the sequences of the aforementioned enzymes are some highly conserved residues, most 
notably the four cysteine residues that coordinate the structural zinc ion (Cys97, Cys100, Cys 103 
and Cys 111), the four residues proposed to co ordinate a catalytic zinc ion (Cys42, His67, Glu68 
and Glu152) and the GxGxxG NAD
+ binding motif (formed by Gly175, Gly 177 and Gly180).  It is 
worth noting that although equivalents to the first three aforementioned residues co ordinating the 
catalytic zinc ion are conserved between TDHs and ADHs, Glu152 is less conserved.  For example 
in E. coli ADH (EcADH) this glutamate residue is substituted for Asp152 and in ApADH this is 
Ala152.  With regards the structural zinc, it is interesting to note that the 15 amino acid sequence of 
TkTDH containing the four cysteine residues 
97CGKCYACKHNRYHVC
111 shows four differences 
(grey shaded region) with the TDH’s of other hyperthermophiles and yet more differences with 
respect to the mesophilic homologues; shown in Figure 5.13 this loop is generally more polar in 
mesophilic enzymes.  The difference in this lobe loop may somehow contribute to the tighter 
binding of the structural zinc to TkTDH compared to P. horikoshii and P. furiosus (unpublished 
data). 
 
 
5.5.2  Structure of the Monomer 
TkTDH exhibits high structural similarity with PhTDH from the hyperthermophile P. horikoshii but 
also has a similar overall fold to medium chain ADHs from mesophilic organisms, as illustrated in 
Figure 5.13.  Superimposition of all 348 C α carbon atoms of the holo form of PhTDH with TkTDH 
reveals an RMS deviation of less than 0.57 Å, indicating how structurally similar these two 
enzymes are.  Although a greater RMS deviation of 1.90 Å is observed between TkTDH and the 
holo form of SsADH, using 300 C α atoms closer than 3.5 Å, this is unsurprising given the low 
sequence homology and still indicates a much higher structural homology than might be predicted 
from the amino acid sequence, which has 29 % identity (Figure 5.12).  
 
138 
 
a)                  b)  
Figure 5.13: Superimposition of TkTDH with PhTDH and SsADH 
 
 
 
 
 
The major functional difference between TDHs and ADHs is the substrate specificity.  Each 
monomer is composed of two domains; a nicotinamide cofactor (NAD
+) binding domain (residues 
153 292), which folds into a classical α/β Rossmann fold motif, characteristic of mononucleotide 
binding proteins and a catalytic domain (residues 3 152 and 293 349).  In total the monomer 
contains 12 α helices and 16 β strands, making up 31 % and 23 % of the structure, respectively.  
The overall topology of the monomer is shown in Figure 5.14 and the assigned secondary structure 
labelling in Figure 5.15 is in keeping with the nomenclature for ADHs (Korkhin et al. 1998). 
 
a) A ribbon diagram showing the fold of a monomer of holo TkTDH (shown in red) aligned by all 348 C alphas with a monomer 
of holo PhTDH (87 % sequence similarity) (shown in pink) with an RMS deviation of 0.57 Å.  b) A monomer of holo TkTDH 
(shown in pale blue) was superimposed on a monomer of holo SsADH (29 % sequence similarity) (shown in blue) with an RMS 
deviation of 1.90 Å for 300 C alpha carbon atoms that are closer than 3.5 Å. 
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Figure 5.14: Overall topology of a TkTDH monomer 
 
 
 
 
Figure 5.15: TkTDH nomenclature 
α helical segments are shown in blue and β strands are shown in red.  The five α helices (A, 
B, C, D, E) and 310S and seven β strands (A, B, C, D, E, F and S) from residues 171 to 290 
form the α/β Rossmann fold of the co factor binding domain. 
This ribbon diagram shows the assignment of nomenclature to the secondary structure of TkTDH and 
indicates the main regions of interest.  Helices 1 4, 6 and 7 and β strands 1 7, 8 and 9 comprise the 
catalytic domain, helices B E and 3
10S and β strands A F and S form the NAD
+ binding domain and helix 
5 acts as a linker between the two.  
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The five helices (A, B, C, D, E) and 310S and seven β strands (A, B, C, D, E, F and S) from residues 
171 to 290 form the α/β Rossmann fold of the co factor binding domain.  Six of these β strands 
make a parallel β pleated sheet flanked by the 5 helices and the seventh β strand.  The catalytic 
domain consists of a core of mostly antiparallel β strands (1 9) with seven α helices (1 7) at the 
surface of the molecule. 
 
The short α3 helix is contained within a protruding lobe loop region containing the 4 conserved 
cysteine residues that are expected to co ordinate the structural zinc ion with tetrahedral geometry, 
on the basis of the PhTDH structure (Ishikawa et al. 2007).  It is thought this may confer further 
thermostability to the enzyme, although this is also present in some mesophilic medium chain 
dehydrogenases.  This region appears disordered in the TkTDH structure; although it is expected 
that in the presence of Zn
2+ it would be more ordered.  There is a long 18 residue α5 helix (residues 
145 to 162, the longest in the molecule, which forms a linker between the two domains, possibly 
acting as a hinge when NAD
+ and threonine bind.  This helix is well defined in the electron density 
map, but is clearly kinked part way along at Pro153, indicating a possible bending site.  Three cis 
peptide bonds are observed in the structure preceding Pro62, Pro194 and Trp297.  Pro62 is highly 
conserved amongst both TDHs and ADHs, as is the cis peptide conformation that it adopts in the 
tertiary structure.  However, both Pro194 and Trp297 appear to only be conserved in TDHs, but not 
ADHs.  Trp297, a rare non prolyl cis peptide observed on the surface of the catalytic domain of 
both TkTDH and PhTDH appears to form part of a hydrophobic cluster with Trp137, Trp300 and 
Tyr301.  The electron density for this region surrounding the cis peptide itself is very well defined 
in both structures.  All four of these hydrophobic residues appear to be conserved amongst TDHs 
from hyperthermophiles, suggesting this may be a contributing factor to their thermostability.  
However, this hydrophobic cluster is not constitutively present in ADHs from hyperthermophiles 
and in some mesophilic ADHs alternative hydrophobic resides constitute this cluster. 
 
Electron density was observed in the cofactor binding domain for NAD
+.  It is thought that binding 
of NAD
+ to TDH causes a conformational change in which residues of the active site are brought 
closer together, thereby enabling threonine to bind and the reaction to occur (Ishikawa et al. 2007).  
This ordered Bi Bi mechanism of binding is supported by the work done with PhTDH (Ishikawa et 
al. 2007;Higashi et al. 2008) and has been reported by Aoyama et. al. 1981.  This binding of 
threonine is thought to cause a further rearrangement of α1 helix into a closed conformation, 
bringing it closer to the active site, as observed in horse liver ADH (HlADH) (LeBrun et al. 
2004;Ramaswamy et al. 1999).  The unstable intermediate 2 amino 3 ketobutyrate leaves the 
enzyme prior to the release of NADH.  
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5.5.3  Structure of the Tetramer 
TkTDH exhibits a homo tetrameric structure within the crystallographic asymmetric unit, with an 
estimated solvent content of 64.9 % (v/v), VM=3.5, and this is believed to be the biologically active 
form of the enzyme, in keeping with many medium chain dehydrogenases of lower organisms.  The 
structure is very similar to PhTDH (RMS deviation 0.57 Å) and, despite low levels of sequence 
identity, is quite structurally similar to PaTDH (87.6 % identity) and SsADH (28.5 % identity) as 
can be seen in Figure 5.16. 
 
 
Figure 5.16: Tetrameric structure of TkTDH compared to PhTDH, PaTDH and SsADH 
 
a) This shows the tetrameric structure of TkTDH as a dimer of dimers with the co factor NAD
+ bound.  Monomer A 
is shown in red, B in green, C in blue and D in yellow.  The overall fold of this enzyme is very similar to that of other 
medium chain dehydrogenases such as b) P. horikoshii TDH, c) P. aeruginosa ADH and d) S. solfataricus ADH, 
with an extended β sheet formed by the Rossmann fold of monomers A and B (and C and D). 
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Essentially the quaternary structure comprises a dimer of dimers.  The formation of dimers between 
monomers A and B (and C and D) buries 1552.6 Å
2 of the 15,425.4 Å
2 accessible surface of each 
monomer, resulting in a solvent accessible surface area of 27,287.8 Å
2 for each dimer.  This dimer 
is shown in Figure 5.17. 
 
 
Figure 5.17: TkTDH dimer of monomers A and B 
 
 
 
 
 
Association of the dimers into a tetramer buries a further 5038.9 Å
2 giving a total accessible surface 
area of 50168.9 Å
2.  Figures similar to those are found for PhTDH (Ishikawa et al. 2007).  As has 
been found in many ADHs and PhTDH, the β strands of the Rossmann fold form an extended 12 
stranded β sheet across the dimer interface to create an extensive region of contact between 
monomers A and B (and C and D).  This binding involves β strands F (residues 273–275) and S 
(residues 287 290) of both subunits, where the βF strand of monomer A forms hydrogen bonds with 
the anti parallel βF strand of monomer B, and likewise βS of A hydrogen bonds the anti parallel βS 
of B.  In addition there is a minor interaction at the structural lobe of helix α3 (95 117) where 
hydrogen bonds and electrostatic interactions bridge the two dimers to form the tetrameric dimer of 
β strands of the Rossmann fold form an extended 12 stranded β sheet across the AB dimer 
interface to create an extensive region of contact between the monomers.  This binding involves β 
strands F (residues 273–275) and S (residues 287 290) of both subunits, where the βF strand of 
monomer A forms hydrogen bonds with the anti parallel βF strand of monomer B, and likewise βS 
of A hydrogen bonds the anti parallel βS of B.  The same is true for monomers C and D.  
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dimers: this interaction buries 1172.1 Å
2 accessible surface area between each monomer in the 
following pairings of A/C and B/D.  This dimer is shown in Figure 5.18. 
 
 
Figure 5.18: TkTDH dimer of monomers A and C 
 
 
 
 
Conversely the opposite monomers of A/D and B/C interact primarily through helices αB and α6 as 
shown in Figure 5.19. 
 
 
Figure 5.19: Interaction of monomers A and D in TkTDH 
The small α3 helix, proposed to contain a structural zinc ion, from each 
of monomer A and C form additional bonds to stabilise the tetramer.  
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Specifically Gly 168 in the loop between α5 and βA of monomer A forms 2 hydrogen bonds with 
Ser 305 (α6) of monomer D and Gly 191 (αB) of monomer A hydrogen bonds Ala 189 (αB) of 
monomer D.  The reverse is also true due to the 2 fold symmetry of the tetramer.  This interface 
buries 1150.4 Å
2 solvent accessible surface on each monomer.  The relatively small areas buried by 
these additional dimer contacts, compared with that of the greater surface area that is buried by 
dimer formation, does justify its description as a dimer of dimers. 
 
 
5.5.4  Structural Zinc Ion 
In TkTDH a structural zinc ion is proposed to bind in the lobe loop, which includes helix α3, 
although the zinc was not observed in this structure.  Most medium chain dehydrogenases contain 
both a catalytic zinc ion at the active site, and a second structural zinc ion located in the lobe loop of 
the catalytic domain where it most likely rigidifies the region (Jelokova et al. 1994), thereby 
conserving interfaces important in stabilising the enzymes’ quaternary structure.  However, the zinc 
content does vary between ADHs with either one or two zinc ions being present per subunit, for 
example Thermoanaerobacter brockii ADH (TbADH) (Bogin et al. 1997) contains only a catalytic 
zinc ion whereas EcADH contains both a catalytic and structural zinc ion (Sulzenbacher et al. 
2004).  The importance and functionality of this zinc ion has been demonstrated with mammalian 
alcohol dehydrogenase, where a structural zinc ion is naturally present, by site directed mutagenesis 
of the four co ordinating cysteine residues.  These mutants were unable to ligate zinc and resulted in 
inactive, unstable enzymes (Jelokova et al. 1994).  However the structural zinc ion is not present in 
ADHs from some organisms such as Thermoanaerobacter brockii (Bogin et al. 1997) and 
Clostridium beijerinckii (Korkhin et al. 1998). 
 
Although catalytically active TkTDH was used in the crystallisation trials, no electron density is 
observed for zinc ions in the structure in either the proposed structural or catalytic positions.  It is 
likely that sodium citrate in the crystallisation conditions may have chelated any bound zinc, 
thereby removing it from the protein.  It was also observed that the ‘lobe loop’ region (97 115) 
exhibited highly disordered electron density and proved difficult to model, indicating that the 
structural zinc is indeed required to stabilise the loop, as observed for PhTDH (Ishikawa et al. 
2007).  It was however observed that the four conserved cysteine residues (Cys97, Cys100, Cys103 
and Cys111) did co localise to a central position large enough to accommodate a zinc ion with 
tetrahedral geometry without disrupting other residues.  Mammalian ADHs, although most 
commonly dimeric, do usually contain both catalytic and structural zinc ions, whereas some  
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bacterial ADHs adopting a tetrameric structure lack the structural zinc ion, suggesting that any 
correlation between the presence of a structural zinc in the lobe loop region, and the oligomeric 
state of the enzyme is not straightforward. 
 
 
5.5.5  Active Site 
Each subunit of the tetrameric TkTDH, like other medium chain dehydrogenases, is formed of two 
domains, the catalytic and NAD
+ co factor binding domains that are linked by helix α5 and the 
residues 290 to 298, forming a cleft between them, as shown in Figure 5.20a.  This deep cleft forms 
a pocket large enough to accommodate both the NAD
+ co factor and threonine substrate. 
 
a)   
b)   
Figure 5.20: NAD
+ binding pocket in TkTDH 
A surface representation shows NAD
+ bound to TkTDH in a deep cleft between the catalytic and co 
factor binding domains, where threonine also binds (not shown) b) the co factor forms extensive 
hydrogen bonds with Leu 179, Ser 198, Glu 199, Arg 204, Leu 266, Leu 268 and Ile 291, as well as 
many Van der Waal contacts with the surrounding residues. 
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In both TkTDH and PhTDH, this cleft has been observed to be less hydrophobic than that in ADHs.  
In ADHs the active site can be identified by the presence of a catalytic zinc ion and although this is 
also present in PhTDH, it was absent from the TkTDH structure.  However, as already discussed, 
the absence of both the structural and catalytic zinc from TkTDH is likely to be due to the chelation 
of zinc by sodium citrate in the crystallisation conditions as opposed to it actually being absent from 
the native form of the enzyme.  Although a catalytic zinc ion is absent from the TkTDH structure, 
the four residues postulated to co ordinate it in PhTDH are conserved (Cys42, His67, Glu68 and 
Glu152) and these are positioned in a formation capable of liganding a zinc ion  The residues 
proposed to form the active site in PhTDH are conserved in TkTDH, as shown in Figure 5.21 
 
 
Figure 5.21: Proposed active site for TkTDH 
 
 
 
 
The co factor occupies the active site pocket and is bound to the protein predominantly by Van der 
Waal interactions and hydrogen bonds with the surrounding amino acid residues (Figure 5.19b).  
There are two sequence features common to NAD
+ binding proteins containing the Rossmann fold; 
the highly conserved amino acid sequence motif GxGxxG and the presence of either Asp or Glu at 
the C terminal end of the second β strand (βB) in the co factor binding domain.  This GxGxxG 
sequence forms a glycine rich loop between the C terminus of the βB strand and the N terminus of 
αA, and forms extensive Van der Waal contacts with the phosphate groups of NAD
+.  Mutations in 
The six residues proposed to be involved in forming the active site in PhTDH (as shown in the image 
above taken from (Higashi et. al. 2008) as conserved in TkTDH and are likely to act in a similar 
manner.  A proton relay mechanism has been proposed as the catalytic mechanism for this enzyme. 
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the conserved glycine residues of this loop have been observed to cause a reduction or elimination 
of enzyme activity (Rescigno and Perham 1994).  In TkTDH, Glu199 is present at the C terminal 
end of β strand E in the co factor domain.  This carboxyl residue is highly conserved amongst 
NAD
+ dependent TDHs and ADHs, but is replaced by Gly in NADPH dependent enzymes (Korkhin 
et al. 1998).  This may be because in NADPH dependent enzymes the N terminal of helix α3 is 
longer by 3 residues, causing a structural adjustment in the region of sheet βB and helix α6 and the 
glycine allows provides extra flexibility to accommodate the additional phosphate group.  
Threonine binds in close proximity to the putative zinc binding site and NAD
+ molecule.  The 
distance between the reactive site of NAD
+ and the conserved putative catalytic zinc binding 
residues of Cys42, His67, Glu68 and Glu152 is approximately 7 Å. 
 
The GxGxxG motif is important for determining substrate specificity for NAD
+, possibly by 
enabling the correct tertiary fold for binding at the active site, but other residues are responsible for 
actually binding the co factor.  As can be seen in Figure 5.20, seven residues are involved in 
forming hydrogen bonds and extensive Van der Waal contacts with the NAD
+.  The mainchain of 
Leu 179 forms two hydrogen bonds, one with the nicotinamide ring and the other with an oxygen of 
the first phosphate group.  The nicotinamide ring is also hydrogen bonded by the mainchains of Leu 
266 and Ile 291, with many contacts also being formed with Asn 156 and Gly 267.  The 
nicotinamide ring was observed to bind in a single conformation as shown in Figure 5.22, unlike 
PhTDH where two alternative conformations were observed with equal occupancy (Ishikawa et al. 
2007).  In this model the NAD
+ was refined with 50 % occupancy. 
 
 
Figure 5.22: NAD
+ electron density in the TkTDH model 
 
Strong electron density was observed at the active site for NADH and this was built into the model 
for each monomer.  The nicotinamide ring was observed to bind in a single conformation, unlike 
PhTDH where two alternative conformations were observed with equal occupancy. 
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The mainchain of Leu 268 binds an oxygen of the first ribose ring and makes many other contacts.  
The second phosphate makes contacts with Pro 178 and Arg 204, and this second residue also 
hydrogen bonds this phosphate and an oxygen of the second ribose ring.  A second hydrogen bond 
is made with this ribose ring by Glu 199, as well as many contacts with Gly 175 and Phe 243.  Arg 
204 is highly conserved amongst TDHs but not ADHs, whereas Glu199 is present in both TDHs 
and ADHs.  Kinetic parameters have been measured for mutant enzymes of PhTDH, in which Glu 
199 and Arg204 were mutated to Ala, and this indicated these residues were indeed very important 
for NAD
+ binding (Ishikawa et al. 2007).  The adenosine ring is hydrogen bound to Ser 198, as well 
as making significant contacts with Pro 200.  A significant effect of these binding contacts is that 
the nicotinamide ring is bound in a slot formed by Leu 179, Leu 266 and Leu 268 and the adenine 
ring by Ser 198 and two water molecules. 
 
A number of hydrogen bonds are also formed between the co factor NAD
+ and water molecules at 
the active site, including one found to be conserved at this site in other di nucleotide binding 
proteins containing a Rossmann fold (Bottoms et al. 2002).  A total of eight water molecules have 
been found to directly hydrogen bond with NAD
+ along its length, most of which form further 
bonds with either residues or other water molecules.  One of these waters is a conserved molecule 
that binds the co factor and three residues.  As can be seen from Figure 5.23, this water molecule 
forms four hydrogen bonds to the oxygen of Gly 175, the nitrogen of Gly 180, the oxygen of Phe 
243 at the C terminal of sheet βD and an oxygen of the first phosphate group of NAD
+ in a 
tetragonal co ordination.  
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Figure 5.23: Conserved water molecule at the NADH binding site 
 
 
 
 
Gly 175 and Gly 180 are the first and third Gly in the sequence GxGxxG found to be conserved 
amongst NAD
+ binding proteins, so this conserved water may perform a role in stabilising the 
phosphate binding loop formed by this motif and an inherent role in the structure of the Rossmann 
fold.  It is interesting to note that di nucleotides have huge hydrogen bonding potential with NAD
+ 
containing 22 polar oxygen and nitrogen atoms.  On average NAD
+ forms around 16 hydrogen 
bonds with the protein (Bottoms et al. 2002) and in the case of TkTDH seven are formed with 
residues and a further eight with water molecules.  This illustrates how important these bridging 
waters may be as a component of di nucleotide recognition and binding. 
 
 
It has been found that a water molecule conserved in di nucleotide binding proteins containing the Rossmann 
fold, is present in TkTDH.  This water forms four hydrogen bonds to the oxygen of Gly 175, the nitrogen of 
Gly 180, the oxygen of Phe 243 and an oxygen of the first phosphate group of NAD
+.  
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5.6  Discussion 
 
5.6.1  Thermostability 
It remains difficult to draw any firm conclusions as to the factors that confer high thermostability to 
hyperthermophilic medium chain dehydrogenase enzymes.  Although the extended 12 stranded β 
sheet between AB and CD surely confers structural stability to the enzyme, this motif is not unique 
to hyperthermophilic medium chain dehydrogenases as it is found in mesophilic enzymes.  It 
appears likely that the rigidity of the enzymes’ structure plays at least some role in their 
thermostability, but it is not possible to determine which residues specifically confer this property.  
Further mutational studies could be carried out to identify key residues. 
 
5.6.2  Complex Formation 
TDH is the first enzyme in a two step metabolic pathway that converts threonine to glycine by 
oxidising L threonine to the unstable intermediate 2 amino 3 ketobutyrate.  With the participation 
of CoA as a co factor, the product is acted on by the second enzyme in the degradation pathway, 2 
amino 3 ketobutyrate CoA ligase (KBL).  The products of this final reaction are glycine and acetyl 
CoA.  These reactions catalysed by TDH and KBL have been shown to be coupled, both in vitro 
and in vivo (Marcus and Dekker 1993), which is probably due to the highly reactive nature of the 
intermediate.  Under aqueous conditions it undergoes spontaneous decarboxylation to form 
aminoacetone and CO2.  Gel filtration has been used to demonstrate a physical interaction between 
the two enzymes and along with fluorescence experiments these findings indicate that two dimers of 
KBL associate with one tetramer of TDH (Tressel et al. 1986).  In this experiment bovine TDH and 
KBL enzymes were used. 
 
Since the three dimensional structure of E.coli KBL is known (Schmidt et al. 2001) we used the 3D 
structure of TDH to model the putative interaction between the two enzymes.  The active sites of 
KBL are approximately 24 Å apart in the dimer.  This corresponds well with the active sites in TDH 
of monomers A and B (or C and D), which are approximately 28 Å apart.  One side of the KBL 
dimer, where the active sites are located, has a marked depression that appears to be complimentary 
to the generally convex surface of the TDH tetramer on the sides where the active sites of dimers A 
and B (or C and D) are exposed.  This indeed suggests that a symmetric complex could be formed  
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by the two enzymes to rapidly metabolise the unstable intermediate by channelling it between them.  
A complex could form with one KBL dimer binding to the AB dimer of TDH and a second KBL 
dimer binding to the CD dimer on the opposite face of the TDH tetramer, as shown in Figure 5.24. 
 
 
 
Figure 5.24: Putative docking of KBL with TDH 
Two dimers of KBL have been docked with one tetramer of TkTDH, showing their proposed complex formation.  Each of the two 
KBL dimers can dock with a dimer of TkTDH at a relative angle of approximately 45º, allowing them to fit onto opposite faces of 
the TDH tetramer.  This brings the respective active sites into close contact (approximately 25 Å from one another).  TDH is 
shown in red and KBL in blue.  This putative complex is shown from the active site end of TDH (a) and a perpendicular view is 
shown in (b).  The product from TDH would be able to travel 25 Å to the KBL active site and would be shielded from solvent. 
a) 
b)  
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An approximate model of the complex has been made by docking the two proteins manually and by 
the use of AutoDock (Morris et al. 1998) to optimise the fit.  It appears that a dimer of KBL could 
open like a pair of jaws, to fit up against the central 12 stranded β sheet of each TDH dimer in the 
tetramer.  The KBL enzyme from E.coli has 41% sequence identity with that from T.kodakaraensis, 
similar to the level of identity between the TDHs from the two organisms, which is 43%.  The 
SWISS MODEL server (Arnold et al. 2006) was used to model the structure of KBL from 
Thermococcus kodakaraensis and the electrostatic potentials calculated, showing a large central 
region of positive charges on the face of the enzyme thought to bind TDH.  An electrostatics model 
of TkTDH bound to NAD
+ showed a partial negatively charged surface at the face where it is 
thought KBL binds, suggesting that electrostatic interactions may play a role in the complex 
formation between TDH and KBL.  Diagrams showing the electrostatic surfaces of these enzymes 
are shown in Figure 5.25. 
 
 
Figure 5.25: Electrostatic surface of TkTDH and KBL 
 
 
 
 
 
The electrostatic surfaces of TDH and KBL.  It can be seen from (a) that although in general the surface charges are relatively 
evenly distributed across the surface of the TDH protein, there is a region of negative charge in the vicinity of the two active sites 
at each end of the tetramer where it is proposed KBL binds.  Conversely, the KBL proteins of both E.coli (b) and T. 
kodakaraensis (c) show regions of positive charge in the centre and across the active sites, suggesting electrostatic interactions 
may play a role in the formation of the TDH KBL complex. 
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5.6.3  Mechanism of Action 
Although our model of TkTDH does not contain either a structural or catalytic zinc ion, the model 
is still consistent with the proton relay system proposed by Higashi et al. (Higashi et al. 2008) as the 
reaction mechanism for TDHs.  The triad of residues (Cys 42, His 67 and Glu 68) proposed to co 
ordinate the catalytic zinc are highly conserved in both TDHs and ADHs, and in our model these 
residues do lie close enough to one another to co ordinate a metal ion.  However, no electron 
density was observed for an ion in this position in either our TkTDH model, or that published for 
PhTDH (Higashi et al. 2008).  This Zn
2+ is proposed to play a critical role in the deprotonation of 
the hydroxyl group of water or threonine substrate in the relay mechanism, so it is essential that 
efforts are made to determine whether this ion is truly present.  The proposed proton relay 
mechanism for PhTDH is shown in Figure 5.26. 
 
 
Figure 5.26: Proton relay mechanism for PhTDH 
 
 
The catalytic zinc atom is supported by a catalytic triad (Cys42, His67 and Glu68) and an ionizable zinc bound water 
molecule bonded to the hydroxyl group of Thr44 in the active site.  Catalytic zinc has a critical role to deprotonate 
the hydroxyl group of water or threonine substrate, and then the deprotonation process is involved in the proton 
transfer through several residues.  
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Currently there exists conflicting evidence as to whether TDHs contain two zinc ions.  Work done 
by Higashi et al 2008. supports the presence of two zinc ions in PhTDH, but biochemical studies 
carried out by Bashir et al. (unpublished work) concludes that only a single zinc ion is present in 
TkTDH.  Further structural research must be carried out to determine whether a catalytic zinc ion is 
present.  These could include further protein X ray crystallographic studies on TDH crystals that 
have been grown in an excess of Zn
2+ and in non metal ion chelating conditions (such as excluding 
sodium citrate).   
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Chapter 6 
 
Summary 
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6.1  Burkholderia pseudomallei invasion protein D 
 
When work began on solving the structure of BipD, none of these Type Three Secretion System 
(TTSS) translocator proteins had been analysed in detail and relatively little information was known 
about them and how they fulfil their many proposed functions.  During the time course of this PhD 
study, we have solved the structure of BipD from Burkholderia pseudomallei and structural models 
are now available for some of its functional homologues such as IpaD from Shigella flexneri, SipD 
from Salmonella spp., LcrV from Yersinia spp., and PcrV from Pseudomonas aeruginosa.  Our 2.1 
Å  model  of  BipD  is  currently  the  highest  resolution  model  available  for  this  protein  and  has 
contributed to the general understanding of how TTSSs work and what role these translocators play.  
X ray  crystallographic  structural  models  have  enabled  proposals  to  be  made  about  putative 
quaternary  structures  for  the  protein,  which  include  a  homodimer,  a  heteropentamer  and  a 
homopentamer.  These represent different possible forms of BipD, all of which may be correct 
depending on the environment in which the protein is functioning and the role that it is fulfilling.  
Studies are continuing to determine the quaternary structures of these translocators, and efforts are 
being made to establish exactly what role they play in bacterial infection of host cells.  It is hoped 
that this structural information will reveal ways in which these translocators can be targeted to 
prevent invasion by the respective bacterial pathogens, thereby halting the spread of diseases. 
 
6.2  2,4’ dihydroxyacetophenone dioxygenase 
 
Although the structure of DAD has not yet been determined, many achievements have been made in 
expressing and purifying soluble protein and crystallisation conditions have been determined for the 
native enzyme, resulting in a low resolution dataset.  It has also been possible to express and purify 
a selenomethionine derivative of DAD, which is necessary for structure determination using X ray 
crystallography,  to  solve  the phase  problem.   Unfortunately  this  derivative  does  not crystallise 
under  the  same  conditions  as  the  native  protein,  so  crystallisation  screens  are  being  set  up  to 
determine suitable conditions.  Upon the successful collection of a selenomethionine dataset it will 
be possible to determine the three dimensional structure of DAD.  Because this enzyme shares 
relatively little sequence homology with any other known dioxygenase, this structure should be 
particularly  useful  in  determining  how  it  is  able  to  fulfil  its  function  and  cleave  its  substrate.  
Because this mechanism is unusual, it will be of benefit in improving our knowledge of how these 
enzymes  function,  as  well  as  contributing  to  our  overall  understanding  of  bacterial  catabolic  
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pathways.    It  is  hoped  that  eventually  enough  will  be  understood  about  how  these  enzymatic 
pathways function to enable the rational manipulation of enzymes to act on substrates other than the 
naturally occurring chemical.  This would be a huge step forward in bioremediation protocols as it 
could allow pollutant hydrocarbons to be removed from the environment as harmless products. 
 
6.3  L threonine dehydrogenase 
 
It is only recently that the three dimensional structures of TDHs have elucidated, revealing a high 
degree of structural homology with alcohol dehydrogenases (ADH).   Like the ADHs, it has been 
proposed that each monomer of TDH contains a structural and a catalytic zinc ion, however, neither 
our structure, nor the other published structure from Pyrococcus horikoshii are sufficient to answer 
this question.  Our model contains neither of the zincs, and the PhTDH model contains only a 
structural zinc ion, but both enzymes have the conserved residues proposed to co ordinate the metal 
ions, and these residues have been revealed to be in conformations that would enable them to fulfil 
this role.  Further work is needed to solve the structures of these enzymes in conditions conducive 
to retaining any bound metal ions, as well as biochemical studies of their activity with and without 
zinc.  The known TDH structures are all from thermophilic organisms, so it is difficult to determine 
which structural factors contribute to the proteins’ thermostability as very high temperatures.  For 
this to be possible, structures of non thermophilic TDH proteins are needed such as that from E. 
coli, which we are also working on crystallising.  This would allow a structural comparison between 
the two types and hopefully some differences could be identified.  The structure of TkTDH has 
given  us  intriguing  insights  into  a  putative  complex  that  the  enzyme  forms  with  2 amino 3 
ketobutyrate CoA ligase (KBL) and the structural nature of substrate channelling in the conversion 
of threonine to glycine that is carried out by these two enzymes.  Modelling studies are continuing 
in the hope that a structurally possible complex can be found. 
 
The structures of BipD and TkTDH have been solved and work is continuing on DAD.  These 
achievements have made available a large amount of structural and functional information that 
would  otherwise  be  inaccessible,  contributing  to  our  overall  understanding  of  these 
macromolecules,  as  well  as  providing  specific  information  that  can  be  applied  to  particular 
challenges.  It has also posed many more interesting and relevant questions that will be followed up 
to  further  elucidate  how  the  structure  of  these  proteins  enables  them  to  fulfil  their  biological 
function(s).  
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Appendix 
 
 
UniProt accession numbers for sequences analysed by NeedleP global alignment with an 
Eblosum62 matrix: 
 
B. pseudomallei:  S. flexneri:  S. typhimurium: 
BipB – Q63K34  SipB – Q56019  IpaB – P18011 
BipC – Q63K35  SipC – Q56020  IpaC – P18012 
BipD – Q63K37  SipD – Q56136  IpaD – P18013 
BopA – Q63K42  SopE2 – Q7CQD4  Icsb – P33546 
BopE – Q63K41     
 
 
 
Buffers and Solutions: 
 
 
Glycerol Stocks   
 
0.3ml glycerol 
0.7ml cells 
dropped into liquid nitrogen 
stored at  80ºC 
 
 
Luria Bertani Medium (1L)   
 
10g bacto tryptone 
5g bacto yeast extract 
10g NaCl 
dissolved in 1L H2O 
 
This was divided into 10ml aliquots and autoclaved.  5 l ampicillin (100mg/ml) was added before 
bacterial inoculation. 
 
 
Ampicillin Agar Plates   
 
LB medium was made as above and 15g bacterio agar added.  This was autoclaved, allowed to cool 
to 40ºC and 500 l ampicillin (100mg/ml) added.  The plates were cooled, dried and stored at 4ºC. 
 
 
( ovagen
   ) Overnight    Express Instant TB Medium (1L)   
 
The 60g sachet was poured into a large growth flask and dissolved in 1L H2O and 10ml glycerol.  
The flask was autoclaved and 500 l ampicillin added. 
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Agarose D A Gel   
 
The gel casing was placed in the running tank to seal both ends.  The gel was made up by 
microwaving the TAE buffer, H2O and agarose to melt the agarose.  This was allowed to cool to 
50ºC and 5 l ethidium bromide was added.  The molten solution was poured into the gel casing to a 
depth of 0.5cm, the comb inserted at one end, and allowed to set.  The gel casing was rotated so the 
samples would run anode to cathode and covered with 1x TAE running buffer.  The prepared 
samples were loaded onto the gel and run at 100mA until the dye was 
2/3 way along. 
 
 
50x TAE Buffer 
24.2g TRIS 
5.71g glacial acetic acid 
3.72g Na2EDTA 2H2O 
 
Agarose Gel 
2ml 50x TAE buffer 
98ml H2O 
1g agarose 
 
1x TAE Running Buffer 
300ml H2O 
6ml 50x TAE buffer 
 
D A Sample Preparation 
5 l 1kb DNA ladder + 3 l 10x Orange G + 2 l H2O 
1 l sample DNA + 3 l 10x Orange G + 6 l H2O 
 
 
SDS PAGE Gel Electrophoresis 12%   
 
The glass plates were cleaned firstly with H2O then methanol, and the small and big plates clamped 
together with a separating strip at each outside edge.  It was important to ensure the bottoms of the 
plates are level to avoid leaks.  The separating solution was made up and cast between the plates 
and filled to the top with methanol to keep the gel level. 
 
Once the gel set, the methanol was blotted off using filter paper.  The stacking gel was made up cast 
immediately on top of the running gel.  The comb was inserted and left to set.  The gel was then 
clamped firmly in to the apparatus and the centre filled up with running buffer.  5 l Sigma wide 
(M4038) molecular weight marker and 10 l samples (boiled and diluted 1:1 with LAMELI sample 
buffer) were loaded into the wells.  The tank was then filled to a depth of 3cm with running buffer 
and the gel run at 24mA for 40 minutes or until the samples reached the bottom.  The gel was 
removed from the plates and left in coomassie blue gel stain for 15 minutes.  This was then placed 
in destain until the bands were clearly visible. 
 
SDS PAGE running buffer 5X 
7.5g TRIS base 0.125M 
36g glycerine 
2.5g SDS (0.5 w/v) 
dH20 to 500ml 
titrated to pH 8.3 
Store @ 4ºC  
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4x TRIS Separating Buffer pH 8.8 
91g TRIS base (1.5M) in 300ml 
H20 adjust to pH8.8 with 1M HCl 
Add dH20 up to 500ml total volume 
Filtered through 0.45ml filter paper 
Add 2g SDS (0.4% w/v) 
 
4x TRIS Stacking Buffer pH 6.8 
6.05g TRIS base (0.5M) in 40ml 
H20 adjust to pH 6.8 with 1M HCl 
Add dH20 up to 100ml total volume 
Filtered through 0.45ml filter paper 
Add 0.4g SDS (0.4% w/v) 
 
12% Separating Gel 
3ml 30% Acrylamide/ N,N1 methylene  bis acrylamide 
1.87ml TRIS pH 8.8 
2.6 ml dH20 
50ml 10% APS 
10ml TEMED 
 
12 % Stacking Gel 
0.65ml 30% Acrylamide/ N,N1 methylene  bis acrylamide 
1.25ml TRIS pH 6.8 
3.05ml dH20 
50ml 10% APS 
10ml TEMED 
 
LAMELI Sample buffer 
8ml of 50% glycerol 
2.5% of 1M TRIS pH 6.8 
0.8g of SDS 
2ml β mecaptoethanol 
3mg bromophenol blue 
7.5ml dH20 
 
Coomassie Blue Gel Stain  
50% (w/v) Tricholoroacetic acid 
0.25% (w/v) Brilliant Blue 
 
Destain 
30% methanol 
10% acetic acid 
 
 
GSTrap Affinity Column Buffer Solutions   
 
Binding Buffer (phospho buffered saline) 
140nM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4 
 
Elution Buffer 
50mM TRIS HCl, 10mM reduced glutathione pH 8.0  
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Solutions for Selenomethionine Growth   
 
M9 Minimal Medium (1L) 
2g NH4Cl 
6g KH2PO4 
13.6g Na2HPO4 
1g MgSO4 
40mg FeSO4 . 7H2O 
 
This solution was autoclaved in 2l conical growth flasks and 12ml 20% (8g in 20ml) filter sterilised 
(0.20 m) glucose was added. 
 
Amino Acid Mix 1 (20ml) 
80mg of each of 16aa (Ala, Asn, Asp, Arg, Cys, Glu, Gln, Gly, His, Ile, Leu, Lys, Pro, Ser, Thr, 
Val) 
=4mg /ml 
Filter sterilise and store at  20ºC 
 
Amino Acid Mix 2 (20ml) 
80mg of each of Tyr, Trp, Phe in 20ml H2O 
adjust pH to 8.0 with NaOH 
=4mg /ml 
Filter sterilise and store at  20ºC 
 
Vitamins (2ml) 
2ml H2O 
2mg – riboflavin, nicitinamide, thiamine and pyridoxine monohydrochloride 
=1mg / ml 
Filter sterilise and store at  20ºC 
 
Selenomethionine (20ml) 
80mg L selenomethionine in 20ml H2O 
=10mg / ml 
Filter sterilise and store at  20ºC 
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